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Abstract 
 
Non-coding RNAs (ncRNAs) have recently emerged as important regulators of gene 
expression and are now appreciated to control development, homeostasis and 
evolution of higher organisms. Natural antisense transcripts (NATs), a form of long 
ncRNA, are fully processed mRNA-like transcripts originating from the opposite 
strand of protein coding genes. NATs are believed to regulate the expression of the 
corresponding sense transcripts and may lead to transcriptional silencing. A few bi-
directionally transcribed genes have been studied extensively. Ectopically expressed 
NATs have also been linked to diseases such as cancer, Alzheimer’s and α-
thalassemia. However, many questions remain about the specific biological roles 
and mechanisms of actions of NATs.  
This study examines a specific sense/antisense system during zebrafish 
embryogenesis where the sense transcript, Slc34a2a, encodes a Na+-dependent 
phosphate transporter. The Slc34a2a sense and antisense (Slc34a2a(as)) 
transcripts demonstrate a reciprocal relationship were both transcripts are expressed 
at a near equal amount at 48 hours post fertilization. Both transcripts locate to the 
same tissues: the pharynx, endoderm, primordial midbrain channel and primordial 
hindbrain channel. No relation was found between Slc34a2a(as) and the paralog 
Slc34a2b. Slc34a2a(as) shares a bidirectional promoter with Rbpja but does not 
undergo simultaneous divergent transcription. 
Ectopic overexpression of Slc34a2a RNA during early embryogenesis caused failure 
to develop a cerebellum. Cerebellar loss lead to behavioral impairments including 
loss of balance and delayed reaction times. Upon investigating the molecular basis 
for the deleterious effect, overexpression of the protein was ruled out via injection of 
a frameshift containing Slc34a2a RNA. Injections of RNA fragments from the 
Slc34a2a locus determined that cerebellar development failure required 
Slc34a2a/Slc34a2a(as) RNA complementarity. The phenotype was rescued by Dicer 
knockdown, indicating short interfering RNA (siRNA) formation through RNAi. 
Mapping and extraction of synthesised and endogenous dsRNA with an anti-dsRNA 
monoclonal antibody was unsuccessful. Additional experiments are required to 
determine the exact function of Slc34a2a(as) in zebrafish embryogenesis though 
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knock-out and methylation studies. Further conditions need be examined to 
determine the specific circumstances under which J2 antibody would be able to 
extract dsRNA from whole fish.  
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Chapter 1. Introduction 
 
1.1 Non-coding RNA  
 
Deoxyribonucleic acid (DNA) is a molecule in which genetic information is stored as 
sequences of nucleotides. This genetic information holds instructions that are 
required for growth, development, reproduction and general operations. However, 
these functions are not directly carried out by the DNA itself but instead by 
ribonucleic acid (RNA) polymeric molecules and/or proteins. DNA, which is double 
stranded and organized into chromosomes within the nucleus of a cell, gets 
transcribed into single stranded RNA by a RNA polymerase. Three RNA 
polymerases exist in eukaryotes and each transcribes differing types of RNA: RNA 
polymerase I transcribes ribosomal RNAs (rRNA), RNA polymerase II transcribes 
small regulatory RNAs and future messenger RNAs (mRNA) whilst RNA polymerase 
III transcribes small RNAs like transfer RNAs (tRNA) (Clancy, 2008). Primary 
transcribed RNA is then usually modified in accordance to its future function. Post-
transcriptional modification can including capping (addition of a 7-methylguanosine 
to the 5’ end with the help of a phosphatase enzyme), splicing (introns are removed 
from the primary RNA transcript by a large spliceosome protein complex) and 3’ 
processing (cleavage of the 3’ end and addition of roughly 250 adenine residues to 
form a poly(A)tail) (Day and Tuite, 1998).  
Information encoded in DNA that is to become protein is first transcribed into 
messenger RNA (mRNA) within the nucleus by RNA polymerase II. This pre-mRNA 
is then subjected to 5’ capping, splicing and 3’ polyadenylation prior to export into 
the cytoplasm for translation. All these post-transcriptional modifications ensure the 
stability of the RNA, prevent degradation and provide it with the necessary 
components for nuclear export and efficient translation (Day and Tuite, 1998). 
Translation, which consists of three phases (initiation, elongation and termination), 
can occur at ribosomes that are free-floating in the cytoplasm, or in the endoplasmic 
reticulum. During initiation, the ribosome assembles around the target mRNA by 
interacting with the 5’ cap. A transfer RNA (tRNA), a short non-protein coding 
adaptor molecule, carries an amino acid to the ribosome as directed by the first 
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three-nucleotide sequence (codon) in the mRNA. During elongation, tRNA transfers 
an amino acid to the tRNA corresponding to the next codon (Clancy and Brown, 
2008). As the ribosomes moves along the mRNA, working with tRNAs, reading the 
three-nucleotide codons, an amino acid chain is formed.  Termination occurs once a 
stop codon is reached which itself does not code for an amino acid but instead 
initiates the release of the polypeptide from the ribosome (Day and Tuite, 1998; 
Clancy and Brown, 2008).  
Non-coding RNAs (ncRNAs), otherwise occasionally known as non-messenger 
RNAs (nmRNAs), are RNA transcripts that do not get translated into proteins. The 
exact number of ncRNAs encoded within the human genome remain unknown, but 
bioinformatics and transcriptomic studies have found that they are highly abundant 
and most likely number in the thousands (Bertone et al., 2004; Washietl et al., 2005; 
Jeggari et al., 2012). In the latest figures from Ensembl, 22,219 ncRNAs have been 
found in humans. As only ~1.5% of the mammalian genome encode proteins, it 
would appear as if the rest is either devoted to RNA-based regulatory circuitry or is 
just transcriptional noise (Venter et al., 2001; 'Initial sequencing and comparative 
analysis of the mouse genome,' 2002). ncRNAs come in many forms; combinations 
of long/short, sense/antisense and functional/non-functional features make up a 
plethora of ncRNA transcripts as seen in Table 1.1. It is of no surprise that with so 
many diverse features, ncRNAs have a multitude of functions including involvement 
in translation, splicing, DNA replication, gene regulation, chromatin structure and 
genome defence (table 1.1). It has been hypothesised that it is this second tier of 
gene expression regulation via ncRNA that gives higher eukaryotes their complexity, 
cogitative ability and evolutionary plasticity (see works by John Mattick including 
(Mattick, 2001; Barry and Mattick, 2012; Amaral et al., 2013)). Being responsible for 
many vital biological processes also means that structurally altered or mis-regulated 
ncRNAs are often implicated in disease. Many ncRNAs have been linked to ailments 
such as cancer (Matouk et al., 2007), neurodegenerative disorders (review: (Salta 
and De Strooper, 2012)), Alzheimer’s disease (review: (Tan et al., 2013)), Prader-
Willi syndrome (Galiveti et al., 2014), autism (Velmeshev et al., 2013) and even 
hearing loss (Mencia et al., 2009).  Even though many ncRNAs remain to have their 
function validated, it is still possible that many are non-functional products of 
spurious or pervasive transcription.  
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Table 1.1 Main features and functions of different types of non-coding RNAs. It 
is important to note that RNAs can fall in more than one category, for example 
microRNA can be classified as non-coding RNA and extracellular RNA. 
Abbreviations; bp: base pairs, nt: nucleotides.  
Name Acronym Features Main functions 
Long non-coding 
RNA 
lncRNA Over 200 bp in 
length, can be 
transcribed from 
positive and 
negative strands 
Epigenetic regulation (imprinting, X-
chromosome inactivation, telomere 
maintenance) gene transcription 
regulation, post-transcriptional 
regulation (Wilusz et al., 2009). 
Transfer RNA tRNA 79-90 nt in length in 
eukaryotes 
Link between mRNA and amino 
acids during translation. 
Ribosomal RNA rRNA Range in size from 
121-5070 nt in 
eukaryotes 
Constitute part of the ribosome, 
catalysing peptide bond formation 
during translation. 
Small nucleolar 
RNA 
snoRNA 60-250 nt in length. 
Depending on class, 
contain conserved 
boxes C, D or H.  
Guide chemical modification of other 
RNAs through methylation and 
pseudouridylation (Scott and Ono, 
2011). 
Micro RNA miRNA Derive from hairpin 
structures, about 
21-24 nt in length.  
Function in RNA silencing and post 
transcriptional gene expression 
regulation. 
Short interfering 
RNA 
siRNA Derive from double 
stranded RNA, 21-
23 nt in length 
Gene regulation through RNAi, 
chromatin structure. 
Small nuclear 
RNA 
snRNA Usually around 150 
nt in length 
Processing pre-messenger RNA, 
telomere maintenance, regulate 
transcription factors. 
Extracellular 
RNA 
exRNA Various lengths and 
orientations 
possible 
Function not fully understood but 
linked to syntrophy, intercellular 
communication and cell regulation. 
Piwi-interacting 
RNA 
piRNA 26-31 nt in length. 
Form RNA-protein 
complexes through 
piwi proteins 
Epigenetic and post transcriptional 
silencing of retrotransposons. 
Subspecies include rasiRNAs (Rajan 
and Ramasamy, 2014). 
Small Cajal body 
RNA 
scaRNA Resemble snoRNAs RNA maturation of snRNAs in Cajal 
bodies of the nucleus. 
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1.2 Natural antisense transcripts  
  
Natural antisense transcripts (NATs) can be classified as a subcategory of long non-
coding RNAs. NATs, which are naturally occurring fully processed mRNA-like 
transcripts originating from the opposite strand of protein coding genes, share 
sequence complementary with other endogenous RNA transcripts. Two types of 
NATs occur; cis-NATs and trans-NATs. Cis-NATs are transcribed from the same 
genomic loci as the cognate sense transcripts whilst trans-NATs are transcribed 
from a different genomic location with respect to their partnering sense transcript. 
Another type of closely related antisense transcripts exist; the so-called non-
overlapping antisense transcript (NOTs) are transcribed from the same genomic 
locus as the sense transcript but after processing do not share sequence 
complementarity with the sense RNA (Figure 1.1). Thus, NOTs can act like NATs at 
the transcriptional level but no so after splicing. NAT biogenesis involves the same 
transcriptional machinery as the sense strand partner involving RNA polymerase II 
(Sigova et al., 2013). Antisense and sense partner strands can be found in three 
different orientations as exemplified in figure 1.1; in complete overlap, tail to tail 
where the 3’ ends of the transcripts overlap or head to head where the 5’ ends align. 
  
 
 
Figure 1.1 Representation of the different arrangements in which cis- natural 
antisense RNA transcripts (cis-NATs) can be found in relation to their cognate 
sense transcripts. Boxes represent exons. Antisense transcripts do not always 
align with the sense RNA after processing and these are known as non-
overlapping transcripts (NOTs).  
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Comprehensive studies predict that in humans and mice, respectively, 40-72% of all 
transcriptional units show evidence of bi-directional transcription (Chen et al., 2004; 
Katayama et al., 2005b). A few of these bi-directionally transcribed genes have been 
studied in detail such as fibroblast growth factor (Baguma-Nibasheka et al., 2012), α-
globin (HBA) (Tufarelli et al., 2001), β-secretase (Faghihi et al., 2008; Faghihi et al., 
2010), low-density lipoprotein receptor-related protein 1 (Lrp1) (Yamanaka et al., 
2015) and brain-derived neurotrophic factor (BDNF) (Modarresi et al., 2012) but the 
list is quickly growing. Several approaches were used to identify these antisense 
transcripts, either by annotating cDNA clones to genome sequences or by applying 
the BLAST algorithm between complete mRNA or expressed sequence tag (EST) 
sequences. To date, more than 2000 human cis-NATs, 2400 mouse cis-NATs and 
>1000 Drosophila cis-NATs are predicted to exist in the respective genomes (Lehner 
et al., 2002; Cheng et al., 2005; Katayama et al., 2005a). 
 
 
1.3 Natural antisense transcript functions 
 
NATs have been shown to control development and homeostasis in bacteria, plants 
and mammals, and are thought to do so by regulating the expression of the 
corresponding sense transcript (see reviews (Faghihi and Wahlestedt, 2009; 
Esteller, 2011; Piatek et al., 2016)). However, the concrete mechanisms by which 
this occurs is intensely researched and evidence so far has identified a number of 
possibilities. Current theories as to how NATs regulate gene expression are through 
transcriptional interference, RNA masking, double-stranded dependent mechanisms 
and methylation/ chromatin remodeling (figure 1.2). However, as the NAT field is still 
young, it is possible that unknown mechanism through which NATs function are yet 
to be determined. Nevertheless, since NATs can regulate gene expression to such 
an extent, it is not surprising that some ectopically expressed NATs have been 
linked to diseases such as cancer, Alzheimer’s and α-thalassemia (Tufarelli et al., 
2003; Guo et al., 2006). Moreover, viral antisense transcripts have been linked to 
disease progression, for example in HIV pathology (Saayman et al., 2014). 
Therefore, understanding their individual functions and the mechanisms through 
which they act, is pivotal in generating new forms of therapeutics in this growing 
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antibiotic resistant world. A prime example includes that of Davet syndrome, which is 
a disorder caused by a heterozygous mutation in the SCN1A gene that codes for the 
pore-forming alpha subunit of the voltage gated sodium channel Nav1.1 in the brain. 
In mice and non-human primates, knocking down the cis-NAT of SCN1A 
(SCN1ANAT) with oligonucleotide-based compounds (AntagoNATs), SCN1A levels 
increased which in turn alleviated the disorders symptoms (improvement in seizure 
phenotype and excitability of hippocampal interneurons) (Hsiao et al., 2016).  
 
 
 
 
 
Figure 1.2 Representation of the different mechanisms by which cis-natural 
antisense transcripts (NATs) can regulate gene expression. A) Transcriptional 
interference; B) RNA masking; C) double strand dependent mechanisms such as 
RNA editing and RNA interference; D) antisense-induced methylation and 
chromatin remodeling. Figure modif ied from (Lavorgna et al., 2004). 
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1.3.1 Transcriptional interference 
 
Transcriptional interference (TI) is defined as the suppressive influence of one 
transcriptional process directly on a second transcriptional process in cis (Shearwin 
et al., 2005). This does not include processes such as promoter methylation, binding 
of repressors to operators overlapping a promoter, chromatin remodeling or 
obstructing the elongation process of RNA polymerase by DNA-bound obstacles. 
Simply, the idea is that since the transcriptional machinery is large and ‘bulky’, it is 
therefore unlikely for two overlapping transcriptional units to be transcribed 
concurrently. Accordingly antisense transcription would lead to a decrease in 
transcription of the sense transcript. Potentially NAT induced TI may be widespread 
but to date very few established examples exist outside of Neurospora crassa (Xue 
et al., 2014), Saccharomyces cerevisiae (Wang et al., 2014) and Escherichia coli 
(Sneppen et al., 2005). To date, two established examples exist in higher 
eukaryotes. In mice, maternally expressed Murr1 is regulated by the antisense 
U2af1-rs1 (Wang et al., 2004) whilst in resting human peripheral blood T cells, a 
NAT whose start site is located 450 bases downstream regulates the transcription of 
the eukaryotic initiation factor (eIF) 2 alpha (Silverman et al., 1992). Alternatively, 
experimental manipulation of systems, both intentional and unintentional, can result 
in TI (Proudfoot, 1986; Eszterhas et al., 2002; Prescott and Proudfoot, 2002). 
Consequently, systems in which TI is visualized must therefore be tightly controlled 
and validated to confirm that TI is not an unintentional forced artifact of the system 
being handled.  
 
 
1.3.2 RNA masking 
 
This mechanism centers on the formation of duplexes between sense and antisense 
transcript pairs that then can provide a physical barrier against post-transcriptional 
interactions (Wight and Werner, 2013). For example, binding of an antisense 
transcript to the sense RNA may ‘mask’ critical regulatory motifs such as splice sites 
or miRNA-binding sites. This in turn would inhibit binding of other trans-acting 
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factors. Therefore any processes such as mRNA splicing, polyadenylation or 
translation along with RNA stability could be affected.  
In higher eukaryotes, many examples of how NATs function in RNA masking have 
been established and validated. However only two examples have been determined 
thus far to be involved in alternative splicing. Human thyroid hormone receptor-α 
gene (THRα) has two isoforms, of which, only one is fully active (THRα1). The 
second spliceform, THRα2, binds the hormone but does not trigger a downstream 
response. The splicing of the primary transcript is influenced by the antisense 
transcript RevErbAα whose expression correlates with the synthesis of the inactive 
isoform (Munroe and Lazar, 1991; Hastings et al., 1997). Secondly, the 
transcriptional repressor Zeb2, which down-regulates epithelial cadherin expression 
in turn affecting epithelial-mesenchymal transition, has its own expression regulated 
by a NAT. A large intron at the 5’end of the sense transcript (Zeb2 mRNA) is 
retained when the NAT is bound (Beltran et al., 2008). 
Protein and RNA stability can be both positively and negatively affected by NATs 
during RNA masking. In the case of Alzheimer’s disease (AD), multiple NATs have 
been linked to disease progression and severity. One of these NATs works via a 
RNA masking mechanism. The antisense transcript for β-site amyloid precursor 
protein-cleaving enzyme 1 (BACE1), whose levels are elevated in the brains of AD 
patients, affects BACE1 stability through two different processes both involving RNA 
hybridization; RNA duplex formation not only alters the secondary structure of 
BACE1 to increase stability but also masks a miRNA binding site which prevents 
BACE1 mRNA degradation (Faghihi et al., 2008; Faghihi et al., 2010). The stability 
of inducible nitric oxide synthase (INOS), an important gene in inflammatory 
diseases, is affected by its cis-NAT interacting with the 3’ end of human antigen R 
(ELAV1) RNA (Matsui et al., 2008). Interestingly, an antisense transcript (aHIF), 
which is complementary to hypoxia inducible factor (HIF-1α) mRNA, destabilizes the 
protein-coding sense transcript by exposing AU-rich sequences which consecutively 
would lower tumours growth and progression (Uchida et al., 2004).   
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1.3.3 Double stranded RNA-dependent mechanisms  
 
Once transcribed and processed, NATs can form dsRNA with their sense partner. 
Depending on the cellular location, dsRNA can affect gene expression through RNA 
editing or gene silencing pathways such as RNA interference (RNAi). During RNA 
editing, long duplexes with near perfect complementarity are hyper-edited so that up 
to 50% of adenosines are deaminated by an enzyme of the ADAR protein family. 
Deamination can lead to either retention in the nucleus by the RNA binding protein 
p54nrb multiprotein complex or degradation by a cytoplasmic endonuclease (Kumar 
and Carmichael, 1997; Zhang and Carmichael, 2001). However, since RNA editing 
seems to preferentially target intronic stem loops, this suggests RNA editing occurs 
predominantly co-transcriptionally (Neeman et al., 2005). Therefore, as majority of 
NATs are processed, mRNA/ endogenous NAT hybridization would occur post-
transcriptionally (Bass, 2002). Consequently, only one example can be provided; 
mouse ubiquitin carboxyl-terminal hydrolase L1 (Uchl1), a gene involved in brain 
function and neurodegenerative disease, is controlled by antisense Uchl1 which is 
found in a  head to head orientation and contains two embedded repetitive 
sequences of SINEB1 and SINEB2 (Carrieri et al., 2012). Various other reports fail 
to provide evidence of RNA editing of sense/antisense complementary regions in 
mammals (see review: (Lavorgna et al., 2004)).  
In RNAi, cytoplasmic dsRNA is recognized by the enzyme Dicer which is responsible 
for cleaving the dsRNA into short 21-23 nucleotide duplexes which in conjunction 
with a protein of the Argonaute family exhibit a regulatory function. RNAi was first 
discovered in Caenorhabditis elegans in 1998 (Fire et al., 1998) but has since been 
reported in plants, fungi and certain higher eukaryotes (nematodes and fruit fly) 
(Cogoni and Macino, 2000; Waterhouse et al., 2001).  RNAi and Dicer dsRNA 
products, along with their pathways, are discussed in more detail in section 1.4. 
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1.3.4 Chromatin remodelling   
 
NATs are also involved in epigenetic regulation of transcription through mechanisms 
such as DNA methylation and chromatin modification, which may in turn induce 
monoallelic expression. The exact mechanisms of action as to how NATs induce 
methylation or cause chromatin changes are still unclear, but several established 
occurrences have been discovered in higher eukaryotes including mice and humans.  
In the case of imprinted genes, which tend to be found in clusters in human and 
mouse genomes, certain antisense RNAs recruit repressor complexes to inactivate 
chromatin. This is how insulin-like growth factor type 2 receptor (Igf2r) (by the 
antisense RNA Airn) (Sleutels et al., 2002) and the imprinting control region of 
Kcnq1 are regulated (by the antisense RNA Kcnq1ot1) (Pandey et al., 2008). In 
mouse studies, when Airn was shortened, both alleles from both parents were active 
resulting in small sized offspring being born showing the importance of the antisense 
transcript (Sleutels et al., 2002). Tumour suppressor gene p15 is too affected by a 
cis-NAT; p15-NAT expression led to heterochromatin formation and transcriptional 
silencing of the sense p15 transcript (Yu et al., 2008). A NAT has also been 
implicated in X chromosome inactivation; Tsix (X inactive specific transcript, 
antisense) silences Xist (X inactive specific transcript) through chromatin structure 
remodelling in the Xist promoter region (Ohhata et al., 2008).  
As mentioned previously, many NATs have been implicated in disease progression 
and severity including Alzheimer’s disease (AD). Low-density lipoprotein receptor-
related protein (LRP) 1 and its spliced cis-NAT, LRP1-AS, regulate one another 
negatively. LRP1 is important in a variety of physiological processes such as cellular 
transport of cholesterol, transcytosis across the blood-brain barrier and in the 
systemic clearance of AD amyloid-beta. LRP1-AS, which is higher in AD patients, 
directly binds to high-mobility group box 2 (HMGB2) and inhibits the activity of 
HMBG2 to enhance SREBP1A-dependent transcription of LRP1.  Therefore, the 
increase levels of LRP1-AS in AD patients cases lower transcription levels in LRP1, 
consequently progressing the disease (Yamanaka et al., 2015). In certain cases of 
α-thalassemia, an inherited autosomal recessive anaemia, a chromosomal deletion 
disturbs the normal production of the α-globin gene (HBA2); an antisense HBA2 RNA 
transcript is produced which in turn causes the methylation of the HBA2 CpG island 
consequently silencing the intact gene (Tufarelli et al., 2003).  
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There too remain examples that are not fully understood, such as in the case of the 
antisense Paupar and Interleukin 1 antisense transcripts, which are known to affect 
or act as regulatory elements for protein-coding genes. The central nervous system 
expressed lncRNA Paupar, is located antisense and upstream to Pax6 which is 
required for eye and diencephalon specification. Knockdown of Paupar disrupts the 
normal cell cycle of neuroblastoma cells and induces neural differentiation. Paupar, 
however not only acts in cis to regulate Pax6 RNA levels but has also been found to 
regulate genes on multiple chromosomes by in part interacting with the Pax6 protein. 
Paupar binding sites have been located next to several protein-coding gene 
promoters and therefore it remains to be determined how the antisense Paupar 
works as a regulatory element (Vance et al., 2014). In the case of Interleukin 1 (IL-
1α), which is lowly expressed in resting macrophages, IL-1α and its antisense are 
found in cis and have a concordant relationship. IL-1α levels need to be tightly 
regulated since high levels can cause tissue damage. However, in the case of 
infection, IL-1α levels need to go up and this is done via the antisense transcript 
which, through a yet undermined pathway, acts by recruiting RNA polymerase II to 
the initiation site of IL-1α (Chan et al., 2015).  
 
 
1.4  RNA interference 
 
RNA interference (RNAi), is a process that leads to post-transcriptional gene 
silencing (PTGS) where gene expression is inhibited in a sequence-specific manner. 
The RNAi pathway is found in most eukaryotes including zebrafish (Schyth, 2008), 
mice (Watanabe et al., 2008) and humans (Schwarz et al., 2002) but was first 
demonstrated in the worm, C elegans (Fire et al., 1998). Essential to this process 
are the type III ribonucleases Drosha and/or Dicer which cleave the dsRNA 
precursors along with the endonuclease Argonaute 2 (Ago2) which is part of the 
RNA-Induced Silencing Complex (RISC) (Matranga et al., 2005). The RNAi pathway 
is affected and slightly differs depending on the source of dsRNA and in which 
organism RNAi is taking place. Double stranded RNA can come from three places. It 
can be endogenous like the transcription of inverted repeats which in turn get 
processed into microRNA. Secondly, via Watson-Crick base pairing, endogenous 
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long dsRNA can form between RNA sharing sequence complementarity, such as in 
the case of sense/antisense transcripts which then get processed into endogenous 
short interfering RNAs (endo-siRNAs). Thirdly, dsRNA can be exogenous such as in 
the case of viral infection. RNAi plays a critical role in plant and insect resistance 
against viruses, however, in mammals, RNAi as an antiviral defence mechanism has 
yet to be validated (Burgess, 2013).    
MicroRNA (miRNA) biogenesis involves RNA polymerase II transcribing long RNA 
precursors called pri-miRNAs. Majority of pri-miRNAs tend to come from introns of 
their pre-mRNA host genes (Lee et al., 2004). The pri-miRNAs get post-
transcriptionally processed in such that a 5’ cap and poly(A) tail are added before 
processing by the microprocessor complex consisting of the RNAse III enzyme 
Drosha and double stranded RNA binding protein Pasha / DGR8 (Han et al., 2006). 
The result is pre-miRNAS that are roughly 70 nucleotides long that fold perfectly 
back on themselves to form stem loops (hairpin like structures). Exportin 5 and RAN-
GTP complex export the processed pre-miRNAs into the cytoplasm for further 
processing by the type III ribonuclease Dicer (Han et al., 2006). Dicer produces 
miRNAs by cleaving the hairpin like structures into 21-23 nucleotide double stranded 
fragments, with two nucleotide overhangs on the unphosphorylated 3’ ends (Billy et 
al., 2001; Lee et al., 2003). Dicer also activates the RISC ribonucleoprotein complex 
which contains proteins from the Argonaute (Ago) family. The dsRNA duplex is 
bound by the endonuclease Argonaute 2 (Ago2) and once within the active site of 
Ago2, one strand, the passenger strand, gets cleaved and released (Matranga et al., 
2005). The other single strand, known as the guide strand, remains bound to the 
RISC complex. It is hypothesized that strand selection is based on either the position 
of the stem loop in Dicer and/or the thermodynamic instability and weaker base 
pairing on the 5’ end relative to the opposing strand (Schwarz et al., 2003). The 
guide strand is then used to find its mRNA target through either complete or 
incomplete base pairing which in turn can then lead to either mRNA degradation, 
translational repression or deadenylation (Martin et al., 2014). For example, by 
complete complementarity, miR16 causes the degradation of many unstable mRNAs 
like TNF alpha, microtubule-associated protein 7 (MAP7) and PR domain containing 
4 (PRDM4); the miRNA/RISC complex binds the AU-rich element in the unstable 
mRNAs (Jing et al., 2005; Yan et al., 2013).  
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The endo-siRNA RNAi pathway is slightly different from miRNA RNAi. Firstly 
Drosha, Pasha and DGR8 are not involved. Dicer works to cleave both endogenous 
and exogenous long dsRNA into short ~21 nucleotide endo-siRNA duplexes. Ago2 
and the RISC complex bind to the duplex and, just like with miRNAs, the passenger 
strand gets cleaved and released whilst the guide strand remains in the complex. 
The siRNA within the RISC complex hybridises to its target messenger RNA via 
complete sequence complementarity which in turn initiates mRNA cleavage by the 
Ago2 within the complex (Matranga et al., 2005).  However, unlike miRNAs which do 
not require perfect complementarity to their target mRNA to induce cleavage or 
translational repression, siRNAs do require perfect binding to their target to induce 
cleavage (Chu and Rana, 2006). 
There is still speculation about where in the cell the endo-siRNA RNAi pathway 
occurs. In cell line studies, such as those using Hela cells, RISC and Ago proteins 
were found to be both in the cytoplasm and the nucleus (Berezhna et al., 2006). 
Contradictory, in vivo studies claim that endo-siRNAs, just like microRNAs, get 
processed by Dicer and get incorporated into RISC only in the cytoplasm (Much et 
al., 2016). Therefore, unlike the fairly well understood miRNA pathway, much work is 
left to be done in the field of endo-siRNA generation and function. However, 
endogenously occurring siRNA existence and importance can no longer be disputed. 
High levels of endo-siRNAs have been found in developing haploid sperm cells 
where NATs are predominantly expressed. These NATs form long dsRNA with their 
sense partners and are processed via Dicer into these endo-siRNAs where they 
function in genomic quality control (Wight and Werner, 2013; Yuan et al., 2016).  
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Figure 1.3 Representation of the main steps of RNA interference (RNAi)  
relevant to this thesis. Dicer recognises double strands formed between sense 
and antisense RNA pairs (1) (2) and cleaves the dsRNA into short interfering 
RNAs (siRNAs) of 21-23 nucleotides (3). The siRNAs are incorporated into the 
RNA-Induced Silencing Complex (RISC) (4) where the passenger s trand gets 
cleaved. The guide strand is used to locate the target RNA (5) for degradation 
(6). 
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1.4.1 Interferon immune response  
 
To fight infection, cells have developed a sensitive and intricate defence system that 
comprises of adaptive and innate immune responses which can ultimately lead to 
programmed cell death (apoptosis).  A group of signalling proteins, interferons (IFN), 
are made and released by a host cell in response to invading pathogens including 
viruses, bacteria, parasites and even cancerous cells (Perry et al., 2005; Fuertes et 
al., 2013). During viral infection and in some cases bacterial infection, a major by-
product of replication is double stranded RNA (Kawashima et al., 2013; Hoffmann et 
al., 2015). Once cytoplasmic dsRNA is detected by protein kinase R, a chain of 
events is activated including inhibition of protein synthesis and transcriptional 
induction of interferons, consequently leading to apoptosis of the infected cell. 
Cytokines, including interferons, communicate to neighbouring cells to increase their 
protective defence mechanisms. Thus, dsRNA-activated immune pathways are 
crucial to a healthy immune system (Kawashima et al., 2013).  
The role of RNAi in plants, nematodes and arthropods as an antiviral response is 
well established. However, the purpose of RNAi in higher eukaryotes such as 
mammals, remains controversial. For example, infection of mammalian somatic cells 
with different viruses followed by deep sequencing of small RNAs failed to find 
evidence of virus-derived siRNAs (Parameswaran et al., 2010). Nevertheless, the 
RNAi pathway has become a powerful tool in discovering gene function in higher 
eukaryotes. Studies have found that siRNAs can induce the interferon response 
pathway both in vivo and in vitro (Hornung et al., 2005; Judge et al., 2005; Sioud, 
2005). Therefore, if RNAi is to be further used within molecular and medical 
sciences, understanding how dsRNA can initiate or bypass the immune system is 
vital. To date, it appears as if siRNA activation of immune cells depends on a 
combination of siRNA sequence and cell type. For example, toll-like receptor 3 
(TLR3) is involved in a siRNA induced interferon response, but not all immune cells 
express TLR3 (Karikó et al., 2004). It also appears that siRNA under 30 bp fail to 
activate protein kinase R (PKR). When PKR is activated by dsRNA, it leads to a 
global inhibition of protein synthesis (Judge et al., 2005; Sioud, 2005). However, with 
the recent establishment of endogenous dsRNA existence, such as sense/antisense 
RNA pairing, it begs to questions how not all dsRNA activates an innate immune 
response. 
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1.5  The sodium phosphate cotransporter family  
 
The extracellular concentration of phosphate (Pi) needs to be tightly regulated and 
maintained in mammals as it is important for healthy body function; from bone 
formation to intercellular cell signalling and DNA formation. There are different 
sodium-phosphate cotransporters; the Slc17 family also known as Type I sodium-
phosphate cotransporters, the Slc34 family known as Type II and Slc20 family which 
is Type III (Alexander et al., 2015). There are also other families of cotransporters 
that can influence Pi concentration such as members of the Slc25 and Slc37 family 
(Alexander et al., 2015). The RNA transcripts of interest for this study come from 
Slc34 family genes. Topological modelling of proteins from this family have been 
found to have eight transmembrane domains with both C- and N- termini being in the 
cytoplasm (Murer et al., 2004). The Slc34 sodium phosphate cotransporter family in 
humans and mice comprises of NaPi-IIa, NaPi-IIb and NaPi-IIc (table 1.2) 
(Alexander et al., 2015). In the zebrafish genome, there are four Slc34 genes; 
Slc34a1a (chromosome 14), Slc34a1b (chromosome 21), Slc34a2a (chromosome 1) 
and Slc34a2b (chromosome 23). Slc34a2a and Slc34a2b are occasionally otherwise 
known as NaPi-IIb1 and NaPi-IIb2 respectively. All these members transport 
exclusively phosphate ions in a sodium-dependent manner and are located at the 
apical surfaces of epithelia, predominantly in the intestine and renal proximal tubules 
(Murer et al., 2004).  
 
Table 1.2 Members of the Slc34 Type II sodium phosphate cotransporter family.   
Protein name NaPi-IIa NaPi-IIb NaPi-IIc 
Human gene 
name 
SLC34A1 SLC34A2 SLC34A3 
Substrates Inorganic 
phosphate/ 3 Na 
ions 
Inorganic phosphate  
/3 Na ions 
Inorganic 
phosphate  /2 Na 
ions 
Charge transfer Electrogenic Electrogenic Electroneutral 
Location of 
expression 
Kidney, 
osteoclasts,  
Small intestine, lung, 
testis, liver, secreting 
mammary gland 
Kidney 
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The gene of interest for this PhD is Slc34a2, which is well conserved in many 
organisms including C. elegans, Xenopus laevis, mice and humans (Werner and 
Kinne, 2001). The model organism for this study, zebrafish (Danio rerio), a 
stenohaline freshwater teleost, expresses two paralogs of the Slc34a2 cotransporter; 
Slc34a2a and Slc34a2b (Nalbant et al., 1999; Graham et al., 2003). Repetition of the 
two loci as a result of a partial genome duplication was confirmed by the recent 
sequencing of the zebrafish genome. At the amino acid level, the two proteins are 
66% identical (Graham et al., 2003). However, the main interest of this work lies in 
the natural antisense transcript that is transcribed from the Slc34a2a gene locus. 
Remarkably, even though the genomic structure of the Slc34a2a sense transcript is 
conserved amongst species, the antisense is not. The Slc34a2a antisense transcript 
has been found in zebrafish, flounder, mice and humans, but in each case, the NAT 
is spliced differently giving various lengths and areas of sequence complimentary 
with the sense strand (figure 1.4) (Piatek et al., 2016). 
 
 
 
Figure 1.4 Schematic representation of the sodium phosphate cotransporter 
gene Slc34a2 and its antisense transcript in various vertebrates.  Transcript 
length and exon sizes (boxes) are not to scale. Even though the sense 
transcript is conserved, the antisense is not. For each antisense transcript, 
there is at least one region of sequence complementarity (highlighted in grey). 
Figure modified from (Carlile et al., 2009).  
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Even though transcribed from the same region of chromosome 1, the sizes of 
Slc34a2a and Slc34a2a(as) transcripts differ significantly. The sense transcript 
contains 2,607 bases (encoding a protein of 631 amino acids) whilst the antisense is 
about half the size at 1,351bp. The Slc34a2b transcript is 2,048bp encoding a 
protein of 642 amino acids.  The Slc34a2a(as) transcript has exonic regions 
spanning all the way to the adjacent protein Rbpja but they themselves do not 
overlap (discussed further in section 1.8.1) (figure 1.5). There are 229 base pairs 
between the first exon of Slc34a2a(as) and the first exon of Rbpja.  
 
 
 
Figure 1.5 Representation of the zebrafish Slc34a2a exons (red) and 
Slc34a2a(as) exons (blue). Slc34a2b sequence regions that are highly similar to 
Slc34a2a are shown in purple above the Slc34a2a sense strand; these do not 
overlap with Slc34a2a(as). Polymerase II uses the bi-directional Rbpja promoter 
to transcribe Slc34a2a(as). 
 
 
1.5.1 Slc34a2a and Slc34a2a(as) 
 
Previous work focusing on the Slc34a gene has been done by Dr Andreas Werner 
and Dr Mark Carlile here at Newcastle University. Zebrafish Slc34a2a sense and 
antisense transcripts were found to be differentially expressed during early 
development by end point RT-PCR (figure 1.6, A) (Carlile et al., 2008). The 
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antisense transcript is expressed from fertilisation up to 48 hours post fertilisation 
(hpf). The sense transcript, however, is expressed from 48 hpf onwards. When the 
zebrafish sense/antisense RNA were injected into the cytoplasm of Xenopus oocytes 
in different combinations, the RNA remained intact. However, if injected into the 
nucleus, the transcripts were processed to short RNAs of ~23 nucleotides (Carlile et 
al., 2008). The same was found when the Slc34a1 sense/antisense pair from mouse 
were injected into Xenopus oocytes (Carlile et al., 2009). Work completed with 
mouse Slc34a1 sense and antisense transcripts found that at least 29 base pairs 
were required to induce processing (Carlile et al., 2009). Moreover, northern blot on 
RNA preparations from 48 hpf zebrafish embryos (the phase of sense/antisense co-
expression) found ~23 nucleotide long endogenous small interfering RNAs (endo-
siRNAs) (Carlile et al., 2008). The conclusions from this work was that these small 
~23 nucleotide RNAs were likely to be produced by Dicer and feed into a RNA 
interference related mechanism.  
 
 
 
 
Figure 1.6 Findings from Carlile, M and Werner, A on Slc34a2a sense and 
antisense zebrafish transcripts.  (A) Slc34a2a sense and antisense RNA are 
differentially expressed during early zebrafish development as  demonstrated by 
end point RT-PCR. (B) Northern blot experiments found that the generation of 
endogenous small RNAs occurs during co-expression of sense/antisense 
transcripts at 48 hpf and also at 72 hpf in a strand specific form; top panel, 
sense probe and bottom panel, antisense probe. These endo-siRNAs are 
roughly 23 nucleotides in length.  
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1.6  Zebrafish 
 
1.6.1 Zebrafish as a model organism 
 
Danio rerio, a tropical freshwater minnow otherwise known as zebrafish due to its 
horizontal stripes, belongs to the Cypriniformes order (Saitoh et al., 2006). It was first 
established as a vertebrate model organism by George Streisinger and has been 
used in countless studies since. Many advantages exist to using zebrafish as a 
model organism in animal research. Zebrafish are small (2 cm in length in early 
adult/breeding stages) and do not require much in terms of replicating a natural 
environment (Nusslein-Volhard and Dahm, 2002). Overall they are easier to house 
and care for than other vertebrate research animals. Secondly, as fish, the number 
of offspring is remarkably high and mating can occur often. Pairings can be set up 
one-two times a week, with each pair laying 200-300 eggs per mating. Thus, there is 
more offspring for examination and a ready supply of future breeding partners. 
Oocytes are laid external to the female prior to fertilization by the male and embryos 
are completely transparent prior to 32 hpf (Nusslein-Volhard and Dahm, 2002). 
Consequently, it is possible to examine the development and any impact of genetic 
manipulation or medical/chemical treatment with neither invasive assessment nor 
impacting the welfare of the animal. Thus, reproducible results can be collected 
easier and more accurately in comparison to many other model organisms.  
Another benefit to using externally developing zebrafish embryos is that it is easy to 
induce genetic changes. Embryos readily absorb chemicals added to the water 
which can influence their development and gene expression. For example, the 
addition of 1-phenyl-2-thiourea (PTU) to the water of the developing embryos prior to 
24 hpf inhibits melanisation; the embryos stay transparent which facilitates  
examination of 32 hpf and older embryos (Nusslein-Volhard and Dahm, 2002). In 
comparison to rodents, zebrafish can tolerate higher levels of chemical mutagens, 
therefore a higher density of mutations in the genome is possible (Lieschke and 
Currie, 2007; Augustine-Rauch et al., 2010). Mircoinjection of RNA or morpholino 
oligonucleotides to manipulate the expression of specific genes is also easily done in 
fertilized oocytes. Transparency allows for localization of the needle and 
visualization of the injected material. Material injected into the yolk reaches the first 
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cells by diffusion and natural cytoplasmic flow if injection is completed prior the 4-cell 
stage (Nusslein-Volhard and Dahm, 2002; Carmany-Rampey and Moens, 2006).   
Importantly, zebrafish are an excellent model organism due to their genetic similarity 
to humans. Danio rerio contain functional homologs for approximately 70% of human 
disease genes and develop similarly to higher vertebrates (Barbazuk et al., 2000; 
Langheinrich, 2003). Even though there are downsides to modelling human disease 
in zebrafish, such as absence of certain organs (example: lungs, mammary gland) 
and gene duplications resulting in subfunctionalization, they remain highly used in 
medical investigations (Postlethwait et al., 2004). With the aim of treating human 
heart ailments, zebrafish are used in regeneration studies (Poss et al., 2002; Lepilina 
et al., 2006). They are also used in oncology (Li et al., 2012; Yen et al., 2014), 
embryogenesis (Pauli et al., 2012; Dash et al., 2014), and the study of 
neurodegenerative disease (Panula et al., 2010) and behavioural traits (Cachat et 
al., 2013; Tran et al., 2016).   
Furthermore, as zebrafish rise in popularity in biological/medical studies, numerous 
resources have been developed. The main source for information on zebrafish is the 
Zebrafish Information Network (ZFIN), an online database that lists transgenic lines, 
mutants and knockdowns generated, gene expression profiles, antibodies, an atlas 
of zebrafish anatomy and publications. Overall, ZFIN constitutes a comprehensive 
knowledgebase on all aspects of zebrafish research (http://zfin.org/).  
 
 
1.6.2 Zebrafish brain anatomy 
 
No brain development occurs prior to 12 hpf (six somite stage) but by 18 hpf (18 
somite stage), ten neuromeres have developed; the telencephalon and diencephalon 
in the forebrain, mesencephalon in the midbrain, and the seven rhombomeres of the 
hindbrain (Kimmel et al., 1995). By 24 hpf (prim-5 stage), the ventral diencephalon 
has expanded to include what will become the hypothalamus and the epiphysis is 
visible in the midline of the diencephalic roof (figure 1.7). In addition, by the 24 hpf 
stage, the tectum (dorsal midbrain) separates from the tegmentum (ventral midbrain) 
and a cerebellum is now present behind the midbrain-hindbrain boundary as shown 
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in figure 1.7 (Kimmel et al., 1995). Circulation begins between 24-26 hpf and thus a 
beating heart is visible during visual examination. Angiograms of embryo heads 
between 24-28 hpf show that the major arterial vessels (lateral dorsal aorta and 
primitive internal carotid artery) and venous vessels (the primordial midbrain channel 
and the primordial hindbrain channel) have formed (Isogai et al., 2001). The same 
brain divisions visible within the 24 hpf embryo, are visible at 48 hpf (figure 1.8). By 
48 hpf, nearly all morphological features are fully developed outside of the jaw, gill 
arches and pectoral fins (Kimmel et al., 1995; Nusslein-Volhard and Dahm, 2002). 
Prior to 72 hpf, the developing zebrafish is known as an embryo, thereafter, whether 
it has hatched or not from its chorion, it is considered to be a larvae (Nusslein-
Volhard and Dahm, 2002).   
 
 
 
 
 
Figure 1.7 Lateral view of zebrafish brain anatomy at 24 hours post fertilization. 
A) Sketch showing the different features visible in a whole embryo. B) Figure 
depicting the different brain segments; telencephalon (T), diencephalon (D), 
epiphysis (E), mesencephalon (M), cerebellum (C), rhombomeres (r1-r7) and 
floor plate (FP). C) Photograph of embryo pointing out the epiphysis (green 
arrow), mesencephalon (blue arrow), cerebellum (red arrow) and midbrain -
hindbrain boundary (orange arrow). Scale bar at 0.1  mm. Figures for A) and B) 
taken from (Kimmel et al., 1995).  
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Figure 1.8 Zebrafish head anatomy at 48 hours post fertilization. Lateral (A) and 
dorsal (C) representations indicating the different visible structures where navy , 
mesencephalon; red, cerebellum; purple, rhombomeres (r1-r7); green, otic 
vesicle (ear); pink, eye; orange, heart and cream, yolk. Lateral (B) and dorsal 
(D) view photographs of an embryo visualized by light microscope. Scale bar at 
0.1 mm. 
 
 
 
1.7 Cerebellar agenesis 
 
Cerebellar agenesis is an extremely rare condition in which the brain develops either 
with an incomplete or absent cerebellum, irrespective of the etiology (Altman et al., 
1992; Romaniello and Borgatti, 2013). The condition was first reported in humans in 
1831 and since 1982, only 9 living cases of complete cerebellar agenesis have been 
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reported (Yu et al., 2014). Understanding pathogenesis is still undergoing but certain 
genetic causes have been determined such as single gene mutations in FOXC1, 
CASK or ZIC (Grinberg and Millen, 2005; Najm et al., 2008), chromosomal copy 
number aberrations, i.e. trisomies 9, 13 and 18 (Chen and Shih, 2005) and certain 
sequence deletions or duplications (Ballarati et al., 2007; Boland et al., 2007). The 
cerebellum, an area in the hindbrain, is comprised of three lobes; the anterior lobe 
receives information from the spinal cord, the posterior lobe that receives information 
from the cerebral cortex and the flocculonodular lobe receives information from the 
vestibular nerve. The cerebellum is involved in many important functions ranging 
from movement coordination, balance, equilibrium and muscle tone. Thus, people 
born with this condition or those that have had cerebellar damage, experience 
severe developmental delays, impaired motor control, language deficits and 
neurological abnormalities (Yu et al., 2014). Children born with the disorder regain 
some control over their movements with age as the normally developed areas of the 
brain partially compensate, but can never do so completely (Taylor et al., 2010). By 
itself the condition is not fatal, but can be when coinciding with other malformations 
like anencephaly (neural tube defect leading to smaller and misshapen head and 
brain), holoprosencephaly (no brain division leading to median cleft lip and cyclopia) 
and microencephaly (abnormal smallness of the head) (Velioǧlu et al., 1998).  
Cerebellar agenesis is not unique to humans since incomplete cerebellar 
development has been noted in many other species including primates, mice and 
zebrafish. Genes of the ZIC family that are linked to cerebellar agenesis in humans 
have orthologos in mice which produce the same phenotypic effect when mutated 
(Aruga et al., 1998). Functional orthologues for PTF1A, a pancreatic transcription 
factor, have been found in frogs, zebrafish and mice; mutation resulted in the 
incomplete development of the midbrain hindbrain boundary and cerebellar agenesis 
(Sellick et al., 2004). The repercussions of cerebellar agenesis in animals is similar 
to that in humans; impaired balance, decomposition of movement, involuntary 
tremors and compromised working memory (Moens and Prince, 2002; Lalonde and 
Strazielle, 2003; Morton and Bastian, 2004). 
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1.8 Zebrafish genes examined within this study 
 
Throughout the course of this study, multiple zebrafish genes will be referred to 
including, Engrailed homeobox 2a (Eng2), Presenilin2 (Psen2), Wingless-type 
MMTV integration site family member 4b (Wnt4b) and RAS-like, family 11, member 
B (Rasl11b). All relevant information about each gene will be located in the 
corresponding section in which the gene is examined.  
 
 
1.8.1 Recombination Signal Binding Protein for Immunoglobulin Kappa J Region A  
 
Recombination Signal Binding Protein For Immunoglobulin Kappa J Region A, 
abbreviated as Rbpja, is also occasionally known as recombining binding protein 
Suppressor of Hairless (Su(H)). Orthologs are present in humans (RBPJ), mice 
(Rbpj) and in Drosophilia (Su(H)). Located on chromosome 1 in Danio rerio, it is 
expressed from fertilization (Echeverri and Oates, 2007). As seen in figure 1.5, 
Rbpja is the gene adjacent and downstream to Slc34a2a. Found within the nucleus, 
Rbpja has transcription factor activity; by interacting selectively and non-covalently, 
Rbpja assists sequence specific DNA binding and modulation for transcription by 
RNA polymerase II (ZFIN, 2002). Rbpja is also involved in numerous cell biological 
processes including the notch signalling pathway (Sieger et al., 2003), left/right 
symmetry determination (Echeverri and Oates, 2007; Lopes et al., 2010), 
neurogenesis (Echeverri and Oates, 2007), somite specification (Sieger et al., 2003; 
Echeverri and Oates, 2007), and the development of many organs like the adrenal 
gland  (O'Brien et al., 2011), glomerulus (O'Brien et al., 2011) and heart (Echeverri 
and Oates, 2007).   
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1.9 Aim 
 
The overall aim of this project is to gain insight into the fundamental mechanisms of 
how NATs regulate gene expression during zebrafish embryogenesis. This study 
focuses on the well-defined bi-directionally transcribed Slc34a2a gene. To achieve 
the main goal of this project, three specific questions were investigated in detail. 
First, a temporal spatial expression pattern for all RNA transcripts of interest within 
this project was determined by in situ hybridization and RT-qPCR. A potential co-
expression and co-localisation would give first indications towards a putative 
mechanistic interaction between sense and antisense. Second, the sense/antisense 
balance was perturbed by microinjection. Thorough phenotypic characterization 
determined how Slc34a2a and Slc34a2a(as) affected one another and characterised 
the consequences of ectopic expression of the transcripts. Third, experimental 
evidence was sought to establish an involvement of RNA interference in the 
processing of co-expressed sense and antisense transcripts. 
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Chapter 2. Materials and methods 
 
Fine chemicals were purchased from Sigma Aldrich, Poole, UK, unless otherwise 
stated. Consumables and plastic ware were purchased from Starlab, Milton Keynes, 
UK. 
 
2.1 General molecular biology techniques and buffers 
 
2.1.1 Small scale DNA preparation 
 
All small scale plasmid preparations were done in accordance to the Qiagen protocol 
with the Qiagen Spin miniprep kit (Qiagen). DNA and RNA samples were quantified 
by spectrophotometry at 260 nm (Thermo Scientific Nanodrop 1000). The purity of 
preparations was estimated by the ratio of the readings at 260 nm and 280 nm. 
Reading values for OD260/OD280 of 1.8 and 2.0 were considered pure for DNA and 
RNA respectively. 
 
 
2.1.2 Ethanol precipitation 
 
Ethanol precipitation was carried out to either concentrate or purify DNA by adding 3 
M NaOAc pH 5.5 to a final concentration of 0.3 M, followed by 2.5 times the volume 
of cold 100% ethanol. This was mixed by inversion and placed either at -80⁰C for at 
least half an hour or at -20⁰C for at least 2 hours but typically overnight. 
Centrifugation at top speed (14000 rpm; Juan BR4i centrifuge) for 20 minutes at 4⁰C 
was completed and the DNA/RNA pellet was washed with 1 ml 70% ethanol. This 
was followed by another centrifugation at top speed (14000 rpm; Juan BR4i 
centrifuge) for 15 minutes. Ethanol was removed with water suction and the pellet 
was air dried for 10 minutes prior to re-suspension with distilled water. 
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2.1.3 Transformation of competent bacteria 
 
Single use HB101 E. coli competent cells (Promega) were thawed on ice for roughly 
20-30 minutes.  In an Eppendorf tube, 1-5 µl of DNA (10 ng-1 µg) was added to 20-
50 µl of the cells. These were gently mixed and left on ice for half hour. Heat shock 
took place at 42ºC for 60 seconds and transformations were placed back on ice for 5 
minutes. 1 ml of LB medium without antibiotic was added and left shaking (550 rpm; 
Eppendorf® Thermomixer® R) for one hour at 37ºC. Depending on the original 
concentration of DNA used and transformation efficiency, 50-100 µl of transformed 
bacteria was spread on pre-warmed LB agar plates containing relevant antibiotic. 
Plates were left to incubate overnight at 37ºC. Plates were stored in at 4 ºC, sealed 
with parafilm.  
 
2.1.3.1 Lysogeny broth (LB) medium 
To 800 ml of distilled water, 10 g bacto-tryptone, 5 g yeast extract and 10 g 
NaCl were added. pH was adjusted to 7.5 with NaOH. The final volume of 1 
litre was made up and the LB broth was sterilized by autoclaving.  
 
2.1.3.2 LB agar  
To 800 ml of distilled water, 10 g bacto-tryptone, 5 g yeast extract, 10 g NaCl 
and 15 g agar were added. The final volume of one litre was made up and the 
solution was sterilized by autoclaving. Prior to pouring plates 1 ml of Ampicillin 
(50 mg/ml) was added to the warmed solution.  
 
 
2.1.4 Plasmids 
 
Listed in table 2.1 below are all the plasmids used within this study. Plasmids used 
were generated prior to commencing this work either in the Dr A. Werner lab 
(Newcastle University) or were received from the Dr C. Houart group (Kings College 
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London). However all sequences were confirmed with DNA sequencing prior to any 
experimentation.  
 
Table 2.1 Plasmids used within the course of this study.  
Plasmid 
name 
Vector Resistance Sequence (NCBI Reference/ Accession 
number) 
Slc34a2a pSport1 Ampicillin  NM_131624.1 
Slc34a2a(as) pSport1 Ampicillin NR_002876.2 
Slc34a2b pSport1 Ampicillin NM_182877.2 
Engrailed2a pBSK Ampicillin NM_131044.2 
Sonic Hedge 
Hog (SHH) 
pSport1 Ampicillin NM_131063.3 
 
 
2.1.5 Restriction enzyme digestion of plasmids 
 
Restriction enzyme digestion of plasmids was completed using commercially 
supplied restriction endonucleases (Promega) for approximately two hours at the 
supplier recommended temperature in the corresponding buffer. No more than 10% 
of the reaction volume comprised of the restriction enzyme.  
 
Table 2.2 The different uses of restriction endonucleases and their 
corresponding buffers for this study. All enzymes and buffers were purchased 
from Promega unless stated. Buffers were chosen using the Promega 
Restriction Enzyme Tool (Promega, 2016). Abbreviations: SHH, Sonic 
Hedgehog; Eng2, Engrailed-2a. 
Restriction 
enzyme 
Corresponding 
buffer 
Use 
AgeI Buffer K  Slc34a2a RNA synthesis 
 Frameshift Slc34a2a RNA synthesis 
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 Slc34a2a(as) RNA synthesis 
BamHI Buffer E  To confirm insert in clone (pSport1 vector) 
EcoRI Buffer H  Site at which inserts for Slc34a2a, Slc34a2b 
and Slc34a2a(as) occurred 
 Slc34a2b RNA synthesis 
HindIII Buffer E  SHH RNA synthesis  
KpnI Buffer J  Determining Slc34a2a insert presence 
 SHH RNA synthesis  
 Eng2 RNA synthesis  
NdeI Buffer D  To confirm insert in clone (pSport1 vector) 
NotI Buffer D  Site at which inserts for Slc34a2a, Slc34a2b 
and Slc34a2a(as) occurred 
 Slc34a2b and Slc34a2a(as) RNA synthesis  
SmaI Buffer J  To confirm clone has Slc34a2b insert as it 
does not cut in Slc34a2a or antisense 
XbaI Buffer D  Slc34a2a RNA synthesis  
 Frameshift Slc34a2a RNA synthesis 
XhoI Buffer D  To determine size of SHH 
 Eng2 RNA synthesis  
 
 
 
2.1.6 DNA sequencing 
 
DNA (~1 µg) was commercially sequenced (GENEIUS Labs, previously known as 
Gene Vision, Newcastle, UK). Generic primers such as T7 and SP6 were supplied 
by the company; otherwise 10 µl of 10 µM stock of the specific primers was sent in a 
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separate tube. Once sequencing confirmed the integrity of the gene of interest, 
glycerol stocks were generated for long term storage. 
 
2.1.6.1 Glycerol stocks of E. coli containing plasmids 
Glycerol stocks of E.coli containing the corresponding plasmid were 
generated by adding 15 µl of fresh pre-grown culture to 1.5 ml of LB medium 
containing the corresponding antibiotic and left to incubate at 37°C for 4 hours 
at 1400 rpm (Eppendorf Thermomixer Comfort). Cultures were then mixed by 
inversion in a 1:1 ratio with 50% glycerol and placed immediately into a -80°C 
freezer. 
 
 
2.1.7 Agarose gel electrophoresis  
 
Agarose BioReagent (Sigma Aldrich; molecular biology grade) was dissolved in 1x 
TAE (Tris acetate EDTA) electrophoresis running buffer to either 1, 2, or 2.5% w/v 
depending on size of DNA fragments to be separated. The solution was heated by 
microwave until the agarose was fully dissolved. The agarose solution was left to 
cool for 5-10 minutes at room temperature with occasional shaking. Either 1 µl of 10 
mg/ml ethidium bromide (Sigma Aldrich) or 1:10,000 GelRed™ Nucleic Acid Gel 
stain (Biotium) was added prior to pouring the solution into a gel tray with a comb.  
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2.1.8 General buffers 
 
Table 2.3 Recipes of general buffers used within this study 
Solution Method pH Autoclaved Notes 
4% PFA 40 g of 
paraformaldehyde into 
1 L of sterilised 1x 
PBS over small heat 
until solution is clear.  
 No Stored at -20°C 
up to a year. 
20x saline 
sodium citrate 
(SSC) 
150 mM NaCl and 15 
mM trisodium citrate 
7 No  
Maleic Acid 
Buffer pH 7.5 
(MAB, 5x 
Stock) 
150 mM NaCl and 100 
mM Maleic Acid  
7.5 Yes Working 
concentration is 
1x. Tween could 
be added 
subsequently if 
required.  
10 mM PBS 137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4 
and 2mM KH2PO4  
7.4 Yes Working 
concentration is a 
1x solution. 
PBST (PBT) Add 0.1% (v/v) Tween 
20 in 1x PBS. 
 No  
1x TAE 
electrophoresis 
running buffer 
0.04 M Tris-Acetate 
(Fisher Scientific), 
0.001 M EDTA 
 No  
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2.2 Animals 
 
Danio rerio zebrafish were maintained in aerated aquarium conditions in 
dechlorinated filtered water at 27.5 ± 1 ⁰C. Adult fish were fed three times daily; twice 
with commercial feed (Tetra) and once with fresh brine shrimp larvae. Husbandry 
and all other procedures were performed to the regulations stated by the UK Home 
Office (Westerfield, 1995).  
Three different strains were used throughout this thesis: AB, Golden and Islet1. The 
AB strain (Zebrafish International Resource Centre) is a wildtype strain that has 
been specifically outbred over successive generations to maximise genetic variation. 
Embryos from this strain were used for microinjection studies and collection for RT-
qPCR. The Golden strain is like AB wildtype outside of the fact that the melanocytes 
do not produce the black pigment. Therefore, Golden fish appear clear which makes 
them perfect for in situ hybridization studies (ISH). The final strain, Islet1, was used 
for microinjection studies; a transgenic strain which expresses green fluorescent 
Islet1 protein that labels central nervous system cranial motor neurons (Higashijima, 
2008). 
 
 
2.2.1 Embryo collection 
 
 Danio rerio female and male fish were paired the evening prior to the day 
eggs were required. Paired males and females were placed into tanks together but 
were physically separated by a mesh until the following morning. Eggs were usually 
laid and fertilised after the lights were turned on (at 8:30 am regularly). Laying would 
commence upon removal of the physical barrier between male and female fish. 
Embryos were collected in blue water (2 ml of 0.1% methylene blue to 1 L aquarium 
tank water) shortly after being laid. Embryos were raised from the day of collection to 
the required stage at 28⁰C in E3 (5.0 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 
mM MgSO4 and pH adjusted to 7.0 with 1 M NaOH) or E3 PTU (0.2 mM 1-phenyl-2-
thiourea (PTU) added too 1x E3). The solution was changed every 24 hours to 
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prevent fungal growth. Staging of embryos was done in accordance to morphological 
criteria provided by Kimmel et al. (Kimmel et al., 1995).  
Embryos to be used for ISH were collected at the appropriate stage and fixed 
overnight at 4⁰C in 4% PFA. If the embryos were older than 24 hours, they were first 
dechorionated with pronase (see below) (Westerfield, 1993; Brand, 1995). Embryos 
younger than 24 hours were fixed and then dechorionated manually using forceps. 
Embryos were dehydrated using increasing concentrations of methanol in water 
(25%, 50%, 75%, and 100%) prior to storage at -20⁰C in 100% methanol. 
Embryos to be used for RT-qPCR were placed directly into 100% Trizol (Ambion, 
Life Technologies) and stored at -80⁰C until needed. 
Embryos to be used in dsRNA immunoprecipitation were flash frozen. 50 embryos at 
the correct time point were placed on dry ice for half an hour after all liquid was 
removed. Samples were stored -80⁰C. 
 
2.2.1.1 Pronase dechorionation 
Embryos were batch dechorionated in 2 mg/ml pronase. 5 ml pronase/E3 was 
added to approximately 60 embryos and left to incubate for 1-2 minutes at 
28⁰C followed by rinsing the embryos in E3 solution.  
 
 
2.3 Microinjection 
 
2.3.1 In vitro synthesised full length mRNA  
 
Plasmids were linearized as described in section 2.1.4 with the relevant restriction 
enzyme. Full linearization was confirmed by running a sample of uncut and cut 
plasmid on a 1% TAE agarose gel. Capped mRNA synthesis was completed by 
following manual specifications of mMESSAGE mMACHINE kit (Applied Biosystems, 
Thermo Fisher Scientific). Non-capped mRNA was made using either the T7 RNA 
Polymerase or SP6 RNA Polymerase MEGAscript Transcription kit (Thermo Fisher 
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Scientific) by following manual instructions included. Both capped and non-capped 
RNA was DNase treated prior to use in accordance to the kits instructions. The 
product was purified using SigmaSpin™ Post-Reaction Clean-Up Columns (Sigma-
Aldrich) following the manufacturer’s instructions. RNA concentration was measured 
using a nanodrop (Thermo Scientific Nanodrop 1000). Size and integrity of the RNA 
was confirmed by running an aliquot on a 2% TAE agarose gel. RNA was stored at -
80⁰C until required. Prior to injection, RNA was diluted with a 10% Phenol Red 
solution, which served as a visual marker.  
 
2.3.1.1 In vitro synthesised frameshift Slc34a2a RNA 
The frameshift was created by site-directed mutagenesis (QuikChange 
Lightning Site-Directed Mutagenesis Kit, Agilent) by removing a single 
nucleotide 18 base pairs downstream from the start codon. The following 
primers were used in creation of the frameshift via PCR:  
Forward: 5’ GGC ACC ACG TCC AAA GCA GAG CAT GAA TC 3’ 
Reverse: 5’ GAT TCA TGC TCT GCT TTG GAC GTG GTG CC 3’  
Frameshift mutation was confirmed via DNA sequencing (section 2.1.6). Use 
of the online tool ‘Translate’ by ExPASy confirmed the transcript was now 
non-protein coding. Multiple stop codons are present in the frameshift 
sequence. The longest possible amino acid chain that could be produced 
would be 28 amino acids and it shares no similarity with the full Slc34a2a 
protein. 
Capped mRNA synthesis was completed by following the manual protocol 
from the mMESSAGE mMACHINE kit (Applied Biosystems, Thermo Fisher 
Scientific). 
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2.3.2 In vitro synthesised RNA fragments  
 
End-point PCR was utilized to create the short DNA fragments. All primers were 
ordered from Integrated DNA Technologies (IDT) and are listed below. Primers 1+2 
and 3+4 were used on a plasmid containing the Slc34a2a sequence whilst primers 
5+6 were used in a reaction with plasmid containing the Slc34a2a(as) sequence. All 
primers contained a T7 or SP6 RNA polymerase binding site so that the fragments 
could be directly used for in vitro RNA synthesis. 
 
Table 2.4 List of primers used to create Slc34a2a fragments via end-point PCR.  
Primer name Sequence 
1.17/10/13 2a (T7) 5’ – GACAATTAATACGACTCACTATAGGGGCACCACGTC 
CAAAGCATGAGC – 3’ 
2.17/10/13 2a (SP6) 5’ – CAGAGGCATACGATTTAGGTGACACTATAGCAGCAG 
CACCAGGACTGAGAG – 3’ 
3.17/10/13 2a (T7) 5’ – GGCATTGTAATACGACTCACTATAGGGCGGTTGGCG 
ATCCCGAAGCC – 3’ 
4.17/10/13 2a (SP6) 5’ – AGCACTTCATACGATTTAGGTGACACTATAGGCAGCA 
ACAGCAACAGCGGG – 3’ 
5.17/10/13 2a (T7) 5’ – GTCCACTAATACGACTCACTATAGGGCCAGGAGTCC 
CAGCACACTGC – 3’ 
6.17/10/13 2a (SP6) 5’ – GAAGGAACATACGATTTAGGTGACACTATAGGGAAA 
CCCGAGGACTGAGGACC – 3’ 
 
Each PCR reaction consisted of: 
Reagent Volume per reaction Concentration 
Forward primer  1 µl 10 µM 
Reverse primer 1 µl 10 µM 
2x Red PCR Master Mix (Rovalabs) 10 µl  
Plasmid 1 µl 0.002 µg/µl 
Water 7 µl  
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The cycling conditions were as follows:  
Step Temperature Length of time 
Initial denaturing 95°C 2 minutes 
Amplification (30 cycles) 95°C 
60°C 
72°C 
15 seconds 
25 seconds 
10 seconds 
Final hold 4°C ∞ 
 
An aliquot of amplified product was analysed on a 2% TAE agarose gel to confirm 
purity and length of the fragment. The product was purified up using SigmaSpin™ 
(Sigma-Aldrich) following product instructions. RNA probes were synthesised by 
incubating the following reactions at 37°C for two and a half hours: 
 
Reagent Volume per reaction 
DNA template  1 µg 
10x Transcription Buffer 
(Thermo Scientific) 
2 µl 
ATP/GTP/CTP/UTP Mix 
(Thermo Scientific) 
2 mM final 
Concentration 
RiboLock™ RNase inhibitor 
(Thermo Scientific)  
1 µl (50 U) 
Polymerase (T7 or SP6) 
(Thermo Scientific) 
2 µl (20 U) 
Water To make up to 20 µl 
 
 
The DNA template was degraded by adding 2 µl RNase free DNase (Thermo 
Scientific) to the reaction and incubating the mix for 5 minutes at 37 °C. The 
digestion was stopped by adding 1 µl of 0.5 M EDTA pH 8.0. SigmaSpin™ Reaction 
Clean-Up Columns (Sigma-Aldrich) were used to purify the RNA. Thermo Scientific 
Nanodrop 1000 was used to determine the RNA concentration. The integrity was 
confirmed by running a small aliquot on a 2% TAE agarose gel. The RNA was stored 
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at -80 ⁰C. Prior to injection, RNA was diluted with a 10% Phenol Red solution, which 
served as a visual marker. 
 
 
2.3.3 Morpholino oligonucleotides 
 
A morpholino oligonucleotide targeting pre-mRNA splicing of the Slc34a2a(as) 
transcript was designed and ordered from Gene Tools LLC (Philomath, US), along 
with a mismatch morpholino as a control. Both Dicer fluorescein tagged morpholinos 
were a kind gift from Prof. JG Patton (Department of Biological Sciences, Vanderbilt 
University, Nashville, USA) who had them designed and ordered from Gene Tools 
LLC. No Dicer mismatch control morpholino was received. A standard control 
morpholino, with no biological target, was utilized instead. A tested p53 morpholino 
designed by Gene Tools LLC was purchased for co-injection studies and always 
injected at a concentration of 4 ng as per Gene Tools recommendation.  
 
Table 2.5 Morpholino oligonucleotide sequences and their targets. All 
morpholinos were designed by and ordered from Gene Tools LLC.  
Morpholino Sequence Target 
Block AS  5’ – GCCATCTGGTGAAAAGACAGAGTTT – 3’ Antisense pre-
mRNA third exon 
AS 
mismatch 
5’ – GACATCTCGTCAAAACACAGACTTT – 3’ No target 
Dicer 5’ 
UTR 
5’ – CTGTAGGCCAGCCATGCTTAGAGAC – 3’ 5’ UTR of dicer1 
Dicer start 5’ – TCTTTCTCTTCATCTTCCTCCGATC – 3’ Translational start 
site of dicer1 
P53 5’ – GCGCCATTGCTTTGCAAGAATTG – 3’ P53 
Standard 
control  
5' -  CCTCTTACCTCAGTTACAATTTATA -  3' No target  
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2.3.4 Hairpin RNA 
 
Ultramers to generate hairpin RNA for each of the candidate genes were designed 
incorporating T7 and universal M13 primer sites (table 5.1). The designed 
oligonucleotides were amplified by end-point PCR using T7/ M13 primers prior to 
purification with a PCR clean-up kit (GeneJet, Thermo Scientific). Restriction digest 
to remove the M13 primer site was completed with XbaI as stated in section 2.1.4. 
The product was purified using SigmaSpin™ (Sigma-Aldrich) following product 
instructions. RNA probes were synthesised by incubating the following reactions at 
37°C for two and a half hours: 
 
Reagent Volume per reaction 
DNA template  1 µg 
10x Transcription Buffer 
(Thermo Scientific) 
2 µl 
ATP/GTP/CTP/UTP Mix 
(Thermo Scientific) 
2 mM final 
Concentration 
RiboLock™ RNase inhibitor 
(Thermo Scientific)  
1 µl (50 U) 
Polymerase (T7) (Thermo 
Scientific) 
2 µl (20 U) 
Water To make up to 20 µl 
 
 
Thermo Scientific Nanodrop 1000 was used to determine the RNA concentration and 
integrity was confirmed by running a small aliquot on a 2% TAE agarose gel. The 
RNA was stored at -80 ⁰C. Prior to injection, RNA was diluted with a 10% Phenol 
Red solution, which served as a visual marker. 
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2.3.5 Injection set-up and calibration  
 
Injection needles were prepared by pulling filament containing 3.3 borosilicate glass 
capillaries (product code: 1403517 from Hilgenberg GmbH, Malsfeld, Germany) with 
a horizontal pipette puller (Sutter Instrument Co) with the following settings: Heat- 
635, Pull- 50, Velocity- 80, and Time- 200. The tip was opened by snapping off the 
tip of the needle using a pair of sharp forceps. Morpholino or RNA was rear-loaded 
using Eppendorf loading tips The droplet size was measured by injecting into oil on a 
1 mm graticule. A femtojet compressor (Eppendorf) with the settings 280 hPa 
injection pressure, 0.3 sec injection time and 17 hPa compensation pressure was 
used to consistently deliver a droplet volume of 2 nl (diameter of 160 µm). 
Compressed air flow was triggered by a foot pedal. The dilution of RNA or 
morpholino was altered to give the desired dose since the injected droplet size 
remained constant.  
 
 
2.3.6 Embryo loading (Injection) 
 
1 to 4- cell stage embryos (10-30 minutes hours post fertilization) were lined up 
against a glass slide within a petri dish. 2 nl injection was done into the yolk sac as 
close as possible to the first cell and never later than the 4-cell stage (Nasevicius 
and Ekker, 2000). Dual or triple RNA/morpholino injections were completed as a 
mixture in the same needle to ensure equal dosing. From each clutch that underwent 
injection, 50 uninjected embryos were kept as a fitness control group for the entire 
clutch. Both uninjected and injected embryos, where average number of embryos 
per petri dish was 50, were incubated in the dark at 28⁰C within E3 solution. Roughly 
eight hours after collection, all unfertilised and dead eggs from each petri dish were 
removed and discarded. The following morning, at 24 hpf, all embryos that died 
overnight were counted and logged. If percent survival was below 80% in uninjected 
control groups, all embryos from clutch were discarded and data not used.  
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2.3.7 Anaesthetisation and photomicroscopy 
 
Embryos were anaesthetised in 0.2 mg/ml Tricaine ® (Sigma) for 3-5 minutes prior 
to any microscopy. Embryos were orientated using fine tipped forceps and either 
photographed in E3 solution or in 3% methylcellulose in E3. Imaging was completed 
using a Leica dissection light microscope (Leica Application Suite version 4.2.0). For 
fluorescent images a GFP filter was applied. For live imaging, a Chameleon digital 
camera (model CMLN-13S2M, Chameleon) was utilized and images were processed 
with FlyCap2 (Point Grey) software. Prior to returning embryos to the incubator, they 
were washed and left in fresh E3 for five minutes. 
 
 
2.4 Whole mount in situ hybridization (ISH) 
 
2.4.1 Probe generation 
 
Plasmids were linearized as mentioned in section 2.1.4 with the relevant restriction 
enzymes in matching buffers. Full linearization was confirmed by running a sample 
of uncut and cut plasmid on a 1% TAE agarose gel. Cut plasmid was purified using 
QIAprep Spin Miniprep kit (Qiagen) according to the manufacturer’s instructions.  In 
vitro transcription reactions were assembled according to the scheme below and 
incubated at 37°C for 60 minutes for T7/T3 polymerases or 90 minutes for the SP6 
polymerase: 
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Reagent Volume per reaction 
DNA template  1 µg 
10x Transcription Buffer 
(Thermo Scientific) 
2 µl 
10x DIG-NTP mix (Roche) 2 µl 
RiboLock™ RNase inhibitor 
(Thermo Scientific)  
1 µl (50 U) 
Polymerase (T7/T3 or SP6) 
(Thermo Scientific) 
1.5 µl (20 U) 
Water To make up to 20 µl 
 
2 µl of RNase-free DNase I (Promega) was added at the end of the reaction and left 
for a further 30 minutes at 37°C. The RNA was purified using SigmaSpin™ Post-
Reaction Clean-Up Columns (Sigma-Aldrich) following manufacturer’s instructions. 
The presence of RNA was confirmed by agarose gel electrophoresis. The probes 
were stored at -20°C in 1x the probe final volume of 20x SSC and 2x the probe final 
volume of formamide. 
 
 
2.4.2 Embryo paraformaldehyde fixation 
 
Live embryos were placed into sterile 20 ml bijou tubes. Pronase dechorionation was 
completed as described in section 2.2.1.1. The pronase solution was removed and 
replaced with 0.2 mg/ml Tricaine ® (Sigma) in E3 and the embryos were left for five 
minutes. Tricaine® was replaced with chilled 4% paraformaldehyde/PBS (PFA) and 
stored at 4°C overnight. The following morning, PFA was removed and the embryos 
were dehydrated using a gradient of methanol/water at room temperature (five 
minutes each in 25%, 50%, 75% and 100%) prior to being stored in fresh 100% 
methanol at -20°C. 
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2.4.3 Whole mount RNA in situ hybridization 
 
Embryos, which were stored in methanol, were progressively rehydrated on ice by 
adding 2-3 drops of PBST at a time. Once hydrated, two washes in 100% PBST 
were completed at room temperature whilst lightly shaking for five minutes. 10-20 
embryos were placed into 1.5 ml Eppendorf tubes. 10 mg/ml Proteinase K (Sigma) 
was diluted 1:1000 in PBST and added to the embryos to permeabilize the tissue. 
Treatment length differed with age; 1 minute for embryos between 1-8 somites, 3 
minutes for embryos that were 9-18 somites, 10 minutes for those between 18-24 
hpf and 30 minutes for 24-48 hpf embryos. For 56 hpf and 75 hpf embryos, 
proteinase K was diluted 1:500 and embryos were incubated for 20 and 30 minutes, 
respectively. Proteinase K treatment was completed at room temperature whilst 
slightly shaking. The permeabilised embryos were theny washed twice in PBST 
followed by a second fixation in 4% PFA for 20 minutes at room temperature (not 
shaking). Embryos were washed twice in PBST before adding pre-warmed 65°C 
hybridization mix (100 ml: 1 g Boehringer Blocking Reagent (Roche), 50 ml 
formamide, 25 ml 20x SSC, 100 mg Torula yeast RNA (Sigma), 10 mg Heparin 
(Sigma), 0.1% Tween20, 0.1% CHAPS made up with distilled water). Samples were 
placed onto 65°C heat block for five minutes. From this moment onwards, embryos 
were never allowed to cool and remained at 65°C. Pre-hybridization was done for 2-
4 hours with one change of the hybridisation solution. For each sample, diluted 
probe (amount dependent on concentration) was mixed with 300 µl hybridization mix 
and pre-warmed to 65°C for 5-10 minutes. The hybridization/ probe mix was added 
and embryos were incubated overnight at 65°C. 
The following morning, the hybridisation/probe solution was recovered and stored at 
-20°C as it could be used multiple times. Pre-warmed 65°C hybridization mix was 
added to the embryos and incubated 30 minutes. The subsequent washes were 
completed at 68°C. Embryos were washed in 2x SSC for  5 minutes, twice in 2x SSC 
for 30 minutes, twice in 0.2x SSC for 30 minutes and a final wash was done in 0.2x 
SSC for five minutes on a shaker at room temperature.  
Embryos were equilibrated in MAB (0.1% Tween20) for one hour with a minimum of 
four changes of solution prior to a blocking step in MAB/Blocking 2% (0.1% 
Tween20) for 2 hours (Blocking Reagent from Roche). Anti-DIG Antibody (Roche) 
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was diluted 1:4000 in MAB/Blocking and embryos were incubated overnight at 4°C 
rocking slowly.   
The following day, the embryos were washed in MAB for 3-6 hours, changing the 
solution multiple times. Successive washes with PBST were completed for 3-6 hours 
were the solution was replaced every half hour. Embryos were transferred into 12 
well plates and left in PBST overnight shaking at 4°C. 
To develop, embryos were equilibrated 2x 5 minutes in fresh NTMT buffer (for 50 ml: 
1 ml 5 M NaCl, 2.5 ml 2 M Tris HCl pH 9.5, 1.25 ml 2 M MgCl2, 5 ml 10% Tween 20 
and made up with distilled water to the final volume) before the developing solution 
was added. The developing solution consisted of 3.3 µl NBT (nitro blue tetrazolium 
chloride, Roche) and 3.5 µl BCIP (5-bromo-4-chloro-3-indolyl-phosphate, Roche) per 
1.5 ml NTMT buffer. Embryos were incubated in the dark and monitored for staining 
every 30 minutes. To stop the reaction, embryos were washed 3 x 5 minutes in 
PBST and progressively (drop-wise) transferred into 70% glycerol/PBS for imaging 
and storage (at 4°C).  
 
 
2.4.4 Photomicrography 
 
 High power images of fixed embryos in 70% glycerol/PBS were obtained 
using a Leica dissection light microscope (Leica Application Suite version 4.2.0). 
Images were assembled in Microsoft PowerPoint.  
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2.5 Quantification of gene expression by real time polymerase chain reaction 
(qPCR) 
 
2.5.1 Oligonucleotides 
 
Primers for qPCR were either designed by and ordered from PrimerDesign Ltd or 
designed in house and ordered from Sigma Aldrich or IDT (Integrated DNA 
Technologies).  
 
Table 2.6 List of oligonucleotides used in real time PCR reactions.  
Target 
transcript 
Sequence Product 
Length  
Other information 
Actin Company reference gene 
Information not provided 
87 Design and purchased from 
PrimerDesign 
Used for relative quantification in 
non-injected wildtype embryos 
(chapter 3) 
Slc34a2a Forward:  
5’-AACACAGATTTCCCT 
TTTCCATTT- 3’ 
Reverse:  
5’-CAAGAGGAGTTATAGC 
CGATGT-3’ 
121 Design and purchased from 
PrimerDesign 
Used for quantification in non-
injected wildtype embryos 
(chapter 3) 
Slc34a2b Forward:  
5’-ATCTGGCGGTGGGT 
TTGA- 3’ 
Reverse:  
5’-CAGCATGGAGTTCAG 
GAGTTT -3’ 
92 Design and purchased from 
PrimerDesign 
Used for quantification in non-
injected wildtype embryos 
(chapter 3) 
Rbpja Forward:  
5’-CTGTCTCTCTTTGTT 
GTGGTTCT- 3’ 
 
 
96 Design and purchased from 
PrimerDesign 
Used for quantification in non-
injected wildtype embryos 
(chapter 3) 
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Reverse:  
5’-GCATTGATCCTGTGG 
TATCTTGA -3’ 
Antisense  Forward:  
5’-GAGAGTGGGGACG 
GACGGTTG- 3’ 
Reverse:  
5’- CAGGAGTCCCAG 
CACACTGCAGA -3’ 
144 Designed in house and purchased 
from Sigma Aldrich 
Used in all experiments 
Actin Forward:  
5’-CCGTCTTCCCCTCCA 
TCGTTGG -3’ 
Reverse:  
5’-GTTGGTAATGATGCC 
GTCC TCGATG -3’ 
149 Designed in house and purchased 
from Sigma Aldrich 
Used for relative quantification in 
injected embryos and dsRNA IP 
studies (chapter 4-6) 
Slc34a2a Forward:  
5’-CCTGGGAAATGATGG 
AGCTGCAGG-3’ 
Reverse:  
5’-CTCCAACAAGCTGGA 
AAGCTGAGC-3’ 
 
174 Designed in house and purchased 
from Sigma Aldrich 
Used for quantification in injected 
embryos and dsRNA IP studies 
(chapter 4-6) 
Slc34a2b Forward:  
5’-CCACTGGAGACCCTGC 
TGCC-3’ 
Reverse:  
5’-AGCACAGGGCGTCCG 
GAGTG-3’ 
126 Designed in house and purchased 
from Sigma Aldrich 
Used for quantification in injected 
embryos and dsRNA IP studies 
(chapter 4-6) 
 
 
 
2.5.2 RNA extraction 
 
Five embryos from multiple developmental stages were selected and placed into 50 
µl Trizol ® (Life Technologies).  The five embryos at stages 75% epiboly (8 hpf), 
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prim-5 (24 hpf), (32 hpf), long pec (48 hpf), (56 hpf) and protruding mouth (72 hpf) 
were crushed with a pestle in 50 µl of Trizol ® in a 1.5 ml Eppendorf tube. Samples 
were incubated for five minutes at room temperature. 30 µl of chloroform (Sigma 
Aldrich) was added and samples were rocked for 10 seconds prior to a two minute 
incubation at room temperature. Samples were centrifuged at full speed (14,000 
rpm; MSE MicroCentaur centrifuge) for 15 minutes to aid phase separation; a lower 
red phenol-chloroform, an interphase and a colourless upper aqueous phase. The 
upper phase, which contains the RNA, was moved into fresh 1.5 ml Eppendorf tube 
without disturbing the interphase. RNA was precipitated with 50 µl of isopropanol 
and 0.5 µl of Glycoblue TM coprecipitant (Life Technologies). Samples were 
incubated on ice for half an hour prior to being centrifuged at 14,000 rpm for 10 
minutes (Juan BR4i centrifuge). RNA pellets were seen as blue due to Glycoblue 
coprecipitant. Pellets were washed with 1 ml cold 70% ethanol followed by another 
centrifugation at 14,000 rpm for 10 minutes (Juan BR4i centrifuge). The supernatant 
was removed and tubes were left inverted for ten minutes at room temperature to air 
dry.  RNA was resuspended in 16 µl of RNAse free water (vortexed for 10 second 
intervals with alternative intervals being on ice).  
DNase I (Thermo Scientific) treatment to remove all genomic DNA contamination 
was completed in two steps.  In the same tube where RNA was resuspended, 
DNase I treatment was first completed using a MgCl2 containing buffer for half an 
hour at 37°C; MnCl2 was then added and left for a further 20 minutes at 37°C. To 
stop the reaction, 1 µl 0.5M EDTA was added and the sample was then further 
incubated at 37°C for 10 minutes. This was followed by purification using SigmaSpin 
Reaction Clean-up Columns (Sigma Aldrich) as described in corresponding protocol.  
 
 
2.5.3 Analysis of RNA concentration and quality 
 
RNA concentrations were determined using a NanoDrop spectrophotometer 
(NanoDrop Technologies Inc). The quality of the RNA was predicted using the 
260/280 reading. Running 2 µl of the RNA sample on a 2% agarose gel confirmed 
the integrity of the RNA.  
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2.5.4 cDNA synthesis 
 
Total RNA (~ 1 µg) was reverse transcribed to produce cDNA using a Qiagen 
Omniscript RT kit by following the corresponding protocol. Random nonamers 
(Sigma Aldrich) were used as primers and reactions were run for 1 h at 37°C .  
 
Reagent Volume per reaction 
RNA  ~ 1 µg 
10x Reverse Transcription 
Buffer  
2 µl 
Random nonmers (Sigma) 2 µl 
dNTP Mix (5 mM each dNTP) 2 µl 
RiboLock™ RNase inhibitor 
(Thermo Scientific)  
1 µl (10 U) 
Omniscript Reverse 
Transcriptase 
1 µl (4 U) 
Water To make up to 20 µl 
 
 
 
2.5.5 Semi-quantitative real-time RT-PCR 
 
The assembly of the qPCR samples was completed on ice.  The cDNA produced by 
reverse transcription was diluted 1:4 in RNAse free water whilst RNA for control 
purposes was diluted 1:10. Master-mixes comprising of LightCycler ® 480 SYBR 
Green I Master, primers (PrimerDesign or Sigma Aldrich) and water were made prior 
to pipetting into 96-well plates. Each well contained 5 µl of LightCycler ® 480 SYBR 
Green I Mastermix, 1 µl forward primer of 10 µM stock, 1 µl reverse primer of 10 µM 
stock, 1 µl water and 2 µl cDNA,RNA or water.  The plates were centrifuged twice for 
20 second intervals at full speed prior to loading into a LightCycler ® 480 (Roche).  
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The qPCR program was as follows: 
Step Target (°C) Acquisition 
Mode 
Time 
(mm:ss) 
Ramp 
rate 
(°C/s) 
Acquisitions 
(per °C) 
Activation 95 none 10:00 4.40  
Cycling 95 none 00:05 4.40  
 53 (PrimerDesign) 
59 ( Sigma Aldrich) 
None 00:20 2.20  
 72 Single 00:01 4.40  
Melt 
Curve 
95 none 00:01 4.40  
 65 none 00:30 2.20  
 95 Continuous  0.11 5 
Cooling 40 none 00:10 1.5  
 
 
2.5.6 Analysis 
 
Calculated Ct values (Absolute Quantification/ Second Derivative Maximum) were 
produced for each gene along with the melting temperatures via the LightCycler ® 
480 software (release 1.5.0 SP3). Following the removal of outliers based on Ct 
values and melting curves, Ct values were analyzed in Microsoft Excel. Each sample 
was run in triplicate on a plate and a minimum of three samples were collected from 
different clutches. A Ct difference of a minimum of three cycles had to be present 
between cDNA and RNA samples to be included into the analysis. Alternatively, the 
melting temperature and curve between cDNA and RNA samples had to differ 
sizably. Averages and standard deviations were taken from a sample triplicate. 
Using these values, ΔCt was calculated by subtracting the Ct of the reference gene 
(β-actin) from the Ct value of the gene of interest. The ΔCt values from a minimum of 
three different clutches was averaged for a final value displayed in graphical format. 
The standard error was calculated according to the formula: 
SE= √((standard deviation of β-actin)^2+(standard deviation of gene of interest)^2) 
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P-values were not determined due to small N of three. ‘Practical Statistics for 
Environmental and Biological Scientists’ (Townend, 2002) recommends at least six 
replicates to justify T-tests or non-parametric tests such as the Wilcoxon (Mann-
Whitney) test (Townend, 2002). Normal distribution of data cannot be assumed or 
proven with a N number of three. 
 
 
2.6 dsRNA mapping and extraction using the J2 monoclonal antibody 
 
2.6.1 Immunofluorescent staining  
 
PFA-fixed zebrafish (4% PFA in PBS, overnight) were embedded in OCT (Cell Path) 
compound, snap-frozen in isopentane over liquid nitrogen and then stored at -80°C. 
Cryo-preserved zebrafish were sectioned at 5 µm using a Leica cryostat. Sections 
were collected onto Superfrost plus microscopic slides (Thermo Scientific), dried at 
room temperature (RT) for 4-6 hours and then either stored at -80°C or used for 
immunostaining immediately. Sections stored at -80°C were thawed to RT for 1 hour 
before staining. Slides were washed once in 1x PBS for 5 minutes at RT with 
agitation. Non-specific binding of the secondary antibody was blocked by the 
addition of 20% goat serum in 1x PBS followed by an incubation for 1 hour at RT. 
The J2 monoclonal antibody diluted 1:500 in 1x PBS containing 20% goat serum 
was added and incubated overnight in a humidified chamber. The next day, sections 
were washed three times each for 5 minutes, with 1x PBS before incubating in the 
dark at RT for 1 hour with the secondary antibody. Antibodies used were goat anti-
mouse IgG (H+L) alexafluor 488 F(ab’)2 or goat anti-mouse IgG TRITC-conjugated 
secondary antibody (Molecular Probes A11070), diluted 1:200 (stock = 2 mg/ml) in 
1x PBS. Slides were washed four times in 1x PBS (in the dark), each for 5 minutes 
with agitation, before mounting the coverslips with FluorSave reagent (Calbiochem). 
Slides were stored in the dark at room temperature overnight, then transferred to 
4°C. Immuno-stained tissues were visualised using a Zeiss AxioImager fluorescent 
microscope. 
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2.6.2 dsRNA extraction  
 
Slc34a2a and Slc34a2a(as) uncapped RNA was in vitro synthesized as mentioned 
above. Double stranded RNA (dsRNA) was generated by mixing equal quantities of 
Slc34a2a and Slc34a2a(as) RNA in 1x PBS prior to leaving at 72°C for 10 minutes 
which was followed by cooling on ice. Control samples included ssRNA 
Slc34a2a(as) in 1xPBS and a mix of Slc34a2a RNA and Slc34a2a(as) RNA in water. 
Unless stated otherwise, experiment were completed on ice or in the cold room. 
RNA extraction was performed either using the Trizol ® (Life Technologies) method 
mentioned above or the Bioline Isolate II RNA Kit as per the manufacturer’s 
instructions. After RNA extraction (or no extraction for control), the J2 monoclonal 
antibody (mAb) IgG2a (Scicons) was added (1:200) and left rotating overnight at 
4°C. The following morning, 5 µl of goat anti-mouse IgG Magnetic Beads (New 
England Biolabs) were added and left rotating for another hour at 4°C. MACS 
columns were rinsed three times with 1 ml 1x PBS prior to adding the beads bound 
to dsRNA. Samples were washed on the columns twice with 1 ml of ice-cold 1x PBS 
whilst on the magnetic stand. Samples in columns were removed from the magnetic 
stand and the stand was heated for 15 minutes in a boiling water bath. Columns 
were then placed back onto hot magnetic stand, and RNA was eluted using 2x 100 
µl 90°C water. The RNA eluted from J2/beads was reverse transcribed (Qiagen 
Omniscript RT kit) as described above. End-point PCR was completed utilizing 
primers designed in house (table 2.6) with the following cycling conditions: 
 
Step Temperature Length of time 
Initial denaturing 95°C 2 minutes 
Amplification (30 cycles) 95°C 
57°C 
72°C 
30 seconds 
30 seconds 
90 seconds 
Final elongation 72°C 180 seconds 
Final hold 4°C ∞ 
 
Final products from the end-point PCR were separated on a 2% TAE agarose gel 
alongside 100 bp ladder (New England Biolabs) to determine correct band size. 
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Chapter 3. Temporal expression pattern of Slc34a2a sense and 
antisense, Slc34a2b and Rbpja transcripts in wildtype zebrafish 
embryos 
 
The expression pattern and quantity of a transcript can be a key indicator as to its 
possible biological function and mechanism. This is particularly important within this 
project since the interplay of at least three transcripts from two genes (Slc34a2a, 
Slc34a2a(as) and Rbpja) form a regulatory network during zebrafish development. 
Carlile (Carlile et al., 2008) found that the Slc34a2a transcript and its antisense are 
reciprocally expressed in early zebrafish embryos by RT-PCR.  This study lacked the 
specialist detail and quantification required to draw any proper conclusions. 
Therefore mapping and more extensive quantification was further sought-after to 
determine temporal expression patterns for each of the genes of interest. 
 
 
3.1 Temporal expression levels of Slc34a2 sense, antisense and Slc34a2b 
transcripts determined by RT-qPCR 
 
To quantify Slc34a2a and related transcripts during zebrafish development, embryos 
were collected at 8, 24, 32, 48, 56 and 72 hours post fertilization (hpf) as mentioned 
in Chapter 2; Materials and methods. Five embryos from the same clutch were 
stored in 50 µl of Trizol prior to RNA extraction and DNase I treatment. Samples for 
each time point were taken from multiple clutches to account for the minor genetic 
variation between parents such as naturally occurred individual point mutations. A 
minimum of three different samples of five embryos from different parents were 
utilised for semi-quantitative expression analysis. Samples were run in triplicate on 
the same qPCR plate, always including negative controls (RNA without reverse 
transcription and water instead of cDNA) and alongside the reference house-keeping 
gene, β- actin (Sequence information: 
http://www.ncbi.nlm.nih.gov/nuccore/NM_131031.1 ). 
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SYBR Green (Roche) was used within this study to quantify cDNA. SYBR Green 
which is highly specific for double-stranded DNA (dsDNA), fluoresces when bound to 
the minor-groove of DNA (Dragan et al., 2012). This fluorescence is proportional to 
the amount of dsDNA within the reaction. Cycle threshold (Ct) is the number of 
cycles required for the fluorescent signal to be higher than background level 
fluorescence. However, as SYBR Green shows no particular sequence specificity, it 
can detect dimerised primers and unrelated fragments to give false positive 
readings. To rule out such contaminations, a dissociation curve was completed after 
each run. As each fragment has a characteristic melting temperature, the 
dissociation curve can discriminate between a specific amplicon and unspecific 
product.  
Alongside Slc34a2a and its antisense transcript (Slc34a2a(as)), mRNA levels of the 
paralog Slc34a2b were investigated. As mentioned in chapter 1, Slc34a2a and 
Slc34a2a(as) are transcribed from chromosome 1 whilst Slc34a2b is transcribed 
from chromosome 23. 
All results from RT-qPCR experiments were normalised to the house-keeping gene 
β-actin, which maintained a consistent Ct value of about 21 throughout all 
experimental time-points. After careful consideration, a ΔCt value (average Ct of 
three individual reactions of the gene of interest – average Ct of β-actin triplicate) of 
over 13 considered the transcript level to be too low for detection. A ΔCt value over 
13 with β-actin having a Ct of 21 meant individual Ct values were ~35 or over.  
Individual Ct values ± 10 of the positive gene (β-actin) are considered reliable whilst 
individual Ct values above 37 are considered negative (due to low reliability as this is 
near background levels) within SYBR Green studies and according to MIQE 
Guidelines (MIQE: minimum information for publication of quantitative real-time PCR 
experiments) (Bustin et al., 2009; Chugh et al., 2010; Jiang et al., 2014). This cut off 
point is indicated by the dotted line in figure 3.1 and any values above are 
considered non-detectable. 
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Figure 3.1 Temporal expression profiles of Slc34a2a, its antisense transcript 
Slc34a2a(as) and paralog Slc34a2b quantif ied by RT-qPCR. Expression profiles 
are in relation to the house-keeping gene β-actin which maintained a stable Ct 
value.  The dotted line indicates a ΔCt of 13; levels above are considered 
undetectable transcript levels. A decrease in bar size designates an increase in 
transcript level. Sample age, 8, 24, 32, 48, 56 and 72 hpf, is represented as 
lightest to darkest colour of bars for each transcript. N=3 
 
 
Throughout the early stages of development, Slc34a2a was not detectable till 
approximately 48 hpf as seen in figure 3.1. ΔCt values were above 13 for time points 
8, 24 and 32 hpf, with specific ΔCt values of 14.87±0.54, 12.52±1.24 and 13.45±0.82 
respectively (individual Ct values = 37.37±0.38, 33.97±0.81 and 34.19±0.82 
correspondingly). ΔCt values decreased from 12.31±0.42 at 48 hpf to 11.78±0.52 at 
56 hpf and 9.56±0.39 at 72 hpf, indicating an increased expression (individual Ct = 
34.60±0.33, 31.78±0.26 and 30.40±0.34, respectively).  
Contrariwise, Slc34a2a(as) was present from fertilization with levels decreasing from 
24 hpf but the transcript remained detectable at all time points. ΔCt values increased 
to 11.62±0.33, 9.69±0.46 and 10.77±0.43 at 48, 56 and 72 hpf time points, 
respectively (individual Ct values = 30.88±0.32, 28.26±0.37 and 30.14±0.40). With 
comparably low ΔCt values of 5.46±0.26, 4.08±0.20 and 6.96±0.71 for 8, 24 and 32 
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hpf time points (individual Ct values = 27.71±0.25, 27.15±0.17 and 27.49±0.62 
correspondingly), antisense expression was found to be high. 
As Slc34a2a and Slc34a2a(as) are transcribed from the same genomic region and 
share sequence complementarity, the hypothesis was that an expression correlation 
would emerge. From the RT-qPCR data, a reciprocal expression pattern between 
the two transcripts is visible, where at 48 hpf, both transcripts are present at a near 
equal level (ΔCt Slc34a2a 11.78±0.52, ΔCt Slc34a2a(as) 11.62±0.33).   
Slc34a2b was found in higher abundance than its paralog Slc34a2a. Slc34a2b levels 
showed a slight decrease over time with ΔCt values of 3.91±0.28, 3.99±0.82, 
5.34±0.32, 4.82±0.62 and 5.23±0.32 for time points 8, 24, 32, 48 and 72 hpf 
(individual Ct values of 26.40±0.07, 25.44±0.11, 27.19±0.19, 27.11±0.60 and 
25.98±0.20 respectively). At 56 hpf, ΔCt increased to 7.22±0.70 indicating a 
decrease in transcript level (Ct=27.22±0.40).  
The paralogs Slc34a2a and Slc34a2b share 68.4% nucleotide identity as seen in 
Appendix A. As highlighted in figure 3.2, an e!Ensembl BLAST nucleotide alignment 
(EMBL-EBI, 2015), Slc34a2b and Slc34a2a(as) do not share significant regions of 
complimentary (sequence alignment in Appendix A). A sequence alignment between 
Slc34a2b and Slc34a2a(as) finds a maximal complementarity of 14 nucleotides 
between the two transcripts. In addition, the genes are transcribed from different 
chromosomes. Therefore a direct co-regulation of Slc34a2b and Slc34a2a(as) 
seemed unlikely and the RT-qPCR data supported this hypothesis.  
 
 
 
Figure 3.2 Sequence alignment comparing Slc34a2b, Slc34a2a sense and 
antisense transcripts using the BLAST algorithm (EMBL-EBI, 2015).  
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3.2 Mapping of Slc34a2 sense, antisense, and Slc34a2b transcripts by in situ 
hybridization in wildtype zebrafish embryos 
 
Whole mount in situ hybridization (ISH) was completed on wildtype zebrafish 
embryos which were PFA fixed at numerous time-points in development; 8, 24, 48, 
56 and 72 hpf. Digoxigenin (DIG) labelled probes for Slc34a2a, Slc34a2a(as) and 
Slc34a2b were utilized to map the expression of each transcript. Sonic Hedgehog 
(SHH) ISH staining was included as a control. SHH staining, as shown in bottom row 
of figure 3.3, was reproducibly found in the central nervous system, floor plate and 
brain consistent with published work (Sumanas et al., 2005; Thisse, 2005; Jensen et 
al., 2012; Chatterjee et al., 2014).  
Slc34a2a sense and antisense transcripts showed the same temporal expression 
pattern as seen in the RT-qPCR data; Slc34a2a staining was consistently absent in 
early stage embryos and became only detectable at 48 hpf. At later stages Slc34a2a 
localised predominantly to the endoderm and the pharynx (future digestive tract and 
swim bladder) as well as to the primordial midbrain and hindbrain channel.  
Slc34a2a(as) was present from fertilization but was dispersed throughout the head 
region and did not localise to specific structures until 48 hpf. From 48 hpf onwards, 
Slc34a2a(as) was found in the pharynx, endoderm, primordial midbrain channel and 
primordial hindbrain channel. Both the primordial midbrain and hindbrain channels 
only begin to develop at 24 hpf (prim-5 stage). 
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Slc34a2b was found to be expressed from fertilization and was present at all time 
points examined. At the 8 hpf (75%-epiboly stage), Slc34a2b expression did not 
seem to be restricted to any specific group of cells. However, by 24 hpf (prim-5), the 
transcript was visualised throughout the head region with specific localisation to the 
optic vesicle (eye) and the otic vesicle (ear). From 48 hpf onwards (hatching period), 
localisation was specific in the otic vesicle and the intestinal bulb (endoderm which is 
to become the gut) with some very weak but specific staining in the 
midbrain/hindbrain region. All of these data on Slc34a2b localisation, including the 
weak brain staining, is in agreement with the ISH data submitted by Thisse, B and 
Thisse, C to the ZFIN database (Thisse, 2004b). 
The presented ISH experiments are in line with the RT-qPCR data in terms of 
temporal expression profiles; the Slc34a2a(as) staining appeared to decrease at 
later time points whilst Slc34a2a only appeared at 48 hpf onwards. However, 
whereas the RT-qPCR data was quantified relative to β-actin, ISH staining only 
provided non quantitative information about the location of a specific transcript. 
Nevertheless, the intensity of an ISH signal depends on the quantity of the transcript 
and the development time; for example, for SHH which is highly expressed during 
embryogenesis (Yu et al., 2006), staining developed in under an hour whereas 
staining took approximately 15 hours for the lowly expressed Slc34a2a.  
In Slc34a2a(as) probed embryos, as well as in Slc34a2b stained samples at earlier 
time points, the signal appeared to be unspecific. For several reasons, however, this 
is highly unlikely and the dispersed staining is indeed transcript specific but not 
localised to precise cells/organs. Within the final steps of the ISH protocol, stained 
embryos undergo gradient washes in glycerol prior to being stored permanently in 
70% glycerol. The benefit of glycerol washes is that unspecific purple stain is 
washed out. This would also lessen the purple staining if the embryos were over-
stained. An added benefit of the glycerol is that it whitens the yolk for imaging 
purposes. The high number of embryos assessed by ISH with each probe and the 
consistent staining suggest that the pattern is specific. A minimum of 15 embryos 
from three batches of fish were used. The findings reported here are all backed up 
by the current published work that found comparable dispersed staining (Thisse, B & 
Thisse, C and Siger et al).  
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3.3 Slc34a2a(as) and Rbpja share a bidirectional promoter 
 
Rbpja is located downstream of Slc34a2a and is in a head to head orientation with 
Slc34a2a(as). To date there is no published literature stating where the promoter of 
Rbpja is located. Therefore, by using three different online bioinformatics tools and 
searching for specific DNA sequences manually, the 229 base pairs (bp) spanning 
between the first exon of Slc34a2a(as) and the first exon of Rbpja, along with 1500 
bp either way, was examined to pinpoint a possible promoter location.  
Certain DNA sequences, such as the TATA box (sequence TATAAA) which is 
usually located 25-35bp upstream to the start site, can be indicative for where 
transcription commences (NatureEducation, 2014). However, looking at the region in 
and around the first exons of Rbpja and Slc34a2a(as), no TATA box was found. A 
TATA box was found in the 3rd intron of Rbpja but there was no B recognition 
element in the vicinity. Downstream or upstream B recognition elements are DNA 
sequences that allow contact with the transcription factor TFIIB which promotes the 
assembly of eukaryotic RNA polymerase II (Deng and Roberts, 2006). When 
searching for other known DNA sequences that typically bind transcriptions factors, 
only one E-box (also occasionally called a G-box: sequence CACGTG) was located 
close by to the TATA box. Taken together, this was insufficient evidence to pinpoint 
a TATA box promoter sequence to either Slc34a2a(as) or Rbpja.  
Bidirectional promoters tend not to have a TATA box but instead may have a CCAAT 
box (Orekhova and Rubtsov, 2013). There are three CCAAT boxes in the relevant 
area but none of them lie directly in-between the two reported start sites; two boxes 
are in the second intron of Slc34a2a(as) and one is in the first intron of Rbpja. 
Bidirectional promoters for non-coding transcripts, especially those which have 5’ 
ends facing one another, have CpG islands in 90% of cases and are significantly 
enriched with CCG and CGG repeats (Imamura et al., 2004; Uesaka et al., 2014). 
Both of these qualities were found within the region between Slc34a2a(as) and 
Rbpja. The CpG island is highlighted in grey and the 12 CCG/CGG regions are 
bolded in figure 3.4.     
3. Wildtype expression 
 
61 
 
        
     Antisense transcription direction 
 
 
5’ 
GATGATTTATCTGAGATTGAAGGAGGGTCTATATAAGAATATGTAGTAATATCATCA
CTCTAGCTCATTCCTGAATGGAGGAGTCTTGTTGCAACCGTCCGTCCCCACTCTCCC
TACTACAAATACACAGACAGAAAATAAGGTTAAAGTTTTAAAAAATAAAACATATAC
CTCTGTAAAAATCTTCAGAATACAGCTATTAATAGAACTGAAGTTTGGTGTAAGTGT
TGTTGAAGTGGATATTTGCGGCTAAGTGCAGAAAAATTTGAGAATACGGCCTTAAAA
ATACTGTATGTGAATAAACAAATTAGCAAAAGAAAGATAATTTTTAGGATGTTTTCT
ATGCATTTAGACTGAAATAACACGTGTTGGGTCAAAAATAGTATTATGCAATATTTT
GCCTCAAAGAGGAAAACACGTTAGTAACAATATTATAACACTATTAACTTTCACAGA
CTCTTAATTACAACACCCTTTTGATCTGCTCCACGTCAGATCTCCATTTCCTGGTGT
CGGTCCTCAGTCCTCGGGTTTCCTTCCTTCCAGAAATGTTTTTCTCACGGCCCGCGC
TTTAAAGGTGCGGTCTGTCGTGAGAACTTTCACACGCGTTTGGCTGGCAGCCGTCCG
CGACTCACTCTCGCGATAACACGACACTCGCTCTCATCCGCTCCTATTACATTCGAT
TGCGAGTTCTCGCGTGACTTCAGAACTTTCTCACGCCTGTGCCCCCCTTTCCTGGCG
TTATTTGTCACACCGCCCCTCCCCCTCGTCTGGGCAAATCTCGCGAGTCTCGGCGTT
ATTAGAGAGAGTTGGTGAAGATGGCGCCTGTTGTGACAGGGTAAGCAGCGAAATTAT
CAACGGACGGGGCATGGAAAAGTCACAGCTAAAATAAGTTTTGGCTGTTTAGTGAAG
ATAACTAGATTTGATTTATTTATTTACACATCTGGCCGCTTGTCCCTGCGCTGGCGA
CCAGTTTCACTCTACTTCAGTGTGGTTTTTCAGGTTTTCAGCGATGGGCTCTTTTAT
TCAGTTAGCCGCTTAGCTTTTAGTTAGCTGAAAGATTTTCAGCAGTTTTCCTTAATC
ATTGAATGCTGCTGAGAGCTGATCTTTAACTGTAAACATAGTTAGACTTTATTATTG
GCGTCTTTTGAAACTTTAAACCTTACTTAAAGTCTAAAAATATATAAATAGGAAGTG
AACCAAACTAGTGAGTTGTACTAGAGAGATGGAAAGAGAGAAAGCAGGTTAGCAGTT
GCTAGCCAGCCAGGTTAGCTTGTCTAGTCAGTCCATAACAGTCTGGGAGCTTTCTGG 
         3’ 
 
 
 
            Rbpja transcription direction 
 
Figure 3.4 Genome sequence from Danio rerio showing the first exon of 
Slc34a2a antisense (red) and the first exon of Rbpja (blue). CCG and CGG 
repeats, which are enriched in zones around bidirectional promoters , are in 
bold. The CpG island is highlighted in grey. Eukaryotic promoter predication 
software has determined the regions which are underlined or highlighted in 
green to be promoters. 
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CpGFinder software confirmed the presence of a single CpG island which was 
located in between the Slc34a2a(as) and Rbpja sequences (highlighted in grey in 
figure 3.4; GC%= 54.9) (SoftBerry, 2016).  Promoter2.0 prediction software from the 
Center for Biological Sequence Analysis at the Technical University of Denmark 
DTU pinpointed a more specific area as the promoter sequence; with a high score of 
1.082, the sequence is highlighted in green in figure 3.4 (position score likelihood 
above 1.0 indicated the predication is highly likely, while below 0.5 is to be ignored) 
(Knudsen, 2013). The online tool ‘Neural Network Promoter Prediction’ predicated a 
promoter region which is underlined in figure 3.4 (Reese, 2015). With a perfect high 
score of 1.0 on a scale 0-1 for ‘minimum promoter score’, and both located on 
forward and reverse strands, this sequence is within the region denoted by Softberry 
and right next to the predicated site of Promoter2.0. 
Both Promoter2.0 and Neural Network Promoter Prediction predict promoter regions 
in genomes by searching for eukaryotic polymerase II binding sites. The output may 
differ slightly between the two programs as the relative weighting given to different 
elements differed within the coding of each online  tool. Both programs combine the 
use of neural networks with algorithms that identify a set of patterns with various 
distances in the DNA sequence such as TATA-boxes, GC-boxes, and CAAT-boxes. 
When tested with well documented promoters, Promoter2.0 had a correlation 
coefficient of 0.63 whilst Neural Network Promoter Prediction had a correlation 
coefficient of 0.61 (Knudsen, 2013; Reese, 2015).  
 
 
3.4 Temporal expression levels of Rbpja determined via RT-qPCR 
 
Genes that share a bidirectional promoter are often functionally related and may be 
co-regulated since promoter modifications, such as DNA methylation or histone 
modification, would impact both. Therefore, Rbpja transcript levels were examined 
alongside that of Slc34a2a(as) using RT-qPCR and in situ hybridisation experiments. 
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Figure 3.5 Comparison of the Rbpja temporal expression profile to Slc34a2a(as) 
quantif ied by RT-qPCR. Expression profiles are in relation to the house-keeping 
gene β-actin which maintained a stable Ct value. A decrease in bar size 
designates an increase in transcript level.  Sample age, 8, 24, 32, 48, 56 and 72 
hpf, is represented as lightest to darkest colour  of bars for each transcript . 
Results are from three independent quantifications from three different clutches 
are shown. N=3 
 
 
Detectable from fertilization, Rbpja expression showed a U-shaped pattern with 
highest relative quantity recorded at 32 hpf. Thus, from 8 hpf to 32 hpf, a decrease in 
ΔCt values from 5.70±0.33 to 4.61±0.97 (24 hpf) and 3.25±0.49, indicated an 
increase in transcript levels (individual Ct values of 28.20±0.016, 26.05±0.47, 
25.10±0.38 respectively). From 48 hpf, ΔCt values increased from 4.39±0.31 at 48 
hpf, 8.03±0.54 at 56 hpf and 5.77±0.52 at 72 hpf, meaning a decrease in transcript 
quantity (Ct values respectively: 26.69±0.24, 28.03±0.24, 26.52±0.39). These results 
suggest that Rbpja temporal expression levels, shown in figure 3.5, do not relate to 
that of Slc34a2a(as). 
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3.5 Mapping of Rbpja in comparison to Slc34a2a(as) transcripts by in situ 
hybridization  
 
Rbpja is expressed from fertilisation with undefined localization in 8 hpf and 24 hpf 
embryos (figure 3.6). By 48 hpf and onwards, specific staining was found within the 
otic vesicle (ear) and outlining the posterior of the mesencephalon (midbrain). Rbpja 
is involved in the Notch signalling pathway and has many functions including adrenal 
gland, artery and heart development (Echeverri and Oates, 2007; O'Brien et al., 
2011; Sacilotto et al., 2013), determining left/right symmetry and polarity during 
embryogenesis (Sieger et al., 2003; Echeverri and Oates, 2007), angiogenesis 
(Siekmann and Lawson, 2007) and neurogenesis (Echeverri and Oates, 2007), and 
therefore was not expected to be localised specifically in the midbrain and ear.   
As seen previously with Slc34a2a(as) and Slc34a2b probed embryos, Rbpja staining 
in embryos at early developmental stages appears to be unspecific. Nevertheless, 
several lines of evidence confirm that the signal is transcript specific. As mentioned 
previously, the extensive washes and glycerol storage reduced background 
unspecific staining. Moreover, the high number of embryos from different clutches 
that underwent ISH and showed a consistent pattern also supported that this 
staining was specific. Importantly,  current published work on Rbpja (also known as 
Suppressor of Hairless) confirmed the findings reported here (Echeverri and Oates, 
2007).  
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3.6 Discussion 
 
This chapter gives a comprehensive expression analysis of Slc34a2a and related 
genes during zebrafish embryogenesis. Previously, Carlile et al. showed that 
Slc34a2a(as) expression occurs from fertilization up to 48 hpf and a significant 
decrease thereafter by end point RT-PCR data. The sense transcript (Slc34a2a), on 
the other hand, was only expressed from 48 hpf onwards. Both transcripts were co-
expressed at 48 hpf (Carlile et al., 2008). Expression levels determined with the 
more sensitive RT-qPCR strategy in this study confirmed that both Slc34a2a and 
Slc34a2(as) transcripts were present in 48 hpf embryos and a reciprocal expression 
pattern was established with a gradual shift in expression during the examined 72 
hours of development. 
Different types of relationships can exist between cis and trans NAT pairs in 
eukaryotes; concordant, reciprocal (discordant) and occasionally they are 
permanently co-expressed (Knee et al., 1994; Vanhée-Brossollet et al., 1995; 
Lehner et al., 2002; Nakaya et al., 2007). These publications suggest that antisense 
transcript mediated gene regulation is likely to occur when sense and antisense 
RNAs are reciprocally expressed. For example, the sense transcript for infected-cell 
protein number zero (ICP0) is only found in humans suffering with an acute infection 
of herpes simplex virus type 1, whilst the presence of the antisense ICP0 transcript 
is believed to play a role in inducing latency (Croen et al., 1987). In a patient with 
inherited α-thalassemia a genomic deletion repositioned the constitutively active 
LUC7 gene closely downstream of the HBA2 gene. The resulting antisense 
transcript of the α-globin gene (HBA2) transcriptionally silences the HBA2 gene by 
inducing the methylation of a CpG island in the HBA2 promoter (Tufarelli et al., 
2003). Eukaryotic transcription of initial factor 2 alpha (elF2α) and its cis-NAT have a 
discordant relationship at different cell cycle stages and if the NAT promoter is 
deleted or mutated, a sharp increase in sense RNA is detected in T cells (Silverman 
et al., 1992). In chick embryos, a large (>10 kb) cis-NAT is responsible for the down-
regulation of the alpha 1 collagen gene in chondrocytes (Farrell and Lukens, 1995).   
The qPCR data in this chapter confirms a reciprocal temporal expression pattern for 
Slc34a2a and Slc34a2a(as) transcripts. Just as in some of the examples mentioned 
above, this may suggest that antisense-mediated Slc34a2a gene regulation is 
occurring via RNA hybrid formation during zebrafish embryogenesis. The possibility 
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of antisense-mediated Slc34a2a transcript control is further supported by the finding 
that both transcripts localise to the same tissues including the pharynx, endoderm, 
primordial midbrain channel and primordial hindbrain channel in roughly the same 
quantities (ΔCt  Slc24a2a 11.78±0.52, Slc24a2a(as) 11.62±0.33).  No literature 
published to date has demonstrated the localisation of Slc34a2a or its antisense 
transcript in developing zebrafish. However, as Slc34a2a is found in healthy 
digestive tract and kidney tissues (Graham et al., 2003), it was as hypothesised that 
Slc34a2a would be found in the endoderm. 
β-actin was chosen as the reference gene for the above relative quantitative PCR 
experiments for its high and steady expression level throughout zebrafish embryo 
development (Casadei et al., 2011). Quantitative analysis of RNA extraction from 23-
24 zebrafish embryos has shown that β-actin quantity remains at a stable level of 
54.4± 23.9 ng throughout embryo/larvae stages (Casadei et al., 2011). Initially, use 
of one embryo for the above RT-qPCR was attempted but this proved difficult as the 
obtained values were close to the detection limit, making results unreproducible. 
Consequently five embryos were used. Therefore, based on the above results, for 
five embryos at 48 hpf, Slc34a2a, Slc34a2a(as), Slc34a2b and Rbpja levels are 
considerably less than 6.49 to 16.66 ng range. Fold change or ΔΔCt could not be 
calculated as samples were taken only from one condition (wildtype embryos 
maintained under normal developmental conditions).  
Slc34a2b, which is transcribed from chromosome 23, has a nucleotide sequence 
identity of 68.4% to Slc24a2a, which is transcribed from chromosome 1 (EMBL-EBI, 
2016). No relationship between Slc34a2b and Slc24a2a expression was expected as 
the transcripts are transcribed from different chromosomes and therefore are driven 
by different promoters. No published works have reported a correlation between 
Slc34a2a and Slc34a2b expression levels and the above qPCR data endorses 
independent expression of the two genes.  
The nucleotide sequence identity between Slc34a2b and Slc24a2a(as) is 37.7% and 
the longest stretch of complementary base pairs encompasses 11 bp. Therefore, 
hybrid formation between Slc34a2b and Slc24a2a(as) would not support processing 
into endo-siRNAs nor recognition by ADARs (Carlile et al., 2008; Barraud and Allain, 
2012). Thus no expression pattern relation was expected and none was found in RT-
qPCR. In situ hybridization, which found that the Slc34a2b and Slc24a2a/ 
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Slc34a2a(as) transcripts do not locate to the same tissue in developing embryos, 
further supports the idea that Slc34a2b and Slc34a2a(as) RNA transcripts are 
unlikely to interact.  
Eukaryotic promoters are difficult to characterise since there are many diverse 
elements to take into account. Gene promoters tend to be 10-40 base pairs away 
from the transcriptional start site but regulatory elements can be several kilobases 
apart making matters considerably more complicated. In the human genome, nearly 
11% of genes share a bidirectional promoter (Trinklein et al., 2004). These 
promoters are usually short (less than 1000 base pairs) and are found between the 
5’ ends of two genes (Orekhova and Rubtsov, 2013). Even though more than 70% of 
the human genome is transcribed, only 2% is protein coding, indicating that most 
transcription is non-protein coding (Consortium, 2007; Consortium, 2012). Recent 
studies have shown that non-coding RNA transcripts are often linked to the 
promoters of protein-coding genes (Wei et al., 2011).  
Accordingly, many indicators for bidirectional promoter activity were found in the 229 
bp flanked by Rbpja and Slc24a2a(as), including a CpG island, an accumulation of 
CCG and CGG repeats, and a CCAAT box. The region between the protein-coding 
Rbpja gene and the non-coding transcript Slc34a2a(as) can be confidently proposed 
as a bidirectional promoter. This statement could be validated with the completion of 
reporter gene studies.  
Genes that share a bidirectional promoter are often functionally related and tend to 
be co-regulated since any modification, such as DNA methylation or histone 
modifications, to their shared promoter would impact both (Shu et al., 2006). Rbpja 
RNA levels were examined by qPCR and a U-shaped temporal expression pattern 
was found. This Rbpja expression pattern, however, did not correlate with the steady 
decline of Slc24a2a(as) transcript levels.  
Even though certain genes that share bidirectional promoters undergo simultaneous 
divergent transcription and are co-expressed, such as many of those that are 
involved in DNA repair,  this is not the rule for all bidirectional promoters (Xu et al., 
2012). Nucleosomes can shift transcription from one strand to the other, or distant 
control elements and cognate transcription factors can affect the direction based on 
being expressed or repressed (Trinklein et al., 2004). This is in line with the RT-
3. Wildtype expression 
 
69 
 
qPCR results which indicate that Rbpja and Slc24a2a(as) are not simultaneously 
present in equal amounts. 
In situ hybridization confirmed Rbpja expression from fertilisation with undefined 
localization in 8 hpf and 24 hpf embryos (figure 3.6). Comparable dispersed staining 
was reported by Sieger et al. when mapping Rbpja in the early stages of 
development (Sieger et al., 2003). The experiments reported in this chapter 
established specific staining within the otic vesicle (ear) and it the posterior of the 
mecencephalon (midbrain) 48 hpf and onwards. However, considering Rbpja’s many 
functions, the localisation in the ear was unexpected. It was hypothesised that Rbpja 
would rather localise to the heart region, the endoderm and the brain due to its 
involvement in adrenal gland, artery and heart development (Echeverri and Oates, 
2007; O'Brien et al., 2011; Sacilotto et al., 2013), determining left/right symmetry and 
polarity during embryogenesis (Sieger et al., 2003; Echeverri and Oates, 2007), 
angiogenesis (Siekmann and Lawson, 2007) and neurogenesis (Echeverri and 
Oates, 2007). It may be possible that Rbpja has yet another role in zebrafish 
development that has not yet been characterised which is why it localises to the otic 
vesicle or mayhap Rbpja is stored in otic vesicle cells until required. No published 
data is available for Rbpja expression past 24 hpf (prim-5 stage). Nevertheless, in 
the presented experiments Slc34a2a(as) and Rbpja probes never localised to the 
same regions within the embryos. These findings indicate that even though the two 
genes share a bidirectional promoter, simultaneous, divergent transcription is not 
occurring within the same cells; their individual transcription is tissue specific. Thus, 
nucleosome placement or additional control elements may have a role in driving the 
expression of Slc34a2a(as) and Rbpja. 
The RT-qPCR experiments show a significant decrease of Rbpja and Slc34a2b 
expression in zebrafish at 56 hpf. These embryos are within the hatching period 
where growth rate has slowed minimally but organ rudiment morphogenesis has 
neared completion outside of gut and related organs (Kimmel et al., 1995). 
Consequently, there is no specific embryonic developmental event that would predict 
the decrease seen in Slc34a2b and Rbpja RNA levels. As this decrease is not visible 
with Slc34a2a or Slc34a2a(as) transcript levels, the incident is unlikely due to the 
experimental procedures.  
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3.7 Conclusion 
 
The aforementioned RT-qPCR and ISH data are consistent in temporal expression 
patterns for all transcripts examined. Even though Slc34a2a(as) and Rbpja share a 
bidirectional promoter, the two do not undergo simultaneous divergent transcription 
as they do not localise to the same embryonic structures. Slc34a2a and 
Slc34a2a(as) transcripts demonstrate a reciprocal relationship and were found within 
the same developing organs. It is conceivable that the two complimentary transcripts 
control each other’s expression like the examples of infected-cell protein number 
zero (ICP0) and initial factor 2 alpha (elF2α) in humans. Whether Slc34a2a(as) is 
controlling Slc34a2a levels, or vice versa, by generating dsRNA and initiating RNAi 
requires interference studies affecting the natural balance of endogenous Slc34a2a/ 
Slc34a2a(as) expression levels.  
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Chapter 4. Interfering with the natural Slc34a2a sense and 
antisense balance leads to cerebellar loss  
 
In the previous chapter characterising wildtype expression, it was found that 
Slc34a2a and its antisense transcript showed a temporal reciprocal expression 
pattern. At time-points when both were expressed, they located to the same regions 
of the developing embryo: the pharynx, endoderm (future digestive tract and swim 
bladder), primordial midbrain channel and the primordial hindbrain channel. For 
genes where the natural antisense transcripts show reciprocal expression, it has 
been widely demonstrated that the complementary transcripts control each other’s 
expressions levels (Kraus et al., 2013; Zong et al., 2016) . Therefore this chapter 
aims to investigate the consequences of a disturbed sense/ antisense balance on 
embryonic development. The time frame of embryogenesis is important because of 
the significant expression changes to both sense and antisense transcripts occurring 
as demonstrated in chapter 3.   
 
 
4.1 Phenotype classification of zebrafish embryos 
 
The following subsections describe experiments where endogenous RNA levels of 
embryos were manipulated via microinjection. A simple classification system, with a 
scale from 1-5, was created to consistently log the phenotypic changes for a high 
number of injected embryos during early development.  
Level 1, as seen in figure 4.1, describes wildtype embryos as observed in non-
injected fitness controls or in water/phenol red injected control embryos. These 
embryos have the correct length (24 hpf length ~1.9 mm, 48 hpf length ~3.1 mm) 
and anatomical features as stated by Kimmel et al (Kimmel et al., 1995).  
Level 2 classified embryos appear like wildtype fish but on closer inspection of the 
morphology, a single developmental defect can be identified. In the case of the level 
2 24 hpf embryo pictured in the top row of figure 4.1, the ‘back’ is bent inwards whilst 
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the 48 hpf embryo (bottom row) has not yet straightened out which in turn shortens 
its overall length. Other examples of individual defects that can lead to level 2 
classification include heart jogging in the wrong direction, incorrect heart rate, blunt 
tail tip or the lack of fin buds (at 48 hpf).  
 
 
 
Figure 4.1 Danio rerio embryos at 24 hpf (prim-5 stage) (top row) and at 48 hpf 
(long-pec stage) (bottom row) separated into a level classification system based 
on phenotype severity. Level 1; wildtype. Level 2 ; one developmental defect. 
Level 3; two or more developmental defects but still recognizable as a fish 
embryo. Level 4; severely disfigured and barely recognizable as a fish embryo. 
Level 5; failure to develop passed the blastula period. Scale bar at 0.1 mm.  
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Embryos classified as level 3, have multiple developmental defects but are still 
recognizable as zebrafish embryos. In figure 4.1, the level 3 24 hpf embryo in the top 
row, has neither initiated eye nor brain development and has a significantly 
shortened and curved body. The level 3 48hpf embryo (bottom row figure 4.1) has a 
significantly shortened and curved body. In addition, it shows an enlarged area 
above the rhombomeres and a flattened face.  
Level 4 embryos are barely recognizable as fish embryos and therefore lack 
numerous features and organs whilst level 5 embryos never developed past the 
blastula period (figure 4.1).  
In addition to the morphological phenotype, heart rate and basic behaviour were 
taken into account. The heart rate for a healthy wildtype embryo within the first three 
days of development is 120-160 beats per minute (De Luca et al., 2014). A reaction 
test was completed by prodding the embryo with forceps to screen for abnormal 
behaviour. A wildtype embryo would not tolerate being touched and would quickly 
swim away to find safety in either the edge of the petri dish or in a group of embryos 
on the other side of the dish. Fish with an abnormal behavioural phenotype could be 
poked either numerous times and would only swim away after a prolonged delay 
and/or would escape only a short distance or swim in a small circle only to end up in 
the original area (in danger of another poke).   
 
 
4.2 Microinjection of full length capped Slc34a2a RNA causes developmental 
deformities 
 
Full length capped Slc34a2a, Slc34a2b and Slc34a2a(as) in vitro synthesized 
transcripts were created as stated in Chapter 2. Different dilutions of each RNA were 
injected into wildtype AB or Golden 1-4 cell stage embryos. Phenol red was used as 
a marker to visualize the injection droplet. Therefore, phenol red mixed with water 
was used as negative control for the injection procedure. Morphological phenotypes 
and behaviour were logged at both 24 and 48 hpf. Data were only collected from 
clutches whose fitness non-injected control group (min 50 embryos) exceeded 80% 
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survival in the first 24 hours of development. Examined embryos came from a 
minimum of three clutches for each injected sample. 
Based on current published work, anywhere between 25-500 pg of RNA material has 
been microinjected into zebrafish embryos to produce a specific effect (Person et al., 
2010; Kim et al., 2011; Lu et al., 2011; Dahlem et al., 2012). Therefore, in a first set 
of experiments, 287 embryos were injected with 165 pg of Slc34a2a RNA. The 
sense transcript Slc34a2a is not expressed within the first 48 hours of development. 
Thus it was hypothesised that injection of exogenous Slc34a2a RNA into fertilized 
eggs would mimic ectopic co-expression of complementary sense and antisense 
Slc34a2a transcripts during early development. 
All 165 pg Slc34a2a RNA injected 24 hpf embryos appeared developmental delayed 
upon first inspection. Although brain sections are fully formed by 24 hpf in wild type 
fish (Kimmel et al., 1995), the embryos injected with Slc34a2a RNA showed no sign 
of brain development since no segment division was visible.  Alongside 
indistinguishable brain features, the majority of embryos had developmental defects 
of the heart, yolk, eyes, body and/or tail. Due to the apparent overall developmental 
delay at 24 hpf, most of the data presented was based on 48 hpf embryos since all 
organs and features were discernible (figure 4.2).  
At 48 hpf (long-pec stage) 60 (20.9%) injected embryos were classified as wildtype 
as seen in figure 4.2. The majority of embryos were classified as level 2 (68 
embryos, 23.6%) or level 3 (101 embryos, 35.1%). Phenotype deformities amongst 
these level 2/3 embryos varied considerably from shortened body length, smaller 
heads, improperly sized and/or shaped eyes, blunt tails, improper yolk shape, and/or 
incorrect heart development (wide-ranging heart rates). If any brain formation was 
present, proportions were incorrect and/or midbrain -hindbrain regions were missing. 
A significant proportion of 165 pg Slc34a2a RNA injected embryos were severely 
affected (stage 4; 39 embryos, 13.5%) including embryos that were completely 
missing upper bodies, cyclops with a twisted curly tail and even a two headed 
embryo was found. A large number of embryos did not progress past the blastula 
stage (19 embryos, 6.6%). All embryos that were stage 2 to 4, were noted to be 
significantly less active and did not react appropriately to stimuli, i.e. did not swim 
away when prodded (Appendix B, videos). Especially those with tail or yolk defects 
could not swim straight or in an upright position.  
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The severity and variety of the phenotypic deformities and behavioural changes 
seen in embryos injected with 165 pg Slc34a2a RNA suggested that the effects were 
mostly unspecific. Hence the amount of injected RNA was reduced to 110 pg and 
82.5 pg, respectively (figure 4.2).  
 
 
 
Figure 4.2 Compiled results of microinjections of full-length capped Slc34a2a 
RNA transcript into fertilised zebrafish eggs. Three different amounts of RNA 
were injected. The embryos were analysed at 48 hpf and scored according to 
the 1-5 classification introduced above. The percentage of embryos with a 
specific degree of deformation (1-5) are presented as a bar graph. A minimum 
of 247 embryos from three clutches were analysed for each injected amount of 
RNA.  
 
 
247 48 hpf embryos were injected with 110 pg Slc34a2a RNA and were scored as 
follows: 21 embryos (8.4%) were classified as level 1 (wildtype) as shown in figure 
4.2. The majority were classified as level 2 (142 embryos, 57.5%) or level 3 (47 
embryos, 19.2%). 34 embryos (13.8%) were severely disfigured and thus classified 
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as level 4 and 3 did not develop past blastula stage (level 5, 1.2%). In comparison to 
the embryos injected with 165 pg Slc34a2a RNA, embryos at level 2/3 of the 110 pg 
injected group appeared to experience less severe developmental malformations. 
Deformations included improper segmentation of the brain, complete loss of 
cerebellum and shortened, bent or kinked tail. These embryos too had slower 
reaction times to stimuli and seemed overall less active in comparison to their non-
injected or water injected control groups. Those with bent or kinked tails were unable 
to swim straight or in an upright position.  
When the amount of Slc34a2a RNA was reduced to 82.5 pg, 25 (7.8%) of 307 
embryos examined were classified as level 1 and over half were level 2 (163 
embryos, 53.1%). 147 of the level 2 embryos shared the same unique malformation, 
a complete loss of the cerebellum. Only 16 embryos differed in their one 
developmental malformation including missing eyes, heart jogging to the right 
instead of the left, or a bent or shortened tail. The majority of level 3 classified 
embryos (86, 28.1%), shared the loss of cerebellum alongside another deformation 
like bent tail, curved body or shortened tail length. The remaining embryos were 
either classified as level 4 (26 embryos, 8.6%) or level 5 (7 embryos, 2.3%) as 
visualised in figure 4.2. All embryos classified as level 2-4 showed slower reaction 
times in the poke test as visualized in the attached videos (Appendix B).  
The highest percentage of embryos classified as level 1, phenotypically ‘normal’, 
were found in the group injected with the highest quantity of Slc34a2a RNA (20.85% 
of 165 pg injected) as compared to the 8.38% of the 110 pg injected and 7.81% of 
82.5 pg injected groups, as depicted in light pink in figure 4.2. This result was 
unexpected as the remaining 165 pg injected embryos had severe malformations 
that were easily recognizable. The majority of embryos injected with 82.5 pg or 110 
pg Slc34a2a RNA were classified as level 2. Upon first inspection of embryos 
injected with 110 pg, in comparison to the 165 pg injected groups, the embryos 
looked affected but were not as severely malformed. In contrast, a first general 
assessment of embryos injected with 82.5 pg of Slc34a2a RNA, majority appeared 
normal. Further detailed inspection of individual fish revealed that they shared the 
same phenotypic imperfection with the cerebellum missing as shown in figure 4.3.  
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Figure 4.3 Zebrafish embryos at 48 hpf (long- pec stage). A) Representation of 
the different segments of the zebrafish brain taken from Kimmel et al (1995); 
FP- floor plate, D- diencephalon, T- telencephalon, E- epiphysis, M-
mesencephalon, C- cerebellum and R (1-7) are the seven hindbrain 
rhombomeres.  B) Fitness control: the cerebellum is clearly visible (red arrow). 
C) 110 pg Slc34a2a transcript injected embryos showing severe brain and eye 
abnormalities. D) 82.5 pg Slc34a2a injected embryos lacking cerebellar 
development (red arrow). Scale bar at 0.1 mm. 
 
 
Slc34a2b is a paralog of Slc34a2a and as the two share 68.4% nucleotide sequence 
identity, Slc34a2b RNA microinjections were completed alongside Slc34a2a. From 
the examined 291 embryos injected with 165 pg of Slc34a2b RNA, 223 were 
classified as wildtype level 1 (76.6%), 44 were level 2 (15.0%), 16 were level 3 
(5.6%), 3 were severely deformed at level 4 (0.9%) whilst 5 never developed past 
the blastula stage (level 5, 1.9%). These values are represented as percentages in 
stack column format in figure 4.4.  In contrast to Slc34a2a injected embryos, the 165 
pg Slc34a2b controls that were classified as level 2 or 3, did not have consistent 
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malformations. Deformations included body curvature, tail length and shape, eye 
size and form, size of ‘nose’ and heart rates. When the amount of Slc34a2b RNA 
was reduced to 110 pg, the bulk of the 247 embryos assessed were classified as 
level 1 (194 embryos, 78.6%). Of the remaining embryos, 14 were level 2 (5.7%), 14 
were level 3 (5.7%), 5 were level 4 (2.1%) and 20 were level 5 (7.9%). No consistent 
phenotypic deformations were visible and the malformations noted were comparable 
to the 165 pg Slc34a2b RNA injected group. As these two experiments did not 
produce a specific phenotype, the injected amount of Slc34a2b was not further 
reduced. 
Capped full length Slc34a2a(as) RNA microinjection was also completed to 
determine whether overexpression of the antisense transcript would interfere with 
normal embryonic development. Slc34a2a(as)  RNA injection was completed with 
110 pg of RNA into fertilised oocytes from three clutches. Of the 94 embryos 
examined, not a single one was found to be affected; thus 100% at level 1 as 
depicted in the 100% stacked column in figure 4.4.  
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Figure 4.4 Compiled results of microinjections of all full-length capped RNA 
transcripts into fertilised zebrafish eggs. The resulting embryos were analysed 
at 48 hpf and the number of embryos with a specific degree of deformations (1 -
5) are presented as a 100% stacked bar graph. The bars represent the 
percentage of a specific phenotype.  A minimum of ninety embryos from three 
clutches were used for these calculations. A total of 1186 embryos were 
analysed; 554 injected with Slc34a2a, 538 injected with Slc34a2b and 94 with 
Slc34a2a(as) RNA. 
 
 
 
4.3 Capping of microinjected RNA transcripts is not necessary  
 
Capped and uncapped in vitro synthesized RNA transcripts were produced for the 
sense transcript Slc34a2a. Upon microinjection, comparable phenotypic changes 
were observed at 48 hpf (figure 4.5). The majority of embryos injected with capped 
and uncapped 82.5 pg Slc34a2a RNA showed the same characteristic loss of 
cerebellum and were classified as level 2.  
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Figure 4.5 Capping of in vitro synthesized Slc34a2a RNA transcript is not 
required to induce phenotypic malformations. At 48 hpf,  loss of cerebellum was 
detected in the majority of  injected embryos whether capped or uncapped 
Slc34a2a RNA was microinjected. 76 embryos from three clutches were tested 
with uncapped Slc34a2a RNA.  
 
 
4.4 In situ hybridization with the specific marker Eng2 confirms the loss of 
cerebellum  
 
To confirm the loss of the cerebellum, in situ hybridization (ISH) was completed 
using a specific marker for the cerebellar region of the brain. A plasmid containing 
the cDNA sequence for the homeobox protein Engrailed-2 (Eng2) was obtained from 
Prof. C. Houart (Kings College London) from which both forward (T7) and reverse 
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probes (T3) were synthesized as mentioned in Chapter 2. No staining was visible 
with the T7 control probes and results for T3 probes are presented in figure 4.6.  
 
 
 
Figure 4.6 Engrailed-2 probe used in whole-mount in situ hybridization to show 
the loss of cerebellum at 48 hpf after full length RNA transcript microinjection.  
A) wildtype (non-injected control) B) 110 pg Slc34a2a injected C) 110 pg 
Slc34a2a(as) injected D) 165 pg Slc34a2b injected. Scale bar at 0.1 mm. 
 
 
Zebrafish Engrailed-2a (Eng2) is transcribed from chromosome 7 and the protein is 
located within the nucleus. Expression commences during the blastula stage (~5-10 
hpf) and continues throughout embryogenesis. As it is vital for proper midbrain-
hindbrain boundary development, expression can be found in the midbrain-hindbrain 
furrow (midbrain-hindbrain boundary) and the cerebellum (Fjose et al., 1992; Thisse, 
2005; D'Aniello et al., 2013). Orthologs in fruit flies, mice and humans also regulate 
pattern formation during central nervous system development and a knock-out of 
Eng2 is lethal (Hanks et al., 1995; Hanks et al., 1998).  
Eng2 was therefore used to corroborate the effect of Slc34a2a RNA microinjections 
on cerebellar development. As seen in figure 4.6 A, the midbrain-hindbrain region, 
including the entire cerebellum, stained as a thick purple wedge in the wildtype non-
injected sample. Comparable staining was visible within embryos injected with 110 
pg Slc34a2a(as) RNA (Fig 4.6, C) and 165 pg Slc34a2b RNA (Fig 4.6, D). However, 
in embryos injected with 110 pg Slc34a2a RNA (Fig 4.6, B), the cerebellar Eng2 
staining was almost completely absent indicating a complete loss of cerebellum and 
a widening of the midbrain-hindbrain boundary furrow (indicated by the sliver of 
purple pointing backwards). 
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4.5 Loss of cerebellum does not alter cranial motor neuron development (in 
Islet1-GFP transgenic zebrafish)  
 
In order to test whether Slc34a2a RNA expression in the first 48 hours of 
embryogenesis affected other less evident brain structures, Slc34a2a RNA 
microinjection was complete in Islet1-GFP embryos. Islet1-GFP transgenic fish 
express green fluorescent labelled Islet1 (Isl1), which is located in all post mitotic 
central nervous system motor neurons (Higashijima, 2008). Islet1-GFP zebrafish 
fertilized eggs were used to establish if the loss of cerebellum altered cranial motor 
neuron development. As demonstrated in figure 4.7, the loss of cerebellum in 82.5 
pg Slc34a2a RNA injected embryos (D) caused neither a change in motor neuron 
development nor arrangement as compared to the non-injected controls (C). 
However, it is important to note that Isl1 containing neurons are neither expressed in 
the mesencephalon nor the cerebellum but localise below these brain segments 
within the rhombomeres (Fig 4.7, A).  
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Figure 4.7 Loss of cerebellum due to Slc34a2a RNA microinjection had no 
impact on CNS motor neuron development in 48 hpf Islet1-GFP transgenic 
zebrafish. A) Lateral view of a wildtype embryo to show the cranial nerve 
fluorescence relative to the mesencephalon (M) and cerebel lum (C).  B) Dorsal 
view of wildtype embryos depicting cranial nerve arrangement in relation to 
brain segmentation where r0-7 indicate the rhombomeres. Figure taken from 
(Moens and Prince, 2002). C) Dorsal view of wildtype non-injected control 
embryo.  D) Dorsal view of an embryo injected with 82.5 pg Slc34a2a RNA. 
Scale bar at 0.1 mm. 
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4.6 Expression profiles of Slc34a2b, Slc34a2a sense and antisense in 
microinjected embryos 
 
Due to the possibility of interaction and cross regulation between all the transcripts of 
interest, endogenous and exogenous levels of Slc34a2a, Slc34a2a(as) and 
Slc34a2b were monitored by semi quantitative RT-qPCR and in situ hybridization. 
RNA extraction was performed on 10 and 24 hpf samples for RT-qPCR analysis due 
to the likelihood of biological interference occurring early after injection.  
During the microinjection process, from each clutch of fertilized eggs, a minimum of 
50 embryos became the non-injected fitness control group, >30 embryos were 
designated for the water/phenol red control injection and the rest were divided into 
injection groups. Five embryos from a minimum of three different clutches were 
collected from groups injected with either 165 pg of Slc34a2a RNA, 165 pg of 
Slc34a2b RNA or 110 pg of Slc34a2a(as) RNA and non-injected controls. RNA 
extraction and RT-qPCR was completed in triplicate as mentioned in chapter 2. 
Water and RNA (negative) controls were always run in triplicate alongside the cDNA 
samples. RNA integrity and concentration were tested for each extraction by 
agarose gel electrophoresis and OD measurements. The average concentration of 
RNA from five embryos used in RT-qPCR was ~90 ng/µl.  Cycle threshold values 
and melting peaks were considered to verify specific qPCR products. β-actin was 
used as reference gene for relative quantification and it maintained a constant Ct 
value of about 21.  
Fertilized eggs that were injected with Slc34a2a, Slc34a2a(as) and Slc34a2b RNA 
underwent RNA isolation after 10 and 24 hours. Comparable results were found for 
the two time points (figure 4.8). Only one transcript had a ΔCt difference greater than 
2, depicted as red bars in figure 4.8, 165 pg Slc34a2a injection altered Slc34a2b 
levels greatly between 10 and 24 hpf; transcript levels increased dramatically from a 
ΔCt 5.40±0.52 to ΔCt 0.35±0.27. Otherwise, transcript levels did not differ greatly 
between 10 and 24 hours post-injection and as a result, only 24 hour data is 
presented for analysis below.  
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Figure 4.8 RT-qPCR analysis of Slc34a2a, Slc34a2a(as) and Slc34a2b 
transcript levels on RNA extracted from zebrafish embryos at 10 and 24 hpf. 
RNA extraction was performed from five embryos for each set of injections. ΔCt 
is calculated by using β-actin as gene reference. β-actin maintained a 
consistent Ct throughout all experiments. N=3 
 
 
To determine the impact of Slc34a2a, Slc34a2a(as) and Slc34a2b RNA injection on 
the Slc34a2a transcript levels, RT-qPCR was completed on RNA extracted from 24 
hpf embryos that underwent each injection. Embryos injected with 165 pg Slc34a2a 
RNA had considerably higher levels of Slc34a2a transcript when compared to non-
injected controls, as well as embryos injected with 165 pg Slc34a2b and 110 pg 
Slc34a2a(as) RNA (figure 4.9).  In embryos injected with 165 pg Slc34a2a, Slc34a2a 
transcript levels were near β-actin levels (ΔCt = 0.98±0.22). Based on the data 
provided in figure 4.9, Slc34a2a expression appears to have decreased by a ΔCt of 
1-2 in Slc34a2a(as) and Slc34a2b RNA injected samples in comparison to wildtype 
samples (ΔCt Slc34a2a(as) =9.25 ±0.35, ΔCt Slc34a2b =10.45 ±0.85, ΔCt non-
injected control =7.62 ±0.38). However, as established in the previous chapter, the 
Slc34a2a transcript is not endogenously present at 24 hpf. The discrepancy of the 
background values for Slc34a2a between this and the previous chapter reflect the 
fact that two different primer pairs were used.   
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Figure 4.9 Examination of Slc34a2a transcript levels by RT-qPCR after RNA 
microinjection. RNA was extracted from five 24 hpf zebrafish embryos that 
underwent microinjection with either Slc34a2a, Slc34a2a(as) or Slc34a2b RNA.  
ΔCt were calculated by using β-actin as the gene of reference. β-actin 
maintained a consistent Ct throughout all experiments. N=3 
 
 
Upon injecting 110 pg Slc34a2a(as) RNA, embryos were found to have decreased 
Slc34a2a(as) levels since ΔCt increased from 4.61±0.29 in non-injected embryos to 
7.87 ±0.62 (figure 4.10, middle). Moreover Slc34a2b levels were found to increase 
since ΔCt decreased from 3.85±0.99 in non-injected to 1.10±0.49 in injected 
samples (figure 4.10, right). As mentioned previously, the apparent Slc34a2a 
expression decrease in Slc34a2a(as) RNA injected samples in comparison to control 
embryos is irrelevant (ΔCt Slc34a2a of 110 pg Slc34a2a(as) injected =9.25 ±0.35, 
ΔCt Slc34a2a in non-injected control=7.62 ±0.38) since Slc34a2a is not 
endogenously expressed at 24 hpf (chapter 3 results).  
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Figure 4.10 Semi quantitative RT-qPCR analysis of RNA extracted from five 
fertilised zebrafish oocytes 24 hours post injection with 110 pg Slc34a2a(as) 
RNA (blue) in comparison to non-injected samples (grey). ΔCt is calculated by 
using β-actin as gene reference. N=3  
 
 
In a subsequent set of experiments, the consequences of 165 pg Slc34a2b RNA 
microinjection were examined. Slc34a2a sense transcript levels were found to be 
below detection level (chapter 3; Slc34a2a is not present at 24 hpf in wildtype 
embryos). Interestingly, Slc34a2a(as) levels decreased significantly upon Slc34a2b 
RNA injection with a ΔCt difference of ~4 when compared to the non-injected control 
group (figure 4.10, ΔCt Slc34a2a(as) in 165 pg Slc34a2b RNA injected=9.28±0.33, 
ΔCt Slc34a2a(as) in non-injected control=4.61±0.29). Upon injecting Slc34a2b, 
Slc34a2b transcript levels increased sizeably in 24 hpf embryos as shown in figure 
4.11 (right) (ΔCt change of 2.75; ΔCt Slc34a2b in 165 pg Slc34a2b RNA 
injected=1.10±0.49, ΔCt Slc34a2b in non-injected control= 3.85±0.99).  
 
4. Cerebellar loss 
 
88 
 
 
 
 
Figure 4.11 Semi quantitative RT-qPCR analysis of RNA extracted from five 
fertilised zebrafish oocytes 24 hours post injection with 165 pg Slc34a2b RNA 
(purple) in comparison to non-injected samples (grey). ΔCt is calculated by 
using β-actin as gene reference. N=3 
 
 
4.7 Localization of transcripts after microinjection 
 
Endogenous and exogenous levels of Slc34a2a, Slc34a2a(as) and Slc34a2b were 
monitored by in situ hybridization (ISH) after microinjection of the different transcripts 
into fertilised embryos. The purpose of these experiments was to monitor the fate of 
the injected material and investigate possible interactions and cross regulation 
between the transcripts. Mapping by ISH was completed on microinjected PFA-fixed 
embryos at 24 hpf and 48 hpf in line with the experiments described in chapter 3. 
Digoxigenin labelled probes for Slc34a2a, Slc34a2a(as), Slc34a2b and Rbpja were 
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used. Sonic Hedgehog was used as a control (figures 4.12 and 4.13) and staining 
located to the central nervous system, floor plate and brain as in published work 
(Sumanas et al., 2005; Thisse, 2005; Jensen et al., 2012; Chatterjee et al., 2014). 
These findings included the embryos that were severely developmentally affected by 
165 pg Slc34a2a RNA injection (figures 4.12 and 4.13, second column). 
Slc34a2a was undetectable in non-injected and all injected 24 hpf embryos as seen 
in the top row of figure 4.12. The 165 pg Slc34a2a RNA injected embryo, which is 
developmentally hindered with a lack of eye formation and shortened body length, 
shows no Slc34a2a purple staining whatsoever. This is contradictory to the above 
RT-qPCR results which found a significant increase in Slc34a2a transcript levels 
after Slc34a2a injection. Slc34a2a was undetectable in 24 hpf zebrafish embryos by 
both ISH and RT-qPCR in chapter 3 (non-injected samples). 
Slc34a2a(as) was found to be dispersed in the head region and in the endoderm of 
24 hpf non-injected wildtype embryos and 165 pg Slc34a2a2b RNA injected 
embryos (figure 4.12, second row). The Slc34a2a(as) staining in the Slc34a2b 
injected embryos appears to be in the same magnitude as that seen in the wildtype 
embryos. This is contrary to the RT-qPCR analysis as Slc34a2a(as) levels were 
determined to decrease upon injection of 165 pg Slc34a2b. In the 110 pg 
Slc34a2a(as) RNA injected embryos, there is reduced staining. This matches the 
RT-qPCR analysis above which determined that Slc34a2a(as) transcript levels 
decreased after Slc34a2a(as) injection. In the developmentally affected Slc34a2a 
injected embryos, minimal staining was visualised behind the eye. This apparent 
reduction in Slc34a2a(as) levels visualised via ISH is consistent to the qPCR results.  
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Rbpja, which shares a bidirectional promoter with Slc34a2a(as), was also examined 
for any change in endogenous levels that could have been influenced by 
microinjection. Rbpja was found to be dispersed in the head region of the non-
injected control, 110 pg Slc34a2a(as) RNA and 165 pg Slc34a2b RNA injected 
embryos (figure 4.12, third row). The strength and dispersion of the Rbpja staining 
appears to be equal in these embryos. Differing, in the 165 pg Slc34a2a RNA 
injected embryos, staining was apparently reduced with only a faint signal found in 
the head directly behind the eye.  
Slc34a2b localised to the otic vesicle (ear) and the eye in the 24 hpf non-injected 
wildtype embryos as demonstrated in figure 4.12 (fourth row). The same staining 
pattern and intensity was visible in Slc34a2a and Slc34a2a(as) injected embryos. In 
the qPCR data above, Slc34a2b levels were found to increase upon Slc34a2a(as) 
injection; this increase was not apparent in the ISH staining. In Slc34a2b injected 
embryos, the same staining of the otic vesicle and eye was visualised but there too 
was extra specific staining located in the midbrain (mesencephalon). This apparent 
increase is consistent with the Slc34a2b transcript increase measured by RT-qPCR 
analysis.  
In 48 hpf embryos, Slc34a2a localised to the endoderm and the pharynx (future 
digestive tract and swim bladder) as well as to primordial midbrain and hindbrain 
channel in wildtype embryos (Figure 4.13, top row). The same staining pattern in 
alike intensity was visible in 110 pg Slc34a2a(as) RNA and 165 pg Slc34a2b RNA 
injected embryos. Within the 165 pg Slc34a2a RNA injected embryos, which all had 
developmental defects, staining seemed more dispersed and differed in localization. 
In the Slc34a2a injected embryo visualised in figure 4.13, dispersed staining 
occurred throughout the head region with specific staining in the endoderm, 
primordial midbrain channel and what appears to the rhombomeres 3-7.  
Slc34a2a(as), localised to the pharynx, endoderm and primordial midbrain and 
hindbrain channel reproducibly in 48 hpf non-injected embryos and those injected 
with 110 pg Slc34a2a(as) RNA and 165 pg Slc34a2b RNA (figure 4.13, second row). 
In 48 hpf 165 pg Slc34a2a RNA injected embryos, just as in 24 hpf embryos, there 
appeared to be reduced staining in the head region.  
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Rbpja was found in the otic vesicle (ear) and the posterior of the mesencephalon 
(midbrain) in near same intensity in all injected and non-injected samples (figure 
4.13, third row). Slc34a2b localised to the otic vesicle and endoderm of non-injected 
48 hpf embryos as visualised in figure 4.13 (fourth row). The same staining pattern in 
a similar intensity was visualised in 110 pg Slc34a2a(as) injected embryos. In 48 hpf 
165 pg Slc34a2b injected embryos, staining was visualised in the endoderm and 
mesencephalon but in apparent higher level than that of the non-injected control and 
Slc34a2a(as) injected samples. This apparent increase in staining for Slc34a2b was 
also seen in Slc34a2b injected 24 hpf samples above. In the developmentally 
malformed 48 hpf embryos injected with 165 pg Slc34a2a RNA, staining was 
inconsistent. The Slc34a2a injected 48 hpf embryo pictured in figure 4.13 (fourth 
row), Slc34a2b localised to the otic vesicle and was otherwise dispersed throughout 
the entire embryo.  
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4.8 Discussion 
 
Microinjections of Slc34a2a, Slc34a2a(as) and Slc34a2b RNA were completed to 
determine if and how the three transcripts interact and if they have any individual 
impact on zebrafish development. Injection of Slc34a2a sense RNA produced a 
phenotype, which at the lowest injection amount of 82.5 pg, produced specific loss of 
cerebellum (figure 4.3). Injection of paralog Slc34a2b and Slc34a2a(as) transcripts 
produced no phenotypic effect.  
Slc34a2a RNA injection, which caused the failure of cerebellar development, was 
confirmed by in situ hybridisation (ISH) using the midbrain-hindbrain marker, 
Engrailed-2a (Eng2). Eng2 is essential for vertebrate embryogenesis by coordinating 
midbrain and hindbrain development. ISH staining for control non-injected embryos 
was analogous to that seen in current literature (Fjose et al., 1992; Scholpp and 
Brand, 2001; Thisse, 2005; D'Aniello et al., 2013). The very faint staining in 
Slc34a2a injected embryos indicates that the cerebellum is completely missing. 
Eng2 ISH findings are supported by behavioural phenotypes. The cerebellum is vital 
for coordinated movement, balance, posture and has been linked to non-motor 
learning. Therefore any damage to the cerebellum can produce severe effects such 
as impaired balance, decomposition of movement, involuntary tremors and 
compromised working memory (Moens and Prince, 2002; Lalonde and Strazielle, 
2003; Morton and Bastian, 2004). Accordingly, Slc34a2a RNA injected embryos 
were noted to have problems swimming upright (loss of balance), did not react 
immediately to the ‘poke’ (impaired predictive movement), would sometimes have 
what looked like an epileptic shock (involuntary tremor) and often would either swim 
in a circle or back to the area of danger (impaired learning). These behavioural 
deficiencies are in line with the loss of cerebellum that was visually identified under 
the microscope and confirmed via Eng2 staining.  
Injection of Slc34a2a RNA did not have an effect on central nervous system motor 
neuron development, even though it effected cerebellar development, as seen in 
figure 4.7. Microinjections were completed on Islet1-GFP transgenic zebrafish as 
they were available at the Centre for Life, Newcastle University, where all fish work 
was completed. Alternatively, a transgenic Islet3-GFP fish could have been included 
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as the Islet3 LIM/homeodomain protein is active during mesencephalon and 
cerebellar development and thus providing a more specifically localized reference.  
In vivo, mRNA is processed to increase stability and translation efficiency. Likewise, 
in vitro synthesized RNA can be stabilized by adding poly-A tails or 5’ untranslated 
regions. Capping is known to provide the RNA with a longer life span and aid in 
dispersion to the correct subpopulation of cells (Moreno et al., 2009). Capping of 
synthesized RNA also promotes the translation process (Contreras et al., 1982). 
Nonetheless, in this study, efficient translation of the Slc34a2a transcript by capping 
the injected RNA, was found not to be necessary for biological activity (figure 4.5). 
Embryos injected with capped and non-capped Slc34a2a RNA resulted in the same 
phenotype, i.e. loss of cerebellum at 48 hpf. 
No RNA Slc34a2a/Slc34a2a(as) co-injections were performed since numerous 
publications reported that injection of dsRNA, even in doses as low as 7.5 pg, leads 
to non-specific phenotypic effects during early zebrafish embryo development (Li et 
al., 2000; Oates et al., 2000; Zhao et al., 2001). These reports aimed at reproducing 
dsRNA induced gene silencing as observed in C. elegans. However, all injected 
dsRNA and co-injected RNA were found to be degraded without sequence specificity 
thus indicating that dsRNA injection caused a nonspecific effect at the 
posttranscriptional level (Zhao et al., 2001).  
For the injection process, fertilised eggs from a single clutch are separated into 
multiple groups. A minimum of 50 eggs are used as the non-injected fitness control 
group and if less than 80% of the embryos survive by 24 hpf, the entire clutch was 
disregarded. As the membrane and structures protecting the first forming cells are 
tougher than the yolk membrane, injections were completed so that RNA was 
injected into the yolk adjacent to the first embryonic cell or through the yolk directly 
into the first cell, where RNA would be most active. Cytoplasmic flow and diffusion 
ensure that the RNA injected into the yolk migrates into the cytoplasm of the 
embryonic cells (Yuan and Sun, 2009; Chang, 2012). If injections are performed at 
the eight-cell stage or later, a mosaic embryo would be generated in which the 
injected RNA is only be found in a subset of cells (Carmany-Rampey and Moens, 
2006). However, since injections were completed before the four cell stage, the 
exogenous RNA reached all cells as demonstrated by the in situ hybridization 
results, figures 4.12 and 4.13.  
4. Cerebellar loss 
 
96 
 
Within the previous chapter, chapter 3, primers purchased from and designed by 
PrimerDesign were utilised for all qPCR experiments. PCR primers for this and 
subsequent chapters were designed and optimised in-house and purchased from 
Sigma Aldrich. Consequently ΔCt values from non-injected controls differed from this 
chapter to the preceding.  
To determine the impact Slc34a2a, Slc34a2a(as) and Slc34a2b RNA injection had 
on transcript levels, RT-qPCR was completed on RNA extracted from 10 and 24 hpf 
embryos that underwent each injection. Transcript levels never differed more than a 
ΔCt of 1.5 between 10 and 24 hpf samples, except Slc34a2b in 165 pg Slc34a2a 
injected embryos. In Slc34a2a injected embryos, the amount of Slc34a2b changed 
by ~ΔCt 5 between 10 hpf and 24 hpf. As no major differences in transcript levels 
were found between 10 and 24 hpf samples that underwent the same injection 
(figure 4.11), consequently only 24 hpf data was presented. 
As described in chapter 3, Slc34a2a is not present from fertilization and only 
appears at 48 hpf. Logic would dictate that injection of a transcript should increase 
its abundance. As expected, data from the above qPCR experiments show an 
increase in Slc34a2a levels at 10 and 24 hpf after 165 pg Slc34a2a RNA injection 
(figure 4.8 and 4.11). However, this Slc34a2a increase was not visible by ISH; 
Slc34a2a was undetectable in non-injected and all injected 24 hpf embryos (figure 
4.12). ISH is based on the complementary binding of probes to the RNA transcript of 
interest. If the injected Slc34a2a RNA was binding to the endogenous Slc34a2a(as), 
ISH probes would be unable to bind and detect the Slc34a2a transcript. Another 
hypothesis involves the storage of the injected Slc34a2a RNA in either GW-bodies 
or P-bodies, which are present during Drosophila melanogaster and Danio rerio 
embryogenesis. These structures are involved in the removal of non-translated 
RNAs from the cytoplasm (Liu et al., 2005; Kloosterman et al., 2006; Patel et al., 
2016). As Slc34a2a encoded protein is not required till 48 hpf onwards, exogenous 
Slc34a2a RNA may be compartmentalized in these P-bodies and GW-bodies and 
thus not available for binding by DIG- labelled probes. For both situations, the phenol 
chloroform extraction process may have freed up the Slc34a2a RNA for detection via 
RT-qPCR. 
Slc34a2a(as) is endogenously expressed from fertilization as demonstrated in 
chapter 3. Slc34a2a(as) levels were expected to increase after Slc34a2a(as) 
injection but the contrary occurred when levels were examined via RT-qPCR and 
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ISH (figure 4.9 and 4.12).  The mechanisms behind how antisense non-coding RNA 
levels are controlled is largely unknown. In yeast, regulation processes of mRNA and 
antisense RNA transcripts differ (Marquardt et al., 2011). Nonetheless, there is well 
documented evidence that endogenous antisense RNA levels are indeed tightly 
controlled (Lehner et al., 2002; Tufarelli et al., 2003; Nakaya et al., 2007). Moreover, 
in eukaryotic systems there are a number of degradation pathways to remove extra, 
unnecessary or faulty transcripts (Houseley and Tollervey, 2009). Therefore, as 
Slc34a2a(as) is already naturally present in the first 24 hours of development, it is 
plausible that one or many of the degradation pathways exceeded the amount of 
Slc34a2a(as) RNA requiring degradation to return to normal levels.  
Slc34a2b is consistently expressed throughout the early stages of embryogenesis as 
demonstrated in the previous chapter. When RNA levels were examined via RT-
qPCR, Slc34a2b levels were found to increase after Slc34a2b injection as expected 
(figure 4.11). This increase was consistent when embryos were examined via ISH. In 
24 hpf Slc34a2b injected embryos, the established staining of the otic vesicle and 
eye was present, but there was additional staining located in the midbrain (figure 
4.12). The added transcript increased signal without triggering an intrinsic feedback 
response to degrade or sequester the exogenous RNA. 
Interestingly, in 24 hpf embryos injected with 110 pg Slc34a2a(as), Slc34a2b levels 
increased. The opposite was seen when Slc34a2a(as) levels decreased upon 165 
pg Slc34a2b injection. When Slc34a2b is aligned to the Slc34a2a antisense, the 
longest stretch of perfect complementarity is less than 11 nucleotides. Nevertheless, 
as both Slc34a2a(as) and Slc34a2b localise to the same structures (Figure 4.12 and 
4.13), it is plausible that the transcripts interact via incomplete sequence 
complementarity. Therefore, as eukaryotic cells detect dsRNA differently depending 
on their source (see review: (Gantier and Williams, 2007)), it is possible that 
Slc34a2a(as) and Slc34a2b are affecting one another either directly or indirectly 
through a dsRNA pathway. It too is plausible that injection of either Slc34a2a(as) or 
Slc34a2b is triggering a physiological function to maintain Pi homeostasis. This 
could be tested, for example, if embryos were exposed to varying levels of Pi and a 
change in gene expression could be detected.  
Whole mount RNA in situ hybridization is a technique used for monitoring the precise 
localisation of transcripts of interest. As mentioned in the previous chapter, the 
abundance of a transcript is related to the development of the stain. Nevertheless, 
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ISH is not a quantitative technique. For example, if left in developing solution for 24 
hours, any SHH probed embryo would irreversibly stain throughout the entire body 
no matter if the RNA of interest is present in that structure or not. Consequently, 
even though the protocol has been optimized for each probe, the results have to be 
interpreted with care.  
One of the limitations is that signal development is terminated based on visual 
examination. Due to human limitation, some overstaining is possible and could 
therefore explain the some of the discrepancy seen here between RT-qPCR and ISH 
data. A second limitation to whole mount ISH in Danio rerio embryos is the large 
yolk. The yolk can hinder examination both by creating a shadow and by making it 
difficult to examine internal structures. Therefore to confirm endoderm staining, 
embryos required yolk removal (photos not shown).  
 
 
4.9 Conclusion 
 
Injection of full length Slc34a2a RNA caused a dose-dependent phenotype in 
fertilized zebrafish oocytes. A specific failure to develop the cerebellum was noted 
upon injections of Slc34a2a RNA that was seen with neither Slc34a2a(as) nor 
Slc34a2b injections. In situ hybridization with Engrailed-2 staining confirmed the 
complete lack of cerebellar development and indicated a possible widening of the 
midbrain-hindbrain furrow. However, the mechanism that leads to cerebellar loss is 
unknown. Full length Slc34a2a transcript was injected which could lead to 
speculation that ectopic production of Slc34a2a protein might be the cause. Another 
hypothesis would suggest that the injected sense transcript hybridised to the 
naturally occurring antisense to create dsRNA. The dsRNA could in turn be inducing 
a protective response by activing Dicer or another dsRNA-related pathway which 
consecutively could lead to gene silencing. Another possibility entails the injected 
Slc34a2a binding to and inhibiting some other unknown sequence that is 
endogenously present and too activating this dsRNA response. In the subsequent 
chapter, possible pathways will be examined to determine by which mechanism this 
phenotype is produced.  
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Chapter 5. Slc34a2a dsRNA is linked to cerebellar loss  
 
Slc34a2a sense transcript expression commences at 48 hpf, unlike the antisense 
transcript which is present from fertilization. Full length Slc34a2a RNA microinjection 
into fertilized zebrafish oocytes was found to cause a specific phenotypic failure in 
cerebellum development. The mechanism which causes this detrimental phenotype 
is unknown. This chapter aims to further investigate the relationship of Slc34a2a and 
its antisense transcript on midbrain/hindbrain development. 
 
 
5.1 Slc34a2a protein production is not the cause of cerebellar loss  
 
Within the previous chapter, full length in vitro synthesized RNA was injected into 1-4 
cell embryos. Injection of capped and uncapped Slc34a2a give rise to cerebellar 
loss, unlike Slc34a2a(as) and Slc34a2b RNA, which resulted in no phenotypic 
change. To determine if the phenotype observed was due to overexpression of the 
Slc34a2a encoded phosphate transport protein, a full length capped Slc34a2a RNA 
which included a frameshift mutation was synthesized in vitro. The frameshift was 
created by removing a single nucleotide 18 bp downstream from the start codon 
resulting in a non-coding transcript. The mutated Slc34a2a transcript (FS-2a) was 
injected utilizing the same procedure and technique as all injections completed in 
chapter 4. Alongside a non-injected fitness group and a negative control 
water/phenol red injected group, capped FS-2a was injected in conjunction with the 
same capped Slc34a2a RNA transcript from chapter 4. Due to prolonged storage, 
synthetic Slc34a2a transcript lost some of its activity and therefore, the concentration 
required to produce the same phenotype for Slc34a2a increased.  
Phenotypic effects caused by microinjections were logged according to the 
standards described in the aforementioned chapter (Chapter 4, figure 4.1). Of the 
364 embryos injected with 165 pg Slc34a2a RNA that were assessed at 24 and 48 
hpf, all showed phenotypic abnormalities (figure 5.1). Nearly all embryos (96.2%) 
had a specific failure in cerebellum development. The remaining embryos, 3.3% at 
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level 3 and 0.3% at level 4, manifested other effects such as shortened body length, 
body curvature and improper eye formation in addition to the brain segmentation 
deformities.  
 
 
 
Figure 5.1 Phenotypic effects caused by microinjection of Slc34a2a RNA 
containing a frameshift mutation (FS-2a) into fertilized 1-4 cell zebrafish 
oocytes. Minimum 364 embryos were used from at least three clutches for each 
RNA injected.  
  
 
As shown in figure 5.1 above, of the 372 embryos injected with 165 pg capped FS-
2a RNA, 71.0% were classified as level 2 at 24 hpf, indicating they had one 
developmental malformation. These embryos did not properly develop their 
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midbrain-hindbrain region as seen by the lack of cerebellum (figure 5.2). The 
remaining 24 hpf embryos were classified level 3 (0.8%), level 4 (0.5%) and level 5 
(0.5%). Those classified level 3 and 4 had shorter body and tail lengths, more-so 
curved bodies and incorrect eye development alongside improper brain 
development, comparable to the Slc34a2a RNA injected embryos. Those classified 
as level 5 did not develop past the blastula stage.  
 
 
 
Figure 5.2 Embryos 24 hpf  injected with 165 pg capped frameshift Slc34a2a 
RNA lacked clear midbrain-hindbrain segmentation with an absence of 
cerebellum (red arrow). (A) Water/phenol red injected controls. (B) 165 pg FS-
2a RNA injected embryo. Scale bar at 0.1 mm. 
 
 
Of the 372 embryos injected with 165 pg capped FS-2a, 370 survived to 48 hpf; 
59.5% were classified as level 2, 0.5% were level 3, 0.3% level 4 and 0.3% level 5. 
Those logged as level 2 showed the same phenotypic loss of cerebellum as those 
injected with protein-coding Slc34a2a RNA. From a dorsal view, in a representation 
of a 48 hpf embryo as seen in figure 5.3, A, the cerebellum is denoted as two red 
semicircles which are clearly visible in non-injected and water injected controls. 
However in FS-2a injected 48 hpf embryos, the semi circular structures are missing 
and replaced with a thin line as pointed out by the red arrow in figure 5.3, C. This 
would indicate that despite the loss of cerebellum the midbrain hindbrain furrow has 
most likely formed. 
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The phenotypic observations recorded in figure 5.1 show an increase in the number 
of embryos classified as level 1 (wildtype) from 24 hpf to 48 hpf (27.2% to 39.5%). 
As the same injected embryos were assessed at these two time points, it appears 
that some embryos overcame the initial defect. 
 
 
 
Figure 5.3 Injections of frameshift Slc34a2a RNA causes loss of cerebellum as 
observed in the dorsal view of 48 hpf embryos. A) Representation of the 
structures visible from a dorsal view: eyes, pink; otic vesicles (ears), green; 
mesencephalon, dark blue; cerebellum, red. B) Fitness control embryo w ith 
correctly developed brain structures. C) FS-2a injected embryo lacking the 
cerebellum. Red arrows point to area of cerebellum. Scale bar at 0.1  mm. 
 
 
As with previous experimental injections, basic behaviour of FS-2a injected embryos 
were recorded. In line with Slc34a2a RNA injected embryos, FS-2a injected embryos 
had delayed reactions in the stimuli ‘poke’ test. Many embryos had difficulties 
swimming in an upright position but those who maintained balance, would either 
swim away after a delayed period, needed numerous stimuli to react and 
occasionally only swam in a circle back to the point of danger (videos of reactions in 
appendix B).  
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5.2 In situ hybridization confirmation of cerebellar loss due to frameshift 
Slc34a2a RNA microinjection 
 
To confirm the loss of the cerebellum, as seen in figures 5.2 and 5.3, in situ 
hybridization (ISH) was completed using a marker that is highly expressed in the 
cerebellar region of the brain, homeobox protein Engrailed-2 (Eng2). An Eng2 probe 
was synthesised as mentioned in Chapter 2. 
 
 
 
Figure 5.4 Engrailed-2 RNA staining in whole-mount in situ hybridization to 
show the loss of cerebellum at 48 hpf after the microinjection of full length 
capped frameshift Slc34a2a RNA.  A) non-injected wildtype embryo. B) 110 pg 
Slc34a2a injected. C) 165 pg FS-2a injected. Scale bar at 0.1 mm. 
 
 
Eng2, a gene essential for midbrain-hindbrain boundary development, was used to 
corroborate if cerebellar development was affected in the same fashion by FS-2a 
RNA injection as it was by Slc34a2a RNA injections. As seen in figure 5.4 A, the 
entire cerebellum including the midbrain-hindbrain region is stained as a thick purple 
wedge in the non-injected sample. In the Slc34a2a RNA injected embryo, there is a 
slight sliver of what would be the back of the midbrain region and a sliver of purple 
pointing backwards. The cerebellum is missing completely but the midbrain-
hindbrain furrow appears developed and widened (figure 5.4, B). In the FS-2a RNA 
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injected embryo, the staining appears significantly reduced (figure 5.4, C). The thin 
sliver in FS-2a injected is position like that of the Slc34a2a injected embryos; the thin 
stained line is above the eye and does not venture further back to create a wedge 
shape. Therefore, it appears that no cerebellum is present (no thick purple wedge) 
but the midbrain-hindbrain boundary/furrow must have formed (thin sliver visible). 
 
 
5.3 Expression profiles of Slc34a2b, Slc34a2a sense and antisense in embryos 
microinjected with frameshift Slc34a2a RNA 
 
RT-qPCR was completed using in-house designed primers (chapter 2) to monitor the 
levels of injected RNA, their impact on biologically related transcripts and detect 
possible cross-regulation. As with other qPCR experiments in this study, β-actin was 
used as a reference gene and was found to be expressed at constant levels 
generating Ct values of ~21. The Slc34a2a qPCR primers used do not distinguish 
between the frameshift Slc34a2a and coding Slc34a2a transcripts. Therefore, as 
seen in figure 5.5 below, Slc34a2a transcript levels increased at both 10 and 24 hpf 
time points after frameshift Slc34a2a RNA injection.   
Slc34a2a(as) levels were found to decrease at both 10 and 24 hpf in response to 
FS-2a RNA injection. The same observation was made after full length coding 
Slc34a2a was injected in chapter 4. The reduction was large at 10 hours post 
injection with a ΔCt change of 4.61±0.29 in 24 hpf wildtype embryos to 8.12±0.79 in 
10 hpf FS-2a injected embryos. Slc34a2a(as) levels seem to decrease closer to 
wildtype level at 24 hpf (ΔCT 5.70±0.34). FS-2a injection did not have any effect on 
Slc34a2b levels (wildtype; ΔCT 3.85±0.99, 10 hpf injected; ΔCT 4.21±0.67, 24 hpf 
injected; ΔCT 3.76±0.42). 
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Figure 5.5 Expression changes of Slc34a2a related genes in response to FS-2a 
RNA injection. Semi quantitative RT-qPCR analysis of RNA extracted from five 
fertilised zebrafish oocytes 10 and 24 hours post injection with 165 pg 
frameshift Slc34a2a RNA (green) in comparison to 24 hpf non-injected samples 
(grey). ΔCt were calculated by using β-actin as gene reference. N=3 
 
 
  
5.4 RNA injection of partial Slc34a2a and antisense RNA transcripts 
 
RNA fragments encompassing various regions of the Slc34a2a locus were produced 
for microinjection into fertilized zebrafish eggs. These in vitro synthesized non-
capped RNA fragments were created to determine if cerebellar loss was caused by a 
specific sequence. Six RNA fragments were produced in total as represented in 
figure 5.6. Three fragments were created from the positive strand (top strand 
encompassing the Slc34a2a gene) and three from the negative strand (bottom 
strand encompassing the Slc34a2a(as) sequence).  
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Figure 5.6 Representation of location of synthesized RNA fragments produced 
for injection. Red connected blocks represent the exons of Slc34a2a. Blue 
connected blocks represent Slc34a2a(as) exons. Fragments (i) T7 (orange) and 
(i) Sp6 (purple) are 614 nucleotides in length whilst fragments (ii) T7 (pink) and 
(ii) SP6 (blue) contain 959 nucleotides. Fragments (iii) T7 (yellow) and SP6 
(green) are 263 nucleotides long. 
 
 
Fragment (i) T7 (highlighted by an orange box in figure 5.6), includes part of the 
Slc34a2a sequence but would not hybridize to endogenously expressed 
Slc34a2a(as) as it shares no sequence complementarity at mRNA level. This is 
represented by the lack of exons (connected blue boxes) on the strand below the (i) 
T7 fragment. Fragment (i) SP6, purple box in figure 5.6, contains the sequence that 
is complimentary to the Slc34a2a but these exons are not included in the 
endogenous, spliced form of the Slc34a2a(as) transcript.  Fragment (ii) T7 contains 
part of the Slc34a2a sequence which would bind to endogenously expressed 
Slc34a2a(as). Contrary, fragment (ii) SP6 which encodes a section of the 
Slc34a2a(as) transcript, would bind to Slc34a2a due areas of exon-exon 
complementarity.  The sequence for fragment (iii) T7 (yellow) does not code for 
exons but it can hybridize to Slc34a2a(as) as it shares complementarity with 
Slc34a2a(as). The fragment (iii) SP6 (green), which codes for the 5’ end of the 
antisense transcript, is not expected to interact with Slc34a2a related transcripts as it 
lacks complementarity to expressed transcripts.   
Standard microinjections into fertilized eggs were performed as described and 
phenotypes were recorded as discussed in chapter 4. As shown in figure 5.7 below, 
the only fragment that interfered with the development of the embryos was the (ii) T7 
fragment. This RNA fragment, part of the Slc34a2a coding sequence, was the only 
one injected that shared exonic sequence complementarity with the Slc34a2a(as) 
transcript that is present naturally from fertilization. Injections of this RNA produced a 
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significant proportion of embryos with a single developmental malformation (34.8%, 
level 2). Almost all these embryos (34.3%) showed evidence of incorrect brain 
segmentation. A loss of cerebellum was witnessed with the (ii) T7 fragment injected 
embryos (figure 5.8) comparable to the frameshift containing Slc34a2a RNA injected 
fish as pointed out with the red arrow in figure 5.8. All other injected RNA fragments 
produced a normal phenotype.  
 
 
 
Figure 5.7 Phenotypic effects recorded at 48 hpf caused by microinjection 
(165pg) of Slc34a2a RNA fragments into fertilised zebrafish oocytes. Results 
are recorded as percentages based on phenotype severity. A minimum of 90 
embryos from three clutches were analyzed for each injected transcript.  
 
 
Injection results were logged at 24 and 48 hpf. For those embryos injected with 
fragment (ii) T7, there was a minor reversion to a wildtype phenotype in 48 hpf 
groups in comparison to 24 hpf embryos (data not shown). Due to their improperly 
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developed brains, the fragment (ii) T7 RNA injected embryos showed unusual 
behavioral traits. Many, could not swim upright and showed delayed reaction prior to 
swimming away in response to a poke. Occasionally the embryos would swim only in 
a small circle after a delayed reaction to the poke, putting themselves back in the 
danger zone. Such behavior was never seen in wildtype embryos.  
 
 
 
Figure 5.8 Injections of fragment (ii) T7 RNA causes loss of cerebellum.  The 
dorsal view of 48 hpf embryos is shown. A) Schematic representation of a 48 
hpf embryo where the cerebellum is denoted as two red semi-circles. B) Non 
injected control embryo. C) 165 pg fragment (ii) T7 RNA injected embryo. D) 
165 pg fragment (ii) SP6 RNA injected embryo. Red arrows point to the 
cerebellum or the area where the cerebellum should be located. Scale bar at 0.1  
mm. 
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5.5 In situ hybridization confirmation of cerebellar loss due to Slc34a2a RNA 
fragment 
 
In situ hybridization (ISH) staining was completed on embryos injected with the RNA 
fragments synthesised from the Slc34a2a locus. The Eng2 probe described in 
previous ISH experiments was utilised to visualize cerebellum presence or absence. 
Wildtype embryos show an intensely stained purple wedge that runs vertically 
throughout the embryo in representation of the midbrain-hindbrain boundary 
including the cerebellum, (figure 5.9 A). From a lateral view, the purple structure is 
located posterior to the eye. All embryos injected with RNA fragment (ii) T7 show 
markedly fainter Eng2 staining as compared to the wild type and the other fragments 
(figure 5.9 E). This result is comparable to frameshift Slc34a2a RNA injected 
embryos (figure 5.4). Injection of the (ii) T7 RNA fragment reduced the intensity of 
the Eng2 staining but not to levels observed after Slc34a2a injection. All other RNA 
fragments produced an Eng2 staining that was comparable to the wildtype.  
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Figure 5.9 Engrailed-2 staining of embryos injected with Slc34a2a fragments. 48 
hpf embryos injected with the various Slc34a2a RNA fragments are presented 
after in situ hybridization using the Eng2 probe. A) Non-injected control embryo; 
B) Capped full length Slc34a2a RNA injected embryo; C) Fragment (i) T7 
injected embryo; D) Fragment (i) SP6 injected embryo; E) Fragment (ii ) T7 
injected embryo; F) Fragment (ii ) SP6 injected embryo; G) Fragment (iii ) T7 
injected embryo; H) Fragment (iii ) SP6 injected embryo. All fragment injections 
were completed with 165 pg of RNA. Scale bar at 0.1 mm. 
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5.6 Slc34a2a antisense knockdown by morpholino microinjection  
 
Microinjection of full length antisense RNA did not induce any phenotypic changes in 
the development of zebrafish embryos as mentioned in chapter 4. In order to 
investigate a possible function of the antisense transcript directly, a morpholino 
oligonucleotide (MO) that interferes with the splicing of the transcript, was designed 
and custom synthesised (Gene Tools, LLC). The morpholino (sequence: 5’ – 
GCCATCTGGTGAAAAGACAGAGTTT – 3’) targeted the third exon in the antisense 
pre-mRNA (chapter 2) in order to cause an exon deletion. The antisense morpholino 
(AS-MO), alongside a mismatch antisense morpholino control, were injected into 1-4 
cell fertilised oocytes. Any developmental changes were logged according to the 
same phenotypic scale used in the previous chapter at both 24 and 48 hpf.  
Injection of 0.4-10 ng of the splice site antisense morpholino caused a severe, 
nonspecific phenotype at 24 hpf. As seen in figure 5.10 A, only embryos injected 
with 0.2 ng of the AS-MO had a substantial proportion of wildtype embryos at 24 hpf 
(67.5%; level 1). Otherwise, the majority of injected embryos at 24 hpf were 
classified as level 3 when injected with 0.4-10 ng AS-MO. Deformities mainly 
included shortened body length, curved body, increased area above rhombomeres 
(engorged fourth ventricle), no clear brain segmentation, and non-circular small 
eyes. An example of a level 3 antisense morpholino injected embryo is pictured in 
figure 5.11. Other, less common malformations included improper heart rate, heart 
or heart sack deformation, non-circular yolks and no tail. Those embryos classified 
as level 2 had one of the problems mentioned at random.  
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Figure 5.10 Phenotypes observed after Slc34a2a antisense morpholino injection 
into fertilised zebrafish oocytes. Different dilutions ranging from 0.2 to 10 ng 
were assessed at developmental time points 24 hpf (A) and 48 hpf (B). A 
minimum of 90 embryos from three clutches were utilised for each injection set.  
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Figure 5.11 Effects of Slc34a2a antisense knockdown by injecting a splice site 
morpholino (Gene Tools, LLC). Embryos were pictured at 24 hpf. A) Non-
injected f itness control. B) 10 ng of mismatch control morpholino. C) 10 ng of 
antisense morpholino. Scale bar at 0.1 mm. 
 
 
The injected embryos appeared to look ‘healthier’ after examination at 48 hpf. The 
percentage of embryos classified as normal (level 1) increased as amount of 
antisense morpholino injected decreased, indicative of a dilution effect (figure 5.10 
B). Embryos injected with 10 ng were still mostly classified as level 3 and had 
malformations including shorted body length, curved bodies, improper brain 
segmentation and incorrect eye development (figure 5.12). In comparison to 24 hpf 
embryos, 48 hpf embryos seemed to recover regardless of the amount injected. At 
48 hpf, 0.2 ng injected embryos appeared as wildtype. The mismatch control 
morpholino caused no phenotypic effect at neither 5 ng nor 10 ng (data not shown). 
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Figure 5.12 Representation of 48 hpf embryos injected with Slc34a2a antisense 
morpholino. Comparison of length and body shape after Slc34a2a antisense 
morpholino injection in comparison to control groups. A) Non-injected fitness 
control. B) 5 ng of mismatch control morpholino. C) 5 ng of Slc34a2a antisense 
targeting morpholino. Scale bar at 0.1 mm. 
 
 
 
5.7 Expression profiles of Slc34a2b, Slc34a2a sense and antisense in embryos 
microinjected with antisense targeting morpholino 
 
Even though injected Slc34a2a antisense morpholino likely produced a non-specific 
phenotype, semi quantitative RT-qPCR was completed to determine if the injected 
Slc34a2a(as) targeting morpholino reduced the concentration of its target transcript 
or had any effect on Slc34a2a or Slc34a2b transcript levels. Five embryos, chosen 
at random, from minimum of three different clutches were utilised as mentioned in 
chapter 2 and assessed by qPCR (figure 5.13). 
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Figure 5.13 Semi quantitative RT-qPCR analysis of Slc34a2a(as) morpholino 
injected zebrafish embryos.  RNA was extracted from five fertilised zebrafish 
embryos at 24 hpf (A) and 48 hpf (B) after injection with 5 ng  Slc34a2a 
antisense morpholino (pink bars) in comparison to non-injected samples (grey) 
and mismatch control morpholino (purple bars). ΔCt was calculated by using β-
actin as gene reference which maintained a consistent Ct throughout all 
experiments. N=3 
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In 24 hpf embryos, antisense morpholino injection did affect Slc34a2a(as) levels, as 
seen in the top graph of figure 5.13. Transcript levels decreased by a ~ΔCt of 4 (ΔCt 
wildtype; 4.61±0.29, ΔCt AS-MO injected; 8.14±0.83). Antisense morpholino 
injection did not have an impact on neither Slc34a2a nor Slc34a2b levels. By 48 hpf, 
Slc34a2a(as) levels of 5 ng antisense morpholino injected samples returned back to 
near wildtype levels (ΔCt wildtype; 11.62±0.33, ΔCt AS-MO injected; 12.65±0.62, 
figure 5.13 B). Slc34a2a and Slc34a2b levels remained unaffected.  
Visualised in both 24 hpf and 48 hpf samples, injected mismatch morpholino did 
appear to result in a ~ΔCt of 1.5 change in Slc34a2a and Slc34a2a(as) levels. 
Slc34a2a sense transcript levels changed such that in 24 hpf mismatch samples, 
ΔCt was 6.00±0.20 and 9.52±0.79 in 48 hpf samples (wt ΔCt at 24 hpf, 7.62±0.38; wt 
ΔCt at 48 hpf, 12.31±0.42). Slc34a2a(as) transcript levels after mismatch morpholino 
injection, ΔCt was 5.65±0.79 in 24 hpf samples and 9.69±1.01 in 48 hpf samples (wt 
ΔCt at 24 hpf, 4.61±0.29; wt ΔCt at 48 hpf, 11.62±0.33). This is unlikely to be 
specific as the mismatch morpholino does not bind with high affinity to any 
endogenous targets in zebrafish (Ensembl, BLAST search) but rather a broader 
systemic effect. Injection of the mismatch morpholino, which is five nucleotides 
different from the antisense morpholino, did not appear to have any effect on 
Slc34a2b transcript levels at either 24 nor 48 hpf. 
 
 
5.8 Co-injection of p53 morpholino reduces morpholino toxicity  
 
Injection of Slc34a2a antisense morpholino decreased Slc34a2a(as) transcript levels 
in 24 hpf embryos, but not 48 hpf embryos, as shown in the above RT-qPCR. 
However, upon visual examination, the injected embryos showed a non-specific 
phenotype with multiple severe deformities including shortened body length, curved 
body, increased area above rhombomeres (fourth ventricle), lack of brain 
segmentation, and non-circular small eyes. These disfigurements are consistent with 
general morpholino toxicity which is caused by the activation of p53 mediated 
apoptosis (Robu et al., 2007). p53 activation causes cell death in somite tissues and 
the central nervous system thus producing these non-target specific phenotypes. To 
inhibit the p53 pathway and mitigate unspecific toxicity, a well characterised p53 
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morpholino was co-injected alongside the antisense morpholino. The double-
knockdown strategy would allow the specific phenotypic effect of antisense RNA 
knockdown to be determined.  
The injection process was completed as described; data was collected from a 
minimum of three clutches which were divided to include a non-injected fitness 
control, a negative control (water and phenol red, mismatch morpholino).Two 
different concentrations of antisense morpholinos were used. All co-injections 
included 4 ng of Gene Tools LLC p53 morpholino. Co-injection (p53 plus AS-MO 
injection) data came from a minimum of 129 embryos. 
 
 
Figure 5.14 Phenotypic classification of 24 hpf embryos after co -injection of 
Slc34a2a(as) and p53 targeting morpholinos. Embryos were injected with either 
2 ng or 5 ng Slc34a2a antisense morpholino with or  without 4 ng of p53 
morpholino. N=3 
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Co-injected embryos at 24 hpf fared better than their counterparts that were solely 
injected with 2 ng antisense morpholino (AS-MO) as seen in figure 5.14 (two left 
bars). 71.9% of embryos injected with 2 ng antisense morpholino were classified as 
level 3 displaying many non-specific phenotypic deformities mentioned previously. 
However, the majority of embryos co-injected with 2 ng AS-MO and 4 ng p53 
morpholino were classified as level 2 (83.7%), indicating morpholino toxicity was 
decreased due to p53 knockdown. This significant recovery to near wildtype 
phenotype was not visible in embryos injected with 5 ng of antisense morpholino. 
The number of embryos classified as wildtype, level 1, remained unchanged at 
10.5% between 5 ng antisense morpholino injected embryos and co-injected 
embryos (figure 5.14, third and fourth bars). Overall, the co-injected embryos (5 ng 
AS-MO and 4 ng p53 morpholino) did not fare better than embryos injected with 5 ng 
AS-MO alone. Overall, no specific phenotype was observed after co-injection. 
Injected embryos examined at 48 hpf showed the same trend as seen at 24 hpf. As 
depicted in figure 5.15, embryos co-injected with 2 ng AS-MO and 4 ng p53 
morpholino were nearly all classified as wildtype (level 1, 98.8%) in contrast to those 
embryos which received solely 2 ng of AS-MO (level 1, 41.1%). When 5 ng of 
antisense morpholino was injected, co-injection of the p53 morpholino did not 
diminish the toxic effect as all co-injected embryos were classified as level 2 or 3. In 
comparison, 5ng AS-MO injected embryos had 31.6% classified as level 1. 
Embryos solely injected with 2 ng of antisense morpholino displayed severe 
developmental malformations at both 24 and 48 hpf; improper body shape and 
length, incorrect brain segmentation and proportions, non-circular eyes, and tail 
deformation such as twisted or blunt tail tips. These developmental deformities 
affected the behaviour so that fish could not swim correctly or not move at all. 
Therefore none of the fish showed a normal escape reaction in response to a poke. 
Co-injection of 4 ng of p53 morpholino rescued the severe phenotype so that by 48 
hpf, embryos showed wildtype behaviour.  
The recovery to wildtype was not seen when 5 ng of antisense morpholino was 
injected. Embryos injected with solely 5 ng of antisense morpholino displayed the 
same severe deformities as observed for the 2 ng antisense injected samples and as 
demonstrated in figures 5.11 and 5.12. Morpholino toxicity was not reduced upon co-
injection of p53 morpholino. Malformations in these embryos were not consistent and 
behaviour continued to be unlike wildtype.  
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Figure 5.15 Phenotypic classification of 48 hpf embryos after co -injection of 
Slc34a2a(as) and p53 targeting morpholinos. Embryos were injected with either 
2 ng or 5 ng Slc34a2a antisense morpholino with and without 4 ng p53 
morpholino. N=3 
 
 
As shown in figure 5.16 (C), the embryo injected with 5 ng antisense morpholino 
alone had an engorged area above the rhombomeres (fourth ventricle), smaller non 
circular eyes, larger nose/face region, and even though the cerebellum was present, 
it appears smaller in size and pushed forward. (The angle of the pictured embryo 
looks different, however, this appearance is due to the deformed body and tail. All 
embryos were pictured laterally with aligned eyes). Knocking down p53 reduced the 
severity of the deformations but the embryos still had a reduced area above the 
rhombomeres figure 5.16 (B). This reduction of space above the rhombomeres was 
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consistent in co-injected embryos whilst the engorged fourth ventricle area was 
common in 5 ng antisense morpholino injected samples.  
 
 
 
Figure 5.16 Injection of Slc34a2a(as) targeting morpholino affected the 
zebrafish hindbrain. 48 hpf embryos are shown. The size of the area found 
above the rhombomeres (fourth ventricle)  was altered as indicated by the red 
arrows. Non-injected fitness control embryo (A) in comparison to an embryo co -
injected with 5 ng of antisense morpholino and 4 ng of p53 morpholino (B) and 
an embryo injected with 5 ng of antisense morpholino (C)  at 48 hpf. Scale bar at 
0.1 mm. 
 
 
5.9 In situ hybridization on antisense morpholino injected embryos  
 
To address whether the injections of the splice site AS-MO reduced the levels of 
Slc34a2a(as), in situ hybridisation was performed. ISH staining was completed on 48 
hpf embryos injected with the antisense morpholino and mismatch morpholino 
alongside wildtype non-injected embryos. Antisense and Engrailed-2 (Eng2) probes 
were utilised as described in Chapters 3 and 4. As shown in figure 5.17 A, the 
antisense probe stained in the pharynx, endoderm (future digestive tract and swim 
bladder), primordial midbrain channel and primordial hindbrain channel of the 48 hpf 
wildtype embryo in agreement with figure 3.3. The mismatch morpholino injected 
embryos (figure 5.17, C), presented a comparable pattern to the wildtype but 
showed slightly weaker staining. The 5ng antisense morpholino injected samples 
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contrasted these findings with no detectable antisense staining in the majority of 
embryos (B). All these embryos displayed the severe developmental deformities 
mentioned in the previous subsections.  
 
 
 
Figure 5.17 48 hpf embryos stained by in situ hybridization with a Slc34a2a(as) 
probe after antisense morpholino injection. All embryos were stained 
simultaneously with aliquots of the same probe. A) Wildtype non-injected 
embryos. B) 5 ng antisense morpholino injected embryos. C) 5 ng mismatch 
morpholino injected embryos. Scale bar at 0.1 mm. 
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Figure 5.18 48 hpf embryos stained by in situ hybridization with an Engrailed -2 
probe after 5 ng antisense morpholino injection. All embryos were stained 
simultaneously with aliquots of the same probe. A) Wildtype non-injected 
embryo. B) 5 ng mismatch morpholino injected control. C and D) 5 ng antisense 
morpholino injected embryos. Scale bar at 0.1 mm. 
 
 
Embryos from the same sets of injections were stained with Eng2 to determine if the 
morpholino injections had an effect on cerebellum development. As reported in the 
previous subsection, antisense morpholino injected 48 hpf embryos displayed 
correctly segmented brains but the proportions were incorrect. Comparable 
malformations were detectable after in situ hybridization as shown in figure 5.18. As 
displayed in both wildtype (A) and mismatch morpholino injected control (B), Eng2 
created the purple wedge staining encompassing the midbrain-hindbrain boundary 
and the cerebellum. Again, the mismatch morpholino injected embryos produced the 
correct but a slightly weaker staining. Embryos injected with 5 ng antisense 
morpholino showed neither consistent nor correct staining. About a third of the 
embryos produced no stain such as in figure 5.18 C, possibly the due to a complete 
lack of brain segmentation and no brain development outside of frontal lobe. In the 
remaining embryos, the cerebellum was present and stained with the Eng2 probe 
but was pushed forward and small (figure 5.18, D). This result is in conjunction with 
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data presented in figure 5.16 that the cerebellum is pinched if the fourth ventricle is 
engorged. These partly conflicting findings are likely due to the unpredictable effects 
of morpholino toxicity on zebrafish development rather than the specific 
consequences of reduced antisense expression. 
 
 
5.10 Evaluation of Dicer morpholino toxicity 
 
The aforementioned sections established that injection of any RNA containing a 
complimentary sequence to the endogenously expressed Slc34a2a antisense 
transcript was found to produce a specific phenotype; failure to develop a 
cerebellum. Dicer is a key RNAi enzyme which is involved in cutting RNA hybrids 
(dsRNA) into short interfering RNAs (siRNAs). To determine if siRNAs were involved 
in the failure to generate a cerebellum, Dicer was knocked down with morpholinos. 
Aliquots of two morpholinos that have been reported to knockdown Dicer were kindly 
provided by James Patton (Department of Biological Sciences, Vanderbilt University, 
Nashville, USA). Both morpholinos were designed by and ordered from Gene Tools 
LLC. The first antisense morpholino, Dicer start MO, targeted the translational start 
site whilst the second one, Dicer UTR MO, was designed against the 5’ untranslated 
region of the Dicer1 mRNA. The sequences can be found in chapter 2, materials and 
methods. Microinjection procedure was completed as previously described. Both 
morpholinos were injected at 10 ng and 6.6 ng dilutions. A standard control 
morpholino with no biological target (Gene Tools LLC) was injected at 8 ng as a 
negative control and produced no phenotypic effect (figure 5.19). 
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Figure 5.19 Phenotypic classification (A1 and B1) and death rates (A2 and B2) 
of embryos injected with two different Dicer targeting morpholinos. Embryos 
were analysed at 24 hpf (A) and 48 hpf (B).  Data was collected from a minimum 
of 60 fertilised oocytes (average 105) from at least three clutches for each 
injection.  
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At both, 10 ng and 6.6 ng, the Dicer translation start site morpholino produced a high 
death rate for embryos examined at 24 hpf; 51.6% of embryos injected with 10 ng 
and 37.9% of those injected with 6.6 ng died within the first 24 hours as 
demonstrated in Figure 5.19 A (first two bars, in blue). The majority of surviving 
embryos were also classified as level 3 or 4 according to their severe phenotypic 
malformations. Those injected with 10 ng Dicer start morpholino, were 48.5% level 3 
whilst 24.2% were level 4. Injection with 6.6 ng did not lessen the severity of 
malformations as 41.7% of the fish were level 3 and 47.2% were level 4. Embryos 
were severely developmentally delayed with small heads, no brain formation, 
extremely short curved or bent tails and occasionally no eye development. By 48 
hpf, the embryos only seemed to worsen as demonstrated in Figure 5.19 B, first two 
bars. The number of embryos classified as level 1, wildtype, dropped from 24.2% to 
12.1% in 10 ng injected samples and from 9.7% to 1.5% in 6.6 ng injected samples. 
Those that were level 1 at 24 hpf, were classified as level 2 or 3 at 48 hpf due to 
incorrect brain segmentation, improper eye formation or shortened body length. 
Overall, injection of Dicer start morpholino seemed to severely developmentally 
hinder the embryos.  
Embryos injected with 10 ng of Dicer UTR morpholino were mostly classified as level 
1 (40.6%) or level 3 (55.9%) at 24 hpf. When the amount of injected morpholino was 
lowered to 6.6 ng, nearly all embryos (99.3%) were classified as level 1, as shown in 
Figure 5.19 A, third and fourth bars. However, embryos worsened by 48 hpf (Figure 
5.19 B, third and fourth bar) as seen with Dicer start morpholino injected samples. 
For both amounts, nearly all embryos were classified now as level 3 (91.6% level 3 
at 10 ng, 92.1% at 6.6 ng). Prevalent phenotypic traits were short body/ tail lengths, 
body curvature and/or small non-circular eyes. Generally, a broader range of 
phenotypic effects was visible upon injecting Dicer start morpholino in comparison to 
Dicer UTR morpholino.  
A key difference between Dicer start and Dicer UTR morpholino injected samples 
was the much lower death rate in Dicer UTR injected groups; 15.4% of the 10 ng 
injected fish died whilst 5.0% died in 6.6 ng injected samples by 24 hours and none 
passed away afterwards. In comparison, over 30% of injected embryos with Dicer 
start morpholino passed away in the first 24 hours and a few more in the following 
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day. The standard control morpholino caused no phenotypic effect with nearly all 
embryos classified as level 1 (fifth bar in figures 5.19 A and B).  
Injection of Dicer start morpholino caused an extreme death rate in embryos prior to 
24 hours that was not witnessed with any other injected materials within this study. 
Alongside the very severe phenotypic deformities Dicer start morpholino caused, it 
was decided all experiments from this point onwards should utilise the Dicer UTR 
morpholino.  
 
 
5.11 Dicer morpholino co-injection with p53 morpholino 
 
Non-target specific phenotypes can be caused by morpholino toxicity through the 
activation of p53 mediated apoptosis (Robu et al., 2007). Therefore, the previously 
used p53 morpholino was co-injected with the Dicer UTR morpholino to mitigate any 
unspecific effects caused by morpholino toxicity. As demonstrated in figure 5.20, co-
injection of 4 ng of p53 morpholino caused a partial rescue of 10 ng Dicer UTR 
injected samples. As established in the previous set of experiments, 91.6% of 
embryos injected with 10ng of Dicer UTR morpholino were classified as level 3; with 
co-injection of the p53 morpholino, only 20% of embryos were scored level 3 whilst 
the remaining majority were either level 1 (46.2%) or level 2 (33.9%). The rescue 
was only visible at high concentrations of Dicer UTR morpholino injections. When 4 
ng p53 morpholino was co-injected with 2.5 ng Dicer UTR morpholino, 98.2% of 
embryos were classified as level 3. These embryos still had shorter body length and 
non-circular eyes as shown in figure 5.21.  
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Figure 5.20 Phenotypic classification (A) and death rates (B)) of embryos co-
injected with p53 and Dicer UTR morpholinos at 48 hpf. Data collection based 
on a minimum of 60 embryos from a minimum of three clutches  for each 
injection. 
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Figure 5.21 Co-injection of p53 morpholino reduced the phenotypic severity 
witnessed in 10 ng Dicer UTR morpholino injected embryos at 48 hpf. Non-
injected fitness control embryo (A) in comparison to a 2.5 ng Dicer UTR 
morpholino/4 ng p53 morpholino co-injected embryo (B) and an embryo 
receiving solely 10 ng Dicer UTR morpholino (C). Scale bar at 0.1 mm. 
 
 
5.12 Dicer knockdown rescues loss of cerebellum caused by Slc34a2a RNA 
injection  
 
Injection of RNA Slc34a2a fragments that are complementary to the endogenous 
Slc34a2a(as) RNA transcript produce a consistent, specific phenotype; the failure to 
develop a cerebellum. As Dicer is the key RNAi enzyme that cuts RNA hybrids 
(dsRNA) into short interfering RNAs (siRNAs), knocking down Dicer may alleviate 
the deleterious effects of Slc34a2a RNA injection. It would also determine if 
Slc34a2a sense/antisense dsRNA formation was required to induce the process that 
leads to the loss of cerebellum. In this hypothesis, Slc34a2a sense and antisense 
transcripts would hybridise upon Slc34a2a RNA injection. Without Dicer, the dsRNA 
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of sense/antisense would not be processed to produce siRNAs. If there is no loss of 
cerebellum upon co-injection, then a siRNA produced from the complementary 
region must be involved in the pathway that results in cerebellar development failure.  
 
 
 
Figure 5.22 Phenotypic classification of fertilized zebrafish embryos injected 
with combinations of 165 pg capped full length Slc34a2a RNA, 10 ng Dicer UTR 
morpholino and 4 ng p53 morpholino assessed at 48 hpf. A minimum of 60 
embryos from three clutches were used for each data set.  
 
 
Due to the high death rate caused by Dicer start morpholino, only the Dicer UTR 
morpholino was used for the following experiments. Co-injection of 10 ng Dicer UTR 
morpholino and 165 pg capped full length Slc34a2a RNA produced a specific 
phenotype in all injected embryos (Figure 5.22, fourth bar). All embryos at 24 (data 
not shown) and 48 hpf examinations had a concoction of the following phenotypes 
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thus classifying them as level 3-5; small non-circular eyes, no brain formation or 
improper brain segmentation, shortened body length, curved body, smaller heads, 
incorrect heart rates, misshapen tails and/or had a clear bump on the head (as seen 
in figure 5.21 C). All embryos also had behavioural insufficiencies such that they did 
not react to the poke stimulus.  
p53 morpholino co-injection has been found to rescue non-specific phenotypes 
caused by morpholino toxicity (figure 5.22, bar 1 vs bar 2). A triple injection 
consisting of Slc34a2a RNA, Dicer UTR morpholino and p53 morpholino was 
completed to reduce any non-specific phenotypes present in the Dicer 
UTR/Slc34a2a RNA injected samples. As shown in figure 5.22, last bar, over 98% of 
triple injected fertilised oocytes were classified as level 1 or 2. Of these embryos, all 
had a cerebellum and exhibited normal behaviour. The 78.2% that were classified as 
level 2 all had a specific phenotype that presented as an enlarged hindbrain region. 
Specifically, there was an enlarged area above the rhombomeres (fourth ventricle) 
(Figure 5.23, red arrow). To confirm the rescue of cerebellar loss caused by 
Slc34a2a RNA injection, in situ hybridization was completed utilising the Engrailed-2 
probe as in previous in situ experiments. Triple injected embryos were stained 
alongside non-injected controls and Slc34a2a RNA injected embryos (not included in 
figure 5.23). As visualised in figure 5.23, triple injected embryos (B and D) developed 
a cerebellum just as wildtype embryos at 48 hpf (A and C).  
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Figure 5.23 Loss of cerebellum caused by Slc34a2a RNA injection was rescued 
upon co-injection of Dicer UTR and p53 morpholinos.  48 hpf embryos are 
shown: A) Fitness non-injected control; B) triple injected embryo with an 
enlarged area above the hindbrain (red arrows); C) f itness non-injected control 
embryo with Engrailed-2 stain; D) Triple injected embryo with Engrailed-2 
staining. Scale bar at 0.1 mm. 
 
 
5.13 Can endo siRNAs mimic microRNA action?  
 
Sense/antisense generated endo-siRNAs could produce a Dicer and RISC mediated 
phenotype reminiscent of an off target effect of microRNAs. A BLAST search was 
performed with the Slc34a2a sense/antisense complementary sequences (exons 
10/13). Hits with a minimal length of 15 nucleotides and 95% identity were further 
investigated. Moreover, matching seed regions were required. Expression patterns 
and knockdown phenotypes of 76 genes with significant identity were manually 
researched (Appendix C). Three candidate genes were identified which had a role in 
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brain development; Presenilin2 (Psen2), Wingless-type MMTV integration site family 
member 4b (Wnt4b) and RAS-like, family 11, member B (Rasl11b).  
Presenilin2 (Psen2), which is transcribed from chromosome 1, is expressed 
throughout embryogenesis, especially within the neural crest (Thisse, 2004a). This 
transmembrane protein is found in the membranes of the Golgi apparatus or 
endoplasmic reticulum (Fraering, 2007). Belonging to the peptidase A22A family, 
Psen2 forms a homodimer and is part of the gamma secretase complex which is 
involved in the cleaving of type-1 transmembrane proteins such as Notch (Nornes et 
al., 2009). Psen2 knockdown studies found a reduction in hindbrain development 
due to reduced notch signalling (Groth et al., 2002; Campbell et al., 2006; Nornes et 
al., 2009). Orthologues have been found in various other species including primates, 
rodents, fish, birds and reptiles (Ensembl, 2016a). 
Wingless-type MMTV integration site family member 4b (Wnt4b), which is 
transcribed from chromosome 16, has three splice variants. They are expressed 
from fertilization and are located in the central nervous system; floor plate and 
hindbrain (Liu et al., 2000; Lu et al., 2011). Wnt4b protein is secreted into the 
extracellular space and has numerous biological functions. It stimulates the Wnt 
signalling pathway which regulates gene transcription, cytoskeleton formation, 
calcium homeostasis and most importantly, is necessary in the proper formation of 
the midbrain-hindbrain boundary (Liu et al., 2000; Verkade and Heath, 2009). It is 
involved in the regulation of mitotic nuclear division, neuron differentiation and cell 
fate commitment. Functional orthologues have been noted in mice, rabbits, birds, 
reptiles, fish and humans (Verkade and Heath, 2009).  
RAS-like, family 11, member B, abbreviated as Rasl11b, is transcribed from 
chromosome 20. Expressed from fertilization through embryogenesis, Rasl11b 
transcript is located in the central nervous system; specifically in the diencephalon 
and the anterior neural rod (Rauch, 2003; Pézeron et al., 2008).  The protein is a 
small cytosolic GTPase which is involved in signal transduction and mesendoderm 
development (Stolle et al., 2007; Ensembl, 2016b).  
For each candidate gene, ultramers were designed incorporating T7 and universal 
M13 primer sites (table 5.1). The hairpin RNAs contain a sequence from Slc34a2a 
locus which binds to a complimentary sequence in the candidate gene thus allowing 
the RNA to fold back on itself (dsRNA joined on one end). The designed 
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oligonucleotides were amplified by end-point PCR using T7/ M13 primers prior to 
purification. Restriction digest to remove the M13 primer site was completed with 
XbaI prior to synthesising the RNA (section 2.3.4). Microinjection of the hairpin RNA 
would determine if the three candidate genes could mimic Slc34a2a sense/antisense 
duplex formation and siRNA production. Each hairpin was injected at two dilutions, 
82.5 pg and 165 pg, alongside a water/phenol red negative control. The phenotypic 
classification of all injected 48 hpf embryos is shown in figure 5.24.  
 
 
Table 5.1 Areas of identity overlap between Slc34a2a and the three candidate 
genes. Below is the sequence of the cDNA oligonucleotides utilised to generate 
RNA hairpins. In red bold is the T7 sequence, purple bold is the M13 universal 
primer, black is an Xba1 restriction site, blue is the gene overlap sequence 
whilst linker sequences are in pink and the loop is in green.  
Gene Overlapping sequence Exon in 
Slc34a2a 
Length 
(bp) 
Orientation Percent 
identity 
Psen2 CTGCTGAATTC_ATGCT
CAA 
10 20 Forward 95 
 
TAATACGACTCACTATAGGGTGAAGCTGCTGAATTCTATGCTCAAGGGACAAAA
GTGTCCCTTGAGCATACAATTCAGCAGCTTCATCTAGACTGGCCGTCGTTTTAC 
 
Wnt4b GAGCCTTTCGGACCT 10 15 Forward 100 
 
TAATACGACTCACTATAGGGAACACGAGCCTTTCGGACCTGGCGGAAAAGTCC
GCCAGGTCCGAAAGGCTCGTGTTTCTAGACTGGCCGTCGTTTTAC 
 
Rasl11b TGTTGCTGTTGCTGCA 13 16 Reverse 100 
 
TAATACGACTCACTATAGGGCCCGCTGTTGCTGTTGCTGCAAGTGCAAAAGTG
CACTTGCAGCAACAGCAACAGCGGGTCTAGACTGGCCGTCGTTTTAC 
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Figure 5.24 Phenotypic classification of embryos injected with RNA hairpins at 
48 hpf. Each RNA hairpin was injected in two different amounts. A minimum of 
50 embryos from three clutches were used for each data set.  
 
 
Fertilised oocytes injected with 82.5 pg Rasl11b produced no phenotype when 
inspected at 24 and 48 hpf. When examined at 24 hpf, embryos injected with 165pg 
Rasl11b were slightly smaller in size but with correct anatomical features in the 
accurate proportions (data not shown). However by 48 hpf, embryos were the same 
size as their non-injected counterparts. No aberrant phenotype was visible when 
82.5pg of Rasl11b was injected at both 24 and 48 hpf. Injections of Wnt4b, at both 
82.5 and 165pg examination time points, generated no phenotype.  
When 82.5 pg Psen2 hairpin RNA injected, no phenotype emerged at both 24 and 
48 hpf examinations. However, when 165 pg was injected, a specific phenotype 
emerged at both examination time points. By 48 hpf, all 165 pg Psen2 hairpin RNA 
injected embryos were classified as level 2 (45.8%) or level 3 (54.2%) as the result 
of hindbrain malformation. As shown in figure 5.25 (24 hpf embryos), the seven 
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rhombomeres that make up the hindbrain were enlarged to the extent that 
rhombomeres were nearly touching the upper epidermis of the fish (no fourth 
ventricle present). Those classified as level 3 presented a slightly 
enlarged/elongated cerebellum in addition to the enlarged rhombomeres. Unlike 
Slc34a2a RNA injected embryos which did not react the stimuli test, all embryos 
injected with the RNA hairpins had normal behaviour and correctly responded to any 
stimuli.  
To test for a synergistic effect, a mix of all three hairpin RNAs was injected. 
However, development was not affected in these embryos (figure 5.24, far right bar).  
 
 
Figure 5.25 The cerebellum is present in all embryos that were injected with 
RNA hairpins at 24 hpf. The area above the rhombomeres is reduced in 165 pg 
Psen2 injected embryos as pointed out with the red arrow (B) in comparison to 
wildtype (A) and 165 pg Ras11b injected embryos (C).  Scale bar at 0.1 mm. 
 
 
5.14 Discussion 
 
5.14.1 Frameshift Slc34a2a RNA and Slc34a2a RNA fragment injections 
 
Injection of capped and uncapped full-length Slc34a2a RNA was found to generate a 
specific phenotype resulting in the loss of cerebellum in the preceding chapter. To 
determine if failure to develop a cerebellum was due to overexpression of the 
sodium-phosphate transporter during early development (first 48 hours), when it is 
not endogenously present, a non-coding Slc34a2a RNA transcript was generated. 
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The in vitro synthesised non-coding Slc34a2a RNA, which contains a frameshift 
mutation after the start codon, was found to produce the same specific loss of 
cerebellum. This failure to develop a cerebellum was confirmed with Engrailed-2 in 
situ hybridization.  Therefore, these results indicate that it is not the Slc34a2a protein 
causing this developmental malformation, but the introduced RNA molecules.  
Not all embryos injected with the frameshift Slc34a2a RNA had a loss of cerebellum; 
less than 30% were classified as level 1 at 24 hpf which increased to near 40% at 48 
hpf. Hence, the severity of the phenotype was slightly less with the frameshift 
construct as compared to Slc34a2a. Both recovery to wildtype and reduced 
penetrance of the frameshift Slc34a2a RNA could be attributed to the notation that 
the injected RNA was not translated. mRNA surveillance mechanisms could be 
recognizing the frameshift containing Slc34a2a RNA and targeting it for degradation, 
reduce its halftime and consequently mitigate cerebellar loss. Otherwise, the 100% 
efficiency seen after injection of coding Slc34a2a RNA, can be attributed to the 
combination of both RNA sequence and protein production.  
Due to the possible cross-reactions between Slc34a2a, Slc34a2a(as) and Slc34a2b 
RNA, semi-quantitative RT-qPCR was completed to determine the impact of 
frameshift Slc34a2a RNA injection on each transcript. Slc34a2a transcript levels 
were elevated at both 10 and 24 hours post injection. As the Slc34a2a qPCR 
primers utilized do not distinguish between the frameshift Slc34a2a and the coding 
Slc34a2a transcripts, this increase was expected. The amount of Slc34a2a transcript 
documented between 10 and 24 hpf did not change, indicating that the injected 
material was not being degraded in the first 24 hpf. However, as there was 
significant phenotypic recovery between 24 and 48 hours in the frameshift Slc34a2a 
RNA injected embryos (figure 5.1) it is plausible that the RNA is either significantly 
diluted or degraded between these two time points. Alternatively, cells could 
sequester translated and non-translated RNAs in different compartments which 
could explain stability but reduced penetrance of the non-translated transcript. 
As there is no relationship between Slc34a2b and Slc34a2a, as anticipated, 
Slc34a2b transcript levels were unaltered after frameshift Slc34a2a RNA injection. 
Interestingly, Slc34a2a antisense levels were affected by exogenous frameshift 
Slc34a2a RNA. Slc34a2a(as) levels decreased significantly at 10 hours post 
injection and returned to near wildtype levels by 24 hours post injection. A similar 
decrease in Slc34a2a(as) levels was seen after coding Slc34a2a RNA injection (data 
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not shown). As frameshift containing Slc34a2a and endogenous antisense 
transcripts share regions of complementarity, it is likely that RNA-RNA interaction 
occurs. Accordingly, injected frameshift Slc34a2a is potentially generating dsRNA 
with the endogenously present antisense transcript. This may in turn decrease 
antisense transcript levels by RNAi or other dsRNA dependent mechanisms. 
According to this study, Slc34a2a(as) is significantly expressed in the first 48 hpf of 
embryogenesis. Therefore, it is conceivable that the reduction is triggering a 
feedback loop resulting in increased transcription of the antisense transcript (Ghosh 
et al., 2005; Janowski and Corey, 2010). This feedback loop would explain why there 
is a return to near wildtype levels by 24 hours post injection.  
Injection of frameshift Slc34a2a RNA demonstrated that loss of cerebellum is likely 
attributed to the Slc34a2a RNA and not protein. To define if a specific region was 
accountable, RNA fragments of both Slc34a2a sense and antisense transcripts were 
in vitro synthesized and injected. Only one of the six RNA fragments produced a 
phenotype upon injection into fertilized oocytes; fragment (ii) T7. This fragment 
contained a region of the Slc34a2a sense sequence that is complimentary to the 
endogenous antisense transcript; Slc34a2a exons 10 and 13 which bind to 
Slc34a2a(as) exon 4 and 5 (figure 5.6). Just like injection of both protein-coding and 
non-coding Slc34a2a RNA, injection of fragment (ii) T7 RNA resulted in the failure of 
cerebellar development (figure 5.8). As Slc34a2a(as) is endogenously expressed 
from fertilization, such a result would indicate that failure in cerebellar development 
is due to sense/antisense RNA interaction because none of the other Slc34a2a 
sense fragments synthesized produced an aberrant phenotype upon injection.  
Interestingly, injection of fragment (iii) T7 RNA, which is complimentary to the first 
three exons of Slc34a2a(as) did not produce a phenotype; failure to develop a 
cerebellum does not solely rely on putative hybridization between sense and 
antisense. There must be a sequence-specific effect that is specific to the naturally 
occurring dsRNA hybrid.  
All embryos examined that endured cerebellar loss had impaired behavioural traits. 
The embryos had problems swimming in an upright position, in a straight line and 
occasionally they could not move in any coordinated way as they exhibited signs that 
could be described as tremors. In the stimuli test, embryos get poked with the end of 
a pair of forceps. Wildtype embryos will swim away as quickly as possible to a region 
of safety even before being touched; either they mix into a large group of embryos or 
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hide in the shadow of the petri dish lip. Embryos with cerebellar loss could either be 
poked numerous times without any response or would escape but only swim a circle 
and return to the area of ‘danger’ (another poke). The cerebellum controls and 
coordinates fine movement, balance, muscle tone and is involved in non-motor 
learning (Moens and Prince, 2002; Lalonde and Strazielle, 2003; Morton and 
Bastian, 2004). Therefore, lack of cerebellum in these young fish is in accordance 
with the behavioural competencies observed.  
Cerebellar loss was confirmed in every case by completing in situ hybridization with 
an Engrailed-2a probe (Eng2). The Eng2 gene is essential for midbrain hindbrain 
development in embryogenesis. The probe marks the midbrain-hindbrain furrow 
(also known as the midbrain-hindbrain boundary) and the cerebellum, thus giving 
what appears to be a purple triangular wedge in the brain (Fjose et al., 1992; Thisse, 
2005; D'Aniello et al., 2013). Within the embryos that displayed repressed cerebellar 
development, ISH with Eng2 presented as a very thin, faint purple line. No individual 
or pair of genes/probes were available for in situ hybridization to determine if both 
sides of the midbrain-hindbrain furrow have developed. However to confirm 
cerebellar loss, Eng2 was sufficient and did so in the aforementioned studies.  
 
 
5.14.2 Slc34a2a(as) knock down 
 
Morpholinos are antisense oligonucleotides that comprise of usually 25 subunits 
which bind via sequence complementarity to their RNA target. These subunits 
include a nucleic acid, a morphine ring and a non-ionic phosphorodiamidate 
intersubunit linkage, which protects the morpholinos from degradation upon injection 
nor do morpholinos induce the degradation of their RNA target. Morpholinos can 
knock down the expression of a gene of interest in numerous ways such as blocking 
translation, modifying pre-mRNA splicing or inhibiting miRNA maturation (Gene 
Tools, 2016).  
To examine a putative function of the Slc34a2a antisense transcript directly, a 
morpholino that interferes with the splicing of the Slc34a2a(as) RNA transcript was 
designed and injected. Based on amounts used to induce target-specific phenotypes 
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in published studies, a range of dilutions from 0.2 to 10 ng were injected. A variety of 
inconsistent malformations appeared in all Slc34a2a(as) morpholino injected 
embryos. Generally, those at 48 hpf appeared less affected than their 24 hpf 
counterparts for all dilutions injected, with the exception of the embryos that received 
10 ng (figure 5.10).  These observations are in agreement with the semi-quantitative 
data from RT-qPCR analysis. A decrease in Slc34a2a(as) transcript levels was 
found in 24 hpf embryos which notions that the knockdown was successful. 
However, the Slc34a2a(as) transcript levels returned to near wildtype and embryos 
appeared slightly healthier by 48 hpf indicating that the effect of the antisense 
morpholino wore off over time. Due to their modified backbones, morpholinos do not 
get degraded in cells or serum since they are not recognized by nucleases (Hudziak 
et al., 1996; Youngblood et al., 2007). For that reason, the lack of Slc34a2a(as) 
knock down and healthier appearance at 48 hpf is likely the result of dilution of the 
morpholino during cell division. Alternatively, the reduction of Slc34a2a(as) could 
trigger a feedback loop that increases Slc34a2a(as) levels, such as the one 
proposed after Slc34a2a RNA injections. A third reason may be due to the 
functionality and specificity of the morpholino itself (morpholino specificity discussed 
further below).  
In situ hybridization utilising a probe for Slc34a2a(as) suggested that knockdown 
was successful at 48 hpf since no purple staining was visible in majority of embryos 
(figure 5.17). However, the 5 ng injected samples utilised were severely deformed 
due to the many off-target phenotypic effects (most likely due to morpholino toxicity). 
It is highly plausible that these 5 ng injected embryos were so highly developmental 
hindered that the organs in which Slc34a2a(as) is normally found, did not develop 
appropriately.  
Various factors need to be considered when using morpholinos; the specificity of a 
morpholino is not linked to effectiveness. For example, 80% knockdown can be 
achieved with 5 ng of morpholino but increasing concentration to 9 ng gives over 
90% knockdown in addition to numerous off-target effects (Eisen and Smith, 2008; 
Bill et al., 2009). The 0.4 ng -10 ng of Slc34a2a(as) morpholino injected triggered 
increasingly severe developmental malformations. However, even though deformity 
severity increased with quantity injected, it may be speculated that since no specific 
phenotype was produced, the amount injected was too high. Over 60% of 0.2 ng 
injected embryos were classified as level 1 at 24 hpf. Perhaps the threshold to 
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producing unspecific phenotypes/ toxicity line with this specific morpholino lies 
between 0.2 ng - 0.4 ng. 
One shortfall of the Slc34a2a(as) knockdown experiments described in this thesis is 
that only one morpholino oligonucleotide was used. There is no guarantee for 100% 
effectiveness as many factors need to be considered when designing the 
oligonucleotide. Any morpholino designed against a splice site junction will cause 
either a complete or partial single exon deletion or insertion. However, skipping or 
retention is dependent on the activation of cryptic donor and acceptor sites which are 
difficult to predict. Thus, morpholinos targeting the same RNA at different splice sites 
will have different optimal doses as different insertions/deletions will have incurred. 
Ultimately, to determine the effect of Slc34a2a(as) knockdown, numerous 
morpholinos targeting multiple splice site junctions should ideally have been trialled 
(this was not done for financial considerations).  In addition, injecting more than one 
morpholino against the same target RNA would strengthen the specific effect seen 
(Bill et al., 2009).  
The morpholino used within this study targeted Slc34a2a(as) via interfering with 
splicing. As mentioned previously, it could be speculated that the natural system of 
the embryo understood that it requires Slc34a2a(as) for normal development and in 
turn transcribed more to deal with the lack of functional Slc34a2a(as) present after 
morpholino knock down. Eventually more Slc34a2a(as) would be transcribed than 
morpholino injected and consequently a near wildtype level can be restored by 48 
hpf. Another option to determine if the Slc34a2a(as) RNA transcript is necessary 
would have been to inhibit it directly at the transcriptional level with a complete 
knockdown. This would have involve utilizing CRISPR-Cas9 technology so that 
either a premature stop codon is inserted in the genomic sequence between the 3’ of 
Slc34a2a and 5’ end of Rbpja or insertion of a premature poly-A site. However, this 
technique is costly and time consuming as it would involve creating a mutant strain 
of zebrafish. Depending on the technique used for mutation introduction, generations 
F0-F2 with confirmed changes, could be used in experimental studies to determine 
if/how Slc34a2a(as) is required (Jao et al., 2013).  
Morpholinos do not activate an innate immune response as they do not activate toll-
like receptors due to their unnatural backbones (Stessl et al., 2012; Gene Tools, 
2016). Nevertheless, they are known to cause many off-target phenotypic effects 
(Ekker and Larson, 2001). The majority of these effects have been linked to p53 
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mediated apoptosis. Danio rerio p53, which is highly similar in function and structure  
to the mammalian orthologues, is found in abundance during embryogenesis (Storer 
and Zon, 2010). The p53 mediated apoptosis has been found to be a direct 
consequence of losing an endogenous transcript and not of the morpholino itself 
since using other antisense knockdown technologies produced the same result 
(Robu et al., 2007). Therefore knockdown of p53 via a p53 targeting morpholino can 
suppress non-target specific effects.  
Co-injection of Slc34a2a(as) morpholino and p53 morpholino were completed to 
determine if Slc34a2a(as) transcript knockdown produced a specific effect. At 24 hpf, 
embryos co-injected with 2 ng Slc34a2a(as) morpholino and 4 ng p53 morpholino 
(majority level 2) fared much better than their counterparts that were only injected 
with 2 ng Slc34a2a(as) morpholino (majority level 3). Nevertheless, no consistent 
phenotype emerged. By 48 hpf, nearly 99% of embryos co-injected with 2 ng 
Slc34a2a(as) morpholino and p53 morpholino returned to wildtype. Even though p53 
knockdown rescued the embryos by suppressing non-specific effects, no specific 
developmental malformation could be attributed to Slc34a2a(as) knockdown. 
A phenotypic rescue was not visible in embryos co-injected with 5 ng Slc34a2a(as) 
morpholino and 4 ng p53 morpholino at neither 24 hpf nor 48 hpf. As mentioned 
previously, there is a fine line between morpholino efficacy and morpholino toxicity. It 
is plausible that the extremely high Slc34a2a(as) knockdown efficiency caused by 
injection of 5 ng of Slc34a2a(as) morpholino has in turn caused Slc34a2a(as) 
transcription via the previously mentioned feed-back loop. It is also conceivable that 
the non-specific phenotypes caused by 5 ng of Slc34a2a(as) morpholino are so 
severe that p53 knock-down could not rescue them since the malformations were 
irreversible.  
 
 
5.14.3 RNAi 
 
Dicer, a key enzyme in eukaryotic development, cleaves dsRNA into short interfering 
RNA (siRNA)  and pre-microRNA into mature microRNAs (miRNA) (see reviews 
(Plasterk, 2006; Carthew and Sontheimer, 2009)). The 20-30 base pair fragments 
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produced by Dicer are then incorporated into a RNA-induced silencing complex 
(RISC) which is crucial for RNA interference (RNAi). RISC can capture and silence 
RNA which shares sequence complementarity to the guide strand of the siRNA or 
miRNA that is incorporated within the RISC complex.  
It has been hypothesised in this study that Slc34a2a and Slc34a2a related 
transcripts hybridise to Slc34a2a(as). If this is the case, siRNAs may be produced, 
which could mimic the action of specific miRNAs and affect cerebellar development. 
To test such possibility, Dicer knock down was completed via morpholino injection. 
Two Dicer targeting morpholinos were received from James Patton (Vanderbilt 
University, Nashville, USA). The first morpholino, Dicer start MO, was designed 
against the translational start site whilst the second, Dicer UTR MO, was designed 
against the 5’ untranslated region of the dicer1 mRNA. 
Injection of Dicer start MO caused severe developmental defects in 24 hpf embryos 
that progressed into 48 hpf. Over 30% of embryos passed away within the first 24 
hpf. No consistent malformations amongst both 24 hpf and 48 hpf embryos were 
visible. An Ensembl BLAST (EMBL-EBI, 2015) search with this morpholino 
sequence returned over 100 hits (all with over 94.74% identity). This morpholino 
could potentially bind to many endogenous transcripts found in zebrafish embryos 
such as Slc8a (a sodium- calcium exchanger), triadin (a protein necessary for heart 
and muscle contractions) and hecw1b (protein ubiquitination involved in ubiquitin-
dependent protein catabolic process). Due to the phenotypic severity, high death 
rate and possible non-specificity, Dicer start MO was not utilised in further 
experiments.  
Gene-specific knockdown studies that utilise morpholinos have come under scrutiny 
recently. Even though it is well established that unspecific morpholino toxicity due to 
p53 activation exists, it has come to light that many morpholinos appear to produce 
the same recurring phenotypes. As seen in this study, the engorged area above the 
rhombomeres (‘megamind’) and misshapen eyes seem to be a phenotype common 
to many morpholino injections (Pollard et al., 2006; Nornes et al., 2009; Fischer et 
al., 2011; Ulitsky et al., 2011; Buhler et al., 2016). Moreover, phenotypes caused by 
morpholino knockdown have also been found to be unreproducible when mutant 
zebrafish lines for individual genes were generated (Kok et al., 2015). Therefore, 
morpholino based studies require concentration curves and thorough examination 
5. Mechanism 
 
144 
 
and validation of the phenotype, ideally via a non-morpholino based approach 
(Bedell et al., 2011; Morcos et al., 2015).  
Co-injection of 6.6 ng and 2.5 ng Dicer UTR morpholino and p53 morpholino 
produced a specific phenotype when embryos were visually examined at 48 hpf. 
Nearly all embryos were classified as level 3 due to having short body/tail lengths, 
curved bodies and/or small non-circular eyes. This phenotypic result is consistent 
with that seen in Wienholds et al. who injected 5 ng of a Dicer morpholino with the 
same sequence as well as other morpholino Dicer knockdown studies (Wienholds et 
al., 2003; Giraldez et al., 2005). As miRNA and siRNAs are vital for development, it 
was anticipated that knocking down Dicer would significantly slow the development 
of the embryos, thus producing the specific phenotype described (Wienholds et al., 
2003; Giraldez et al., 2005; Thatcher et al., 2008; Rajesh K. Gaur, 2009).  
To determine if a siRNA produced by Dicer from Slc34a2a sense/antisense dsRNA 
was interfering with cerebellum development, a triple injection was completed 
involving coding Slc34a2a RNA, Dicer UTR morpholino and p53 morpholino. Over 
98% of triple injected fertilised oocytes were classified as level 1 or 2. Of these 
embryos, all had a cerebellum whose existence was confirmed with Eng2 ISH. 
Those embryos that were classified as level 2 had a specific phenotype that 
presented as an enlarged hindbrain region (figure 5.23).  All triple injected embryos 
exhibited normal behaviour, including in the ‘poke’ test, affirming cerebellar 
presence. Therefore, knocking down Dicer rescued the ‘loss of cerebellum’ 
phenotype produced by Slc34a2a RNA injection. Therefore, knowing Dicers role in 
siRNA production by cleaving dsRNA, dsRNA formation of Slc34a2a and 
Slc34a2a(as) is highly likely.  
 
 
5.14.4 shRNA injection 
 
Endo-siRNAs may mimic microRNA action in silencing endogenous mRNAs which 
could in turn lead to developmental malformation. A BLAST search with the 
Slc34a2a sense/antisense complementary sequences, was performed with the aim 
to identify genes relevant to brain development that would be targeted by 
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Slc34a2a/Slc34a2a(as) siRNAs. Three candidate genes were identified: Presenilin2 
(Psen2), Wingless-type MMTV integration site family member 4b (Wnt4b) and RAS-
like, family 11, member B (Rasl11b).  
Unlike long dsRNA, injection of short hairpin RNAs (shRNA) into fertilized zebrafish 
oocytes has been widely validated for inhibiting gene expression by triggering RNAi 
(Li et al., 2000; Zhao et al., 2001; Su et al., 2008; De Rienzo et al., 2012). 
Consequently, in vitro synthesized hairpin RNAs containing the particular Slc34a2a 
sequence complimentary to the candidate gene were microinjected. The aim was to 
determine if knockdown of one of the candidate genes by shRNA injection produced 
the same ‘loss of cerebellum’ phenotype seen upon Slc34a2a RNA injection.  
Only one of the candidate gene shRNAs resulted in a phenotype. Injection of 165 pg 
Psen2 shRNA was found to affect hindbrain development in 24 hpf and 48 hpf 
visually examined embryos. The cerebellum developed as normal but the 
rhombomeres were so enlarged that they seemed to be touching the upper 
epidermis of the fish (Figure 5.25).  Psen2 is highly expressed within the neural crest 
during embryogenesis; knock down causes a distortion in hindbrain development 
due to reduced notch signalling (Groth et al., 2002; Campbell et al., 2006; Nornes et 
al., 2009). However, no consistent phenotype has been reported in Psen2 knock 
down studies involving morpholinos. In one study, the opposite phenotype was 
observed; the area above the rhombomeres increase and produced a ‘megamind’ 
like phenotype (Nornes et al., 2009). In another Psen2 morpholino knockdown study, 
the embryos would here be classified as level 3-4; they are extremely small with 
curved bodies, no midbrain-hindbrain boundary formation, no eye development and 
the area above the rhombomeres is non-existent (Campbell et al., 2006). As 
mentioned previously, morpholino studies can be a valuable tool in gene knockdown 
analysis but need to be thoroughly controlled and phenotypic results need 
comprehensive validation (Bedell et al., 2011). Therefore, as this study finds a 
phenotype of enlarged rhombomeres by shRNA gene silencing, which is different 
from the published phenotypes by morpholino knockdown (there is no phenotypic 
validation through a non-morpholino experiment in either paper), the Psen2 
knockdown phenotype observed here is difficult to be verified. The Psen2 shRNA 
phenotype does not match that of ‘loss of cerebellum’, but this does not mean Psen2 
is somehow not involved. The brain specific phenotye suggests that Psen2 may play 
a role but that additional factors may be required to create the whole phenotype.  
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5.15 Conclusion 
 
The aim of this chapter was to determine the mechanism behind the failure to 
develop a cerebellum which was caused by Slc34a2a RNA injection. Microinjection 
of a frameshift containing Slc34a2a RNA indicates that the observed phenotype is 
not caused by overexpression of the Slc34a2a protein. RNA fragments 
encompassing different areas of the Slc34a2a locus were generated to identify the 
biologically active region of the Slc34a2a sequence. One RNA fragment produced a 
brain phenotype; the fragment complementary to Slc34a2a(as). Triple injection 
consisting of Slc34a2a RNA, a Dicer morpholino and a p53 morpholino, found that 
the ‘loss of cerebellum’ phenotype can be rescued by knocking down Dicer. 
Therefore, the conclusion was drawn that injected Slc34a2a and Slc34a2a related 
transcripts were creating dsRNA with the endogenous Slc34a2a(as) transcript. 
Three target genes for the endo-siRNAs were identified and knocked down with 
shRNAs: Psen2, Wnt4b and Rasl11b. However, none produced the same ‘loss of 
cerebellum’ phenotype. However, this does not mean Psen2, which created a brain 
phenotype, is not involved through an undetermined pathway. In the subsequent 
chapter, dsRNA extraction will be attempted for the purpose of eventually 
sequencing and confirming Slc34a2a/Slc34a2a(as) endo-siRNA existence. 
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Chapter 6. dsRNA mapping and extraction  
 
Until recently, the existence of endogenous small interfering RNAs (endo-siRNA) 
was not well established and was believed to be limited to nematodes (Piatek and 
Werner, 2014; Piatek et al., 2016). Now that endo-siRNAs and their generating 
enzymes (Dicer/Drosha) have been found to occur in numerous eukaryotes, 
including fruit flies (Kawamura et al., 2008), mice (Babiarz et al., 2008; Flemr et al., 
2013) and humans (Werner et al., 2007; Xia et al., 2013), another layer of complexity 
has been added to how host gene expression is regulated. In the previous chapter, 
evidence was provided that a siRNA produced by Dicer from a sense/antisense 
hybrid (dsRNA) was disrupting zebrafish brain development. The aim of this chapter 
is to study endo-siRNA precursors; endogenously occurring double stranded RNA 
(dsRNA). Using the J2 monoclonal antibody, which has an affinity for dsRNA, 
demonstration of in vivo dsRNA existence was attempted by immunofluorescence 
and end point PCR.  
 
 
6.1 Immunofluorescent staining of dsRNA using J2 monoclonal antibody 
 
A monoclonal anti-dsRNA antibody, J2, was used in immunofluorescent staining to 
determine if endogenous dsRNA could be localised in 24, 36 and 48 hpf zebrafish 
embryos. PFA-fixed embryos, embedded in OCT, were sectioned at 5 µm using a 
Leica cryostat. The J2 mouse monoclonal IgG2a kappa chain antibody was utilised 
as primary antibody with both goat anti-mouse alexafluor 488 and TRITC-conjugated 
secondary antibodies. DAPI nuclear stain was utilised in the mounting process. 5 µm 
sections of mouse testis (from 6-9 month old mice) were utilised as a positive 
control; mouse testis are known to have a high abundance of endogenous dsRNA 
(Werner et al., 2007; Ge et al., 2008; Nejepinska et al., 2012).  
Specific dsRNA related fluorescence could not be localised utilising the J2 antibody 
in any zebrafish embryo sections. Similar fluorescence intensity (as visualised in 
figure 6.1) was found in comparable embryo structures between anti-dsRNA 
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sections and control sections where only secondary antibody was applied. Use of 
two different secondary antibodies with differing emission and excitation spectra 
made no difference to the results in zebrafish tissues. Within mouse testis sections, 
specific anti-dsRNA J2 signal was found in elongating spermatids (figure 6.1, arrows 
in bottom right panel). The connective tissue of the mouse testis stained as well. 
However, as the connective tissue stained in both anti-dsRNA and the control, it is 
considered background fluorescence. Nuclei were stained with DAPI.   
 
 
Figure 6.1 Immunofluorescent staining of dsRNA using the J2 IgG monoclonal 
primary antibody on zebrafish embryos and mouse testis sections. Tissue 
sections are 5 µm thick. Negative control consisted of staining with secondary 
antibody only (left panels). Blue stain is DAPI. Scale bar at 30 µm.  
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6.2 dsRNA immunoprecipitation using J2 monoclonal antibody 
 
With the aim to eventually extract endogenous dsRNA from whole zebrafish 
embryos, preliminary experiments were completed to determine how in vitro 
synthesized dsRNA responded to different extraction processes. Slc34a2a and 
Slc34a2a(as) uncapped RNA was in vitro synthesized and dsRNA was generated by 
mixing equal quantities in 1x PBS prior to incubation at 72°C for 10 minutes, followed 
by cooling on ice (sample called ‘2a/as dsRNA’). Control samples included single 
stranded RNA Slc34a2a or Slc34a2a(as) in 1x PBS and a mix of Slc34a2a RNA and 
Slc34a2a(as) RNA in water without the heating/cooling process, thus non hybridizing 
conditions. RNA extraction techniques tested included Trizol ® and the Bioline 
Isolate II miRNA Kit prior to immunoprecipitation with the J2 monoclonal antibody in 
combination with goat anti-mouse IgG magnetic beads. RNA was eluted from the 
J2/beads using MACS Separation Columns followed by reverse transcription. End-
point PCR was completed on cDNA utilizing primers designed in house (chapter 2, 
table 2.5).  
RNA extraction utilising the Trizol® method was found to favour single stranded RNA 
in comparison to dsRNA after immunoprecipitation since higher intensity Slc34a2a 
and Slc34a2a(as) bands were visible in the Slc34a2a plus Slc34a2a(as) mix (2a+as 
RNA mix) than in the 2a/as dsRNA sample as seen in figure 6.2. 
Immunoprecipitation with J2 without first undergoing RNA extraction confirmed that 
the J2 antibody favours dsRNA over ssRNA since band intensity was stronger in the 
2a/as dsRNA sample in comparison to the 2a+as RNA sample. In both the Slc34a2a 
RNA and Slc34a2a(as) RNA control samples, only the individual respective product 
was found. Bands for both Slc34a2a and Slc34a2a(as) were of higher intensity in the 
samples that did not undergo Trizol® extraction (J2 immunoprecipitation only). As 
only primer bands were visible when PCR was completed with actin primers, no 
contamination occurred (figure 6.2, bottom panel). Negative controls utilising 
respective RNA and water in the PCR reaction produced no result (data not shown).  
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Figure 6.2 Double stranded RNA immunoprecipitation utilizing the J2 
monoclonal antibody on goat anti-mouse IgG magnetic beads with and without 
prior RNA extraction with Trizol®. Expected product sizes were 174 bp for 
Slc34a2a, 198 bp for Slc34a2a(as) and 149 bp for actin primers. PCR with actin 
was completed to control for contamination.  N= 2 
 
 
In contrast, RNA extraction utilising the Bioline Isolate II miRNA Kit prior to 
immunoprecipitation with the J2 antibody was found to favour 2a/as dsRNA over the 
mix of Slc34a2a and Slc34a2a(as) RNA as visualised in figure 6.3. Bands for 
Slc34a2a and Slc34a2a(as) had the same intensity in samples 2a/as dsRNA, 
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Slc34a2a RNA and Slc34a2a(as) RNA which were more intense in comparison to 
the Slc34a2a+Slc34a2a(as) RNA mix. When no extraction was performed prior to 
immunoprecipitation, Slc34a2a and Slc34a2a(as) band intensity did not differ 
between single stranded RNA or dsRNA samples. No contamination was found in 
no-cDNA PCR controls and PCR completed with actin primers (RNA in PCR reaction 
data not shown).  
 
 
Figure 6.3 Double stranded RNA immunoprecipitation utilizing the J2 
monoclonal antibody with and without f irst undergoing RNA extraction with the 
Bioline Isolate II miRNA Kit. Expected product sizes were 174 bp for Slc34a2a, 
198bp for Slc34a2a(as) and 149 bp for actin primers. PCR with actin was 
completed to control for contaminations. N=2 
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The J2 monoclonal antibody has been used in various immunocapture methods in 
both plant extracts and in cell lines but there is limited literature involving eukaryotic 
tissues (Lybecker et al., 2014; Nejepinska et al., 2014; Blouin et al., 2016). It has 
been hinted that J2 antibody favours naturally occurring dsRNA over synthetic 
dsRNA (Schonborn et al., 1991). Even though it remained undermined how the 
above conditions or J2 affected dsRNA stability, dsRNA immunoprecipitation with J2 
antibody was attempted utilizing whole zebrafish embryos. Transcript levels were 
examined via semi-quantitative RT-qPCR. Five embryos were flash frozen without 
liqid on dry ice prior to being crushed with a pestle. Total RNA was examined by 
10% of the tissue slurry undergoing RNA extraction with Trizol® prior to reverse 
transcription as mentioned in the preceding chapters (input control). The remaining 
90% of the sample was divided with one half receiving J2 antibody (with J2) and the 
other half had nothing added (no J2). Five embryos from a minimum of three 
clutches were used for the data presented in figure 6.4. 
The content of Slc34a2a, Slc34a2a(as) and Slc34a2b in the flash frozen embryos 
was examined and did not differ significantly from previous experiments (figure 6.4, 
yellow and blue bars, input control). When immunoprecipitation with the J2 antibody 
was completed using the tissue slurry without prior RNA extraction, levels for all 
transcripts of interest increased (figure 6.4, red bars). When immunoprecipitation 
was completed without J2 antibody, all transcript levels decreased (figure 6.4, grey 
bars). Error bars for no J2 added immunoprecipitation controls, are much larger than 
all others; Ct values within triplicates for each clutch had larger standard deviation 
than the triplicates completed for Trizol® extracted RNA and dsRNA precipitated 
with J2 antibody. The fact that the presence or absence of the J2 antibody had 
indiscriminate effects on all transcripts, whether or not putative dsRNA could be 
present, suggests a lack of specificity for the entire process. 
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Figure 6.4 Semi quantitative RT-qPCR analysis of Trizol® extracted total RNA 
(blue) and dsRNA precipitated with J2 antibody (red) from five flash frozen 
fertilised zebrafish oocytes 48 hours post fertilization. A no J2 antibody control 
was included (grey). RNA extracted from embryos using the previous ly 
described Trizol protocol (chapter 4) is presented in yellow. ΔCt was calculated 
by using β-actin as gene reference. N≥3  
 
 
6.3 Discussion 
 
The J2 antibody has been successfully used in dsRNA detection caused by RNA 
and/or DNA viruses in cell lines and parasites (Weber et al., 2006; Targett-Adams et 
al., 2008; Zangger et al., 2013). Recently, the J2 antibody was used to demonstrate 
dsRNA accumulation after Dicer-knockdown in HEK293 cells (White et al., 2014). 
Thus, it was attempted to determine if endogenous dsRNA could be localised in 
sectioned zebrafish embryos. Attempts were made with two different secondary 
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antibodies but in both cases, the search proved fruitless. As seen in figure 6.1, no 
specific staining was found in 24-48 hpf zebrafish embryos.  
Accumulation of dsRNA within cells activates the interferon-response pathway which 
consequently leads to cell death (Sledz and Williams, 2004; Reynolds et al., 2006; 
White et al., 2014). The function of mammalian cytoplasmic Dicer is well 
documented; as a key enzyme in the RNA interference (RNAi) pathway, Dicer 
cleaves dsRNA into short RNAs. It has been suggested that human nuclear Dicer, 
which interacts with RNA polymerase II, has a specific function in cleaving 
endogenous dsRNA formed from overlapping long non-coding RNA (Gagnon et al., 
2014; White et al., 2014). Knocking down nuclear Dicer, which results in dsRNA 
accumulation, has a catastrophic effect on human cell-line function by activating the 
interferon-response pathway subsequently leading to cell death (White et al., 2014).  
Zebrafish, just like mammals, have an interferon-response pathway and express 
Dicer, which functions in RNAi. The detection of dsRNA could have failed in the 
above experiments due to wildtype embryos being utilized; Dicer would have 
cleaved all dsRNA present to prevent any interferon-response. Thus, if dsRNA exists 
transiently, the J2 antibody may not be able to bind due Dicer masking or quickly 
cleaving the > 40 bp dsRNA structures required for J2 binding. Rapid 
degradation/masking is important as dsRNA presence may trigger an immune 
response since dsRNA is normally foreign and due to viral infection. To date, only 
hyperedited dsRNAs have been found not to trigger the interferon-response pathway 
and apoptosis (Vitali and Scadden, 2010). Therefore, it is conceivable that only 
minimal quantities of dsRNA are formed endogenously; not enough to produce a 
detectable signal. Accordingly, no publications report quantification of endogenous 
dsRNA levels.   
dsRNA detection was unsuccessful in zebrafish embryos. However, many different 
suggestions can be made for further experiments. White et al. detected high levels of 
dsRNA with the J2 antibody after knocking down Dicer in human cells (White et al., 
2014). Attempts for dsRNA detection could be made utilising the Dicer UTR 
morpholino injected embryos from the preceding chapter. Slc34a2a sense and 
antisense transcripts are both expressed at 48 hpf; this however does not mean 48 
hpf has the highest levels of endogenous dsRNA. Attempts to detect dsRNA could 
be made using juvenile and adult fish to determine if dsRNA presence/existence can 
be detected. Other options include manipulations to the immunofluorescence 
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protocol. In this study, embryos were fixed with PFA prior to freezing in OTC which 
could have affected tissue integrity. White et al. used an acetone/methanol fixation 
prior to monitoring immunofluorescence (White et al., 2014). Another route may be 
to permeabilize the cells with Triton x-100 as done in in situ hybridization prior to 
adding the primary antibody.  
Mouse testis, which are potentially high in dsRNA, were utilised as a positive control 
for anti-dsRNA J2 signal (Werner et al., 2007; Ge et al., 2008; Nejepinska et al., 
2012). Within the mouse testis sections, a J2 specific signal appeared to be present 
in elongating spermatids. Dicer-dependent miRNAs and endo-siRNAs play a vital 
role in gene regulation, chromatid condensation and nuclear polarization in 
developing spermatids (Gou et al., 2014; Yadav and Kotaja, 2014). Therefore, 
endogenous dsRNA was expected to be mapped to areas containing developing 
spermatids as visualised in figure 6.1. This finding corresponds with the anti-dsRNA 
granular staining within spermatocyte nuclei that was found by Noora Kotaja and 
group (personal communication).  
Trial dsRNA immunoprecipitation experiments with the J2 antibody were performed 
to confirm the specificity of the J2 monoclonal antibody. In all experiments where 
synthesized dsRNA immunoprecipitation was completed without prior RNA 
extraction, the J2 antibody favoured Slc34a2a/Slc34a2a(as) dsRNA over the mix of 
Slc34a2a and Slc34a2a(as) RNA in water (figure 6.2). However, control samples 
that contained only one RNA strand (either Slc34a2a or Slc34a2a(as) at the same 
concentration used to make the dsRNA or mix) produced bands of similar intensity 
when compared to the dsRNA sample. Slc34a2a and Slc34a2a(as) bands were also 
produced from the sample that contained both the sense and antisense strand under 
non hybridizing conditions. These results indicate that the J2 antibody used under 
these conditions for immunoprecipitation, was not highly specific for dsRNA (figures 
6.2 and 6.3). Alternatively, single and double-stranded RNA could feature differently 
at various steps throughout the test protocol (see below). 
Two different RNA extraction methods were tested prior to dsRNA precipitation with 
J2 to arbitrate if an extraction method could ameliorate the precipitation process: the 
standard Trizol® phenol/chloroform technique and the Bioline Isolate II miRNA Kit 
which can be adjusted to extract both long (>200bp) and short RNA. Phenol 
chloroform extraction using Trizol® prior to dsRNA precipitation was found to favour 
single stranded RNA since Slc34a2a and Slc34a2a(as) bands were of higher 
6. dsRNA 
 
156 
 
intensity in the Slc34a2a plus Slc34a2a(as) mixed sample rather than the 
synthesized dsRNA sample (figure 6.2). Contrary, immunoprecipitation after using 
the Bioline Kit for extraction, favoured the synthesized dsRNA in comparison to the 
Slc34a2a and Slc34a2a(as) mix. However, in both experiments, bands were visible 
for Slc34a2a and Slc34a2a(as) in control samples containing each individually. 
Therefore even though the two different RNA extraction process seem to favour 
different forms of RNA (single versus double stranded), both are extracted 
nevertheless. An additional complication represents the detection by RT-PCR. 
Experience in our lab have confirmed that hairpin RNA in particular and dsRNA in 
general, is not efficiently reverse transcribed. This would favour the detection of the 
individual transcripts. The applied strategy using the J2 antibody, which aimed to be 
dsRNA specific, does not appear to be precise enough to only extract the 
synthesized Slc34a2a/Slc34a2a(as) dsRNA under the conditions tested above.  
In vitro synthesized Slc34a2a and Slc34a2a(as) RNA were hybridized to form 
dsRNA as recommend by numerous groups under low salt conditions with heating 
followed by a slow cooling on ice (DRSC, 2015; BrownUniversity, 2016). Phenol 
chloroform was utilised for RNA extraction as it is the most commonly utilized 
method resulting in high quantities of RNA. Apart from trialling other RNA extraction 
kits produced by differing manufacturers, another option would have been to attempt 
RNA extraction using lithium salt buffers. Specific double stranded RNA extraction 
from plants using lithium salts has determined that the quantity is adequate and the 
quality pure enough for numerous downstream applications including RT-qPCR 
(Tzanetakis and Martin, 2008). Perhaps this extraction process that claims to be 
better for dsRNA extraction could have ameliorated the J2 antibody 
immunoprecipitation method by providing more dsRNA than ssRNA. Other options to 
optimise J2 antibody dsRNA precipitation include manipulating the salt 
concentrations (differing salts), binding time and trialling differing ratios of J2 
antibody to magnetic beads to dsRNA.  
One publication has hinted that J2 antibody favours naturally occurring dsRNA over 
synthetic dsRNA (Schonborn et al., 1991).  Therefore dsRNA immunoprecipitation 
was attempted utilizing crushed flash frozen whole zebrafish embryos prior to 
examining transcript levels via semi-quantitative RT-qPCR. Flash freezing embryos 
on dry ice did not have an impact on total RNA content since ΔCt values for all 
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transcripts examined were consistent with the data from embryos frozen and stored 
in Trizol® (figure 6.4, yellow and blue bars).  
Interestingly, after anti-dsRNA J2 immunoprecipitation, levels for all transcripts 
examined (Slc34a2a, Slc34a2a(as) and Slc34a2b) increased. Phenol chloroform 
with Trizol® extracts both single and double stranded RNA (Flegr, 1987; Castillo and 
Cifuentes, 1994; Sambrook and Russell, 2006) but the above data suggests it may 
partially favour single stranded (similar findings have been mentioned in Biological 
online forums). If phenol chloroform extraction does partially favour ssRNA, then J2 
precipitation from whole embryos could have extracted a higher level of dsRNA than 
Trizol®. Alongside the ssRNA that is eluded through the J2 immunoprecipitation 
process (figure 6.2 and 6.3), this would explain the higher levels of Slc34a2a and 
Slc34a2a(as) RNA detected (figure 6.4, red bars). However, there is a significant 
increase in Slc34a2b RNA levels as well and Slc34a2b does not have a cis-NAT. 
The manufacturer claims that J2 antibody recognition of dsRNA is independent of 
sequence and nucleotide composition as long as the dsRNA is over 40 bp 
(SCICIONS, 2014). However, through scanning force microscopy, some preferential 
binding sites have been determined and verified by site-directed mutagenesis (Bonin 
et al., 2000). Therefore increase in detectable levels may be due to either Slc34a2b 
transiently hybridizing to an unknown RNA partner or J2 antibody having an 
undetermined sequence specify that Slc34a2b binds. 
In the control samples without J2, Slc34a2a RNA levels were found to be less than 
that precipitated with J2 antibody but still higher than that found in the total RNA 
(figure 6.4). The expected result was that the minus J2 control would have less of 
each transcript since no RNA was extracted and all RNA should have been in the 
flow-through after passing through the MACS columns. This was the case for 
Slc34a2a(as) and Slc34a2b RNA levels, which were found to be less than in total 
RNA extracted with Trizol® and J2 precipitated RNA levels. All Ct values for 
transcripts of interest in the minus J2 samples differed substantially within clutch 
triplicates and amongst clutches thus resulting in higher standard deviations for each 
clutch. This in turn gave rise to the large standard error bars presented (figure 6.4, 
error bars on grey bars). Both single and double stranded RNA should flow through 
the columns without J2 added and any signal is due to unspecific binding, consistent 
with the inconsistent Ct values.  
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The above preliminary experiments suggest that the anti-dsRNA J2 antibody in the 
tested set-up is unable to solely extract synthesized Slc34a2a/Slc34a2a(as) dsRNA; 
both single and double stranded RNA is present after immunoprecipitation. The 
semi-quantitative RT-qPCR data would suggest that J2 or the magnetic beads bind 
more RNA than Trizol ® extracts (possibly due to both dsRNA and ssRNA being 
present in eluted samples). This highlights essential problems in the experimental 
setup. Neither of these preliminary studies demonstrate dsRNA in vivo existence in 
zebrafish, nor is the stability of dsRNA determined. Questions such as if the 
extraction process allows for the dsRNA to remain intact or if it disrupted and re-
hybridises further downstream, still need to be answered. It appears that many steps 
of the experimental protocol have a bias toward single or double stranded RNA 
molecules that, at the moment are not fully understood. Secondly, the amount of 
dsRNA in the zebrafish embryos may simply be too low to warrant reliable detection 
by J2 precipitation and RT-PCR. Many further experiments need to be completed 
prior to determining if endogenously occurring dsRNA can be extracted from whole 
zebrafish tissues using J2 antibody.  
 
 
6.4 Conclusion 
 
The J2 antibody has been successfully used in dsRNA mapping and extraction 
caused by RNA/DNA viruses or Dicer knockdown in cell lines and parasites (Weber 
et al., 2006; Targett-Adams et al., 2008; Zangger et al., 2013; White et al., 2014). 
The anti-dsRNA J2 antibody, however, was unable to detect any Slc34a2a/ 
Slc34a2a(as) dsRNA in 24, 36 and 48 hpf section zebrafish embryos. However, 
dsRNA was localised to elongating spermatids in mouse testis validating the 
protocol. The protocol used was found to be unspecific for dsRNA 
immunoprecipitation conducted with both synthesised dsRNA and in whole tissues. 
Eventually, an improved immunoprecipitation protocol would be useful to determine 
whether dsRNA is formed in vivo and how this avoids triggering an interferon 
response throughout development. The sequence of the siRNA generated by 
Slc34a2a/ Slc34a2a(as) dsRNA as seen in the previous chapters could further be 
determined by size selected RNAseq experiments from staged zebrafish embryos. 
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Chapter 7. Discussion  
 
7.1 Summary of major findings 
 
Quantity and temporal expression patterns of a protein or transcript can be a key 
indicator as to function. Within this study, the interplay of four RNA transcripts from 
three genes were examined during Danio rerio embryogenesis; Slc34a2a and its 
naturally occurring antisense transcript (Slc34a2a(as)), Slc34a2b and Rbpja. RT-
qPCR and in situ hybridization data determined that the Slc34a2a sense and 
antisense transcripts demonstrate a reciprocal relationship were both transcripts are 
expressed at a near equal amounts at 48 hpf. Slc34a2a(as) expression was present 
from fertilisation and decreased gradually over time whilst Slc34a2a expression 
commenced at 48 hpf and progressively increased from there on. The two 
transcripts located to the same tissues during the examined 72 hours of 
development: the pharynx, endoderm (future digestive tract and swim bladder), 
primordial midbrain channel and primordial hindbrain channel. These findings 
support the possibility of antisense-mediated Slc34a2a gene regulation.  
Injection of full length in vitro synthesised Slc34a2a RNA caused a dose-dependent 
phenotype in fertilized zebrafish oocytes. A specific loss of cerebellar development 
was noted upon injections of Slc34a2a RNA that was neither seen with Slc34a2a(as) 
nor Slc34a2b RNA injections. Engrailed-2 in situ hybridization confirmed the loss of 
cerebellum and malformation of the midbrain/hindbrain boundary. Microinjection of a 
frameshift containing Slc34a2a RNA produced the same phenotypic failure to 
develop a cerebellum, indicating that it was not overexpression of the Slc34a2a 
protein that caused the observed phenotype. RNA fragments encompassing different 
areas of the Slc34a2a locus were generated for microinjection to determine the 
specific region of the Slc34a2a sequence that caused the phenotype. One RNA 
fragment produced a brain phenotype; the fragment encompassing the Slc34a2a 
sequences (exons 10 and 13) that are complementarity to Slc34a2a(as) caused 
failure to develop a cerebellum. Triple injection consisting of Slc34a2a RNA, a Dicer 
morpholino and a p53 morpholino, found that the ‘loss of cerebellum’ phenotype 
could be rescued by Dicer knockdown. Therefore, the conclusion was drawn that 
injected Slc34a2a and Slc34a2a related RNA transcripts were creating dsRNA with 
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the endogenous Slc34a2a(as) transcript to form a Dicer substrate. The 
Slc34a2a/Slc34a2a(as) derived endo-siRNAs were hypothesised to interfere with a 
transcript necessary for correct brain development. With the aim of defining target 
genes, identified by BLAST, short hairpin RNAs were produced to knockdown three 
candidate genes: Psen2, Wnt4b and Rasl11b. None produced the same ‘loss of 
cerebellum’ phenotype demonstrating that they are not the specific target for the 
Slc34a2a/Slc34a2a(as) siRNA. However, it is plausible that the 
Slc34a2a/Slc34a2a(as) siRNA works through an intricate pathway which Psen2 may 
be part of, but other unknown factors are involved to create the ‘loss of cerebellum’ 
phenotype.  
The J2 monoclonal antibody has been successfully used in previous studies to map 
and extract dsRNA caused by RNA/DNA viruses or Dicer knockdown in cell lines 
and parasites. However, the anti-dsRNA J2 antibody was unable to clearly detect 
any endogenous dsRNA in 24, 36 and 48 hpf sectioned zebrafish embryos within 
this project. Nevertheless, dsRNA was localised to elongating spermatids in positive 
control mouse testis sections. Thus, either dsRNA exist briefly and transiently in 
zebrafish embryos or the dsRNA is bound by other molecules preventing J2 antibody 
binding. Additionally, immunoprecipitation using the J2 antibody followed by RT-PCR 
detection gave inconclusive results likely due to technical difficulties and/ or low 
expression of dsRNA in zebrafish whole tissues.  
 
 
7.2 Putative mechanisms and the biological function of Slc34a2a(as)  
 
In recent years, bioinformatics and transcriptome studies have proposed that 
thousands if not hundreds of thousands of non-coding RNAs (ncRNA) exist in higher 
eukaryotic species (Bertone et al., 2004; Washietl et al., 2005; Jeggari et al., 2012). 
Non-coding RNAs have been linked to numerous pathways involved in RNA splicing, 
DNA replication, chromosome structure and gene regulation (Wilusz et al., 2009; 
Baguma-Nibasheka et al., 2012; Modarresi et al., 2012). Therefore it is no surprise 
that some ncRNAs have been linked directly to diseases such as Alzheimer’s 
(review:(Tan et al., 2013)), autism (Velmeshev et al., 2013), Prader-Willi syndrome 
(Galiveti et al., 2014) and cancer (Matouk et al., 2007). Many ncRNAs have yet to 
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have their function validated but it is likely that many are non-functional products of 
spurious or pervasive transcription. 
A form of non-coding RNA, natural antisense transcripts (NATs), are fully processed 
mRNA-like transcripts originating from the opposite strand of protein coding genes. 
These antisense transcripts can contain sequences of perfect complementarity with 
other endogenous transcripts and thus, can act in cis or trans via hybridization. 
There are a few possible mechanisms as to how NATs regulate cognate sense 
transcripts; Transcriptional inference like in the case of initiation factor 2a (elF2a) 
(Silverman et al., 1992), RNA masking like thyroid hormone receptor ErbAa2 
(Munroe and Lazar, 1991), dsRNA-dependent mechanisms (such as RNA 
interference) like SINE B2 (Fan and Papadopoulos, 2012), antisense-induced 
methylation such as hemoglobin α-2 in α-thalassemia (Tufarelli et al., 2003) or 
chromatin remodelling such as tumour suppressor gene p15 in leukaemia (Yu et al., 
2008).  
Even though the mechanisms through which NATs function have been theorised, 
few validated and thoroughly understood examples exist. Within this study, an 
attempt was made to understand the role of Slc34a2a(as) during embryogenesis. As 
transcriptional interference has only been validated in yeast, and both Slc34a2a 
sense and antisense transcripts are present in the same tissues at 48-72 hpf  (qPCR 
and in situ hybridization data), it is unlikely that Slc34a2a(as) is preventing Slc34a2a 
transcription through TI. However, since knock down studies of Slc34a2a(as) by 
morpholino were unsuccessful, it is difficult to pinpoint what other mechanism 
through which this specific NAT functions, and more so, what  is its designated 
target(s).  
NATs can work in cis on their cognate sense partner or in trans – affecting a distant 
gene, transcript or even protein. RNA masking of Slc34a2a by Slc34a2a(as) seems 
unlikely as there are no known alternate splice forms to Slc34a2a. Nevertheless, this 
does not mean RNA masking can be ruled out completely. As no successful knock 
out of Slc34a2a(as) was completed, it is hard to determine if endogenous 
Slc34a2a(as) is involved in regulating polyadenylation, translation or Slc34a2a 
stability. However, this hypothesis too seems fairly unlikely. Otherwise injected 
Slc34a2a would have been stabilized and/or translation would have been aided by 
Slc34a2a(as) and signs of increased sodium-phosphate transport would be 
exhibited. Experiments observing phosphate level uptake would have been valuable. 
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It too is plausible that Slc34a2a(as) works in trans and this study has been unable to 
determine the specific target by absence of Slc34a2a(as) knock out experiment. If 
Slc34a2a(as) works by masking or unveiling critical factors in a trans transcript, then 
injection of Slc34a2a could be inhibiting Slc34a2a(as) normal function, thus 
producing the loss of cerebellum phenotype. However, knock down of Dicer would 
cleave all Slc34a2a/Slc34a2a(as) duplexes, and as Slc34a2a(as) is transcribed 
within the first 72 hpf, it could resume its normal function in cerebellar development 
after the ratio of Slc34a2a to Slc34a2a(as) switches in its favor.  
To date, there are only a few well established examples of naturally occurring endo-
siRNAs that function in higher eukaryotes as humans and mice. As Dicer knock 
down rescued the ‘loss of cerebellum’ phenotype observed upon Slc34a2a RNA 
injection, it suggests that a siRNA from Slc34a2a/Slc34a2a(as) dsRNA might be a 
possible mediator for the phenotype observed. However, as endo-siRNA presence in 
the first 48 hours is due to exogenously added sense transcript, the loss of 
cerebellum phenotype may simply be an artefact. It is doubtful that endogenous 
Slc34a2a(as) regulates Slc34a2a through RNAi prior to 48 hpf, otherwise lack of 
cerebellar development would be common in zebrafish. Additionally, as 
Slc34a2a(as) knockdown studies were unsuccessful by morpholino injection, it 
remains unknown if Slc34a2a(as) regulates another RNA in trans through a dsRNA-
dependent mechanism. 
If Slc34a2a(as) RNA does regulate Slc34a2a, it might do so through the least 
understood mechanism, antisense-induced methylation or  chromatin remodelling. 
As Slc34a2a and Slc34a2a(as) show a temporal reciprocal pattern, it may be that 
the reduction in Slc34a2a(as) levels affects an unknown transcriptional enhancer or 
repressor of Slc34a2a. It too is possible that Slc34a2a(as) exists to regulate a distant 
gene by chromatin remodelling.  
The work completed within this study highlights the biological importance of 
maintaining a sense/antisense balance and provides a legitimate example as to how 
NATs can affect development through ectopic dsRNA formation. However, many 
questions still remain. Slc34a2a RNA presence in the first 48 hours of development 
caused a detrimental phenotype involving the failure to develop a cerebellum due to 
siRNA production by Dicer from Slc34a2a/Slc34a2a(as) dsRNA. Therefore, if 
Slc34a2a presence is harmful during the first 48 hpf, why does Slc34a2a(as) exist? 
Does Slc34a2a(as) suppress Slc34a2a during the first 48 hours through a 
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mechanism that is not transcriptional interference or RNAi? Would the repercussion 
of Slc34a2a expression during the first 48 hpf without Slc34a2a(as) be worse than 
Slc34a2a/Slc34a2a(as) dsRNA formation? Does Slc34a2a(as) regulate any other 
genes or proteins in trans? Or is Slc34a2a(as) simply the result of transcriptional 
noise? 
Additional questions arise due to Slc34a2a sense and antisense RNA co-existence. 
Both Slc34a2a and Slc34a2a(as) are endogenously present at 48 hpf and it is fair to 
assume that they hybridize to form dsRNA at this time point as both localise to the 
same tissues (these findings are supported by (Carlile et al., 2009)). Double 
stranded RNA can elicit an immune response due to its resemblance to viruses or an 
intermediate formed in genome defence strategies against transposable elements. 
Therefore, it remains to be determined how the endogenous Slc34a2a 
sense/antisense duplex at 48 hpf does not trigger an immune response.  
An antisense RNA transcript for Slc34a2a (and orthologs) is found within humans, 
mice, zebrafish and other higher organisms (Piatek et al., 2016). It seems logical that 
evolution would not have kept a disadvantageous RNA transcript. Therefore, even 
though the exact function of Slc34a2a(as) remains undetermined within this project, 
many possibilities have been eliminated such as TI and RNAi. Many questions still 
remain to be answered about the zebrafish Slc34a2a antisense RNA transcript, but 
this study has proved that maintaining a natural balance is vital for normal 
development. 
 
 
7.3 Impact on the medical field 
 
Within the last decade, the biological importance of regulatory RNA has been 
recognized with major advances in understanding their individual roles in health and 
disease. With a surprisingly large number of human genes being transcribed in both 
directions, both sense and antisense RNA transcripts play a role in gene expression 
regulation and thus make promising targets for therapeutics. Due to emerging and 
rapidly changing challenges to human health, modern medicine requires new forms 
of treatment for both common and unusual ailments. Antisense oligonucleotides 
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designed to bind to target RNAs via well-characterized Watson-Crick base pairing, 
can modulate the target RNA’s function through an assortment of post-hybidizing 
events such as cleaving, degradation or translation prevention (Boisguérin et al., 
2015).  
Many factors however, need to be considered prior to trialling and use. Not only 
must the sequence and function of the target RNA be known, but also the nature of 
related transcripts to avoid unwanted hybridization and off target effects. The work 
within this study highlights the importance of sense/ antisense transcript balance. By 
knocking-down the NAT by microinjecting the Slc34a2a sense transcript, a negative 
phenotype emerged that lead to behavioural impairment and severe physical 
malformation dependent upon dose. Thus, alongside dose, not only is target 
specificity a necessity, knowing no other targets are present is critical.  
Cell-specific delivery of antisense oligonucleotides is also vital as knocking down the 
target RNA in normal healthy tissues might result in negative outcomes. To date, 
numerous delivery strategies have been tested, each having its own advantages and 
disadvantages, including nanocarriers, conjugates of oligonucleotides and various 
ligands (see reviews;. (Juliano et al., 2008; Boisguérin et al., 2015)).  
There is a natural balance between cellular components and regulatory pathways 
within a host, as seen in this study. The Slc34a2a antisense transcript examined 
within this project also naturally occurs in humans and other mammalian species 
(Piatek et al., 2016). Hopefully this study provides insight into how the human 
equivalent functions thus adding to the breadth of knowledge required for designing 
future therapeutic antisense oligonucleotides. Heterozygous loss-of-function 
mutation in SCN1A, a voltage-gated sodium channel, causes a brain disorder called 
Dravet syndrome. Antisense oligonucleotide interference of SCN1ANAT, a NAT 
which controls SCN1A, has been determined to relieve the symptoms of Dravet 
syndrome in both mouse and non-human primate models (Hsiao et al., 2016). In the 
future, a comparable strategy could be used to increase Pi reabsorption by 
SLC34A1 in patients with Pi wasting and kidney stones. Antisense and siRNA 
oligonucleotide clinical trials are already underway with RNA targets involved in 
cancer progression and metastasis (Chi et al., 2010; Cresce and Koropatnick, 2010; 
Bedikian et al., 2014; Natale et al., 2014), neurodegenerative disease such as 
Duchenne’s muscular dystrophy (Takeshima et al., 2006; Koo and Wood, 2013), 
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allergen induced inflammation control (Gauvreau et al., 2008) and Crohn’s disease 
(Monteleone et al., 2015).  
 
 
7.4 Future work 
 
Alongside mapping and more extensively quantifying Slc34a2a sense and antisense 
transcripts, this study has increased the knowledge on how zebrafish 
Slc34a2a/Slc34a2a(as) RNA transcripts interact and affect one another. However, 
much more research needs to be accomplished to complete our understanding of 
Slc34a2a(as) existence. Slc34a2a(as) knockout studies, such as CRISPR-Cas9 
insertion of a premature stop codon within the first 100 bp of the antisense genome 
sequence, would provide insight into the role of Slc34a2a(as). It is plausible that 
Slc34a2a(as) may regulate an unknown transcript in trans through a dsRNA-
dependent mechanism. Antisense-induced methylation is the least understood 
mechanism by which NATs can regulate gene expression. Bisulfite treatment of DNA 
(cytosine converts to uracil unless methylated) from wildtype fish versus 
Slc34a2a(as) knockout fish, followed by next-generation sequencing, would provide 
insight in the methylation status and changes coinciding with presence of 
Slc34a2a(as) RNA.  
Preliminary experiments were completed with anti-dsRNA J2 monoclonal antibody. 
Further experiments need to be conducted to determine the specific conditions 
under which J2 antibody would be able to extract dsRNA from whole tissues. 
RNAseq on all dsRNA extracted would provide novel insight into the quantity of 
endogenously occurring dsRNA at different developmental stages. Completing 
RNAseq on dsRNA extracted from Dicer knock-down fish would be interesting to 
determine the amount of dsRNA that gets processed through RNAi. Perhaps this 
would provide insights as to why some endogenous dsRNAs do not activate the 
interferon response pathway. Additionally, genomic areas with higher levels of 
dsRNA could be determined after alignment of compiled RNAseq data, thus 
providing supporting information for the number of NATs theorised to exist.  If 
dsRNA extraction was found to be successful from zebrafish whole tissues, then it 
would be possible to perform the extraction on human tissues. All sequencing 
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information from human dsRNA could add to the knowledge base to reduce off 
target effects for future antisense and siRNA oligonucleotide therapeutics. 
This thesis will provide a solid foundation to inform future work either in the field of 
antisense-mediated gene regulation or in studies focussing on dsRNA using the J2 
antibody.  
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Appendix A 
 
Sequence similarity and alignments of Danio rerio Slc34a2a, Slc34a2a(as) and 
Slc34a2b. 
 
1.0 EMBOSS matcher: pairwise nucleotide sequence alignment of Slc34a2a 
and paralog Slc34a2b (Waterman-Eggert local alignment) 
 
68.4% nucleotide sequence similarity (1169/1710) 
 
Slc34a2b         146 GAGGTGGACCCGTGGGAGCTGCCGGAGCTCCTGGACACCGGGGTGAAGTG    195 
                     ||||..||.||.|||||..||..||||||.|.|||||||||||||||.|| 
Slc34a2a         366 GAGGATGATCCCTGGGAAATGATGGAGCTGCAGGACACCGGGGTGAAATG    415 
 
Slc34a2b         196 GTCAGAGTTGGACCGGCGCGGAAAGGTCCTGCGGGTCTGCACCTCTGTCC    245 
                     |.||||..|||||.........|||||||||.|.||.|..||..|.|... 
Slc34a2a         416 GGCAGATCTGGACACTAAAAAGAAGGTCCTGAGAGTTTTTACTACAGCAG    465 
 
Slc34a2b         246 TGAAGTTGCTGCTGCTGCTCGGCCTGCTCTACATGTTCGTCTGCTCCCTG    295 
                     ..||..||.|..|||||||.||..|||||||||||||.||.|||||.||| 
Slc34a2a         466 CAAAACTGATCATGCTGCTTGGTTTGCTCTACATGTTTGTTTGCTCTCTG    515 
 
Slc34a2b         296 GACATCCTCAGCTCTGCTTTCCAGCTGGTCGGAGGGAAGGCAGCGGGGGA    345 
                     |||.||||.|||||.|||||||||||.||.|||||.||.|||||.||||| 
Slc34a2a         516 GACGTCCTAAGCTCAGCTTTCCAGCTTGTTGGAGGAAAAGCAGCAGGGGA    565 
 
Slc34a2b         346 CATCTTTAAAGATAATGCGGTGCTGTCCAACCCTGTGGCCGGGCTGGTGA    395 
                     |||.||..|.||.|||..||||||.||.||.|||.||||.||.|||||.| 
Slc34a2a         566 CATTTTCCAGGAGAATAAGGTGCTCTCAAATCCTTTGGCAGGCCTGGTTA    615 
 
Slc34a2b         396 TCGGGGTGCTGGTCACGGTTCTAGTCCAGAGCTCCAGCACCTCCTCCTCC    445 
                     |||||.||||||||||..|..||||||||||.||||||||.|||||.||. 
Slc34a2a         616 TCGGGATGCTGGTCACTCTGTTAGTCCAGAGTTCCAGCACATCCTCATCT    665 
 
Slc34a2b         446 ATCGTGGTCAGCATGGTATCGTCTGGATTGCTGGAGGTGAAGTCAGCAGT    495 
                     ||.||||||||||||||.||.||||||.||||||||||.....|.||.|| 
Slc34a2a         666 ATTGTGGTCAGCATGGTCTCTTCTGGAATGCTGGAGGTCGCAACTGCTGT    715 
 
Slc34a2b         496 GCCTATCATCATGGGTGCAAATATCGGCACTTCAGTAACAAACACTATTG    545 
                     .||.|||||.|||||..||||.||||||||.||.||.||.||||||.||| 
Slc34a2a         716 TCCCATCATTATGGGCACAAACATCGGCACATCCGTCACCAACACTCTTG    765 
 
Slc34a2b         546 TGGCCGTGATGCAAGCTGGAGACCGCAATGAGTTTCGCAGGGCTTTTGCG    595 
                     |.|||.|....||||.|||.|||.|.||..||||.||.|||||.|||||. 
Slc34a2a         766 TAGCCATTGCACAAGTTGGGGACAGGAACAAGTTCCGTAGGGCATTTGCA    815 
 
Slc34a2b         596 GGGGCGACGGTGCATGACTTCTTCAACTGGCTGTCGGTGCTGGTGCTCCT    645 
                     ||.||.||.||||||||.|||||.||||||||.||.||.||.|||||.|| 
Slc34a2a         816 GGAGCCACTGTGCATGATTTCTTTAACTGGCTCTCAGTCCTAGTGCTACT    865 
 
Slc34a2b         646 GCCTCTGGAAGTGGCCTCAGGGATGCTCTACAGACTCACCAAACTTGTGA    695 
                     ||||||||||||||||||.||....||..|.|...|.||.|..||..|.. 
Slc34a2a         866 GCCTCTGGAAGTGGCCTCGGGTTACCTGGAGAAGGTTACGAGCCTCATCG    915 
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Slc34a2b         696 TCGATTCCTTCAACATCCAGACGGGCGCAGACGCTCCAGACCTGCTGAAA    745 
                     |....||.||.||||||.|||..||.|.|.|.||.||||..||.||.||. 
Slc34a2a         916 TGAGATCGTTTAACATCGAGAGTGGAGAAAAAGCACCAGCTCTCCTAAAT    965 
 
Slc34a2b         746 GTCATCACAGAGCCGCTCACCAAGAACATCATTGAGCTGGACACCTCTGT    795 
                     ||.|||||.||.|||||.|||.|....||||||.||||||||...||||| 
Slc34a2a         966 GTTATCACCGATCCGCTTACCCACTCAATCATTCAGCTGGACGAGTCTGT   1015 
 
Slc34a2b         796 GATTCGTGACATCGCCACTGGAGACCCTGCTGCCCGGAACAAAAGTTTGA    845 
                     |||..|.|.|||.||...|||.||.||.|..|||.|.||.|||..|.|.| 
Slc34a2a        1016 GATGAGCGGCATTGCGGTTGGCGATCCCGAAGCCAGAAATAAATCTCTTA   1065 
 
Slc34a2b         846 TCAAGATCTGGTGTAAAACGGAAAAAATTACGAACCTGGTGAACGTGACC    895 
                     |||||.|.|||||..|.||.|.....|..||||...|...|||.|||||| 
Slc34a2a        1066 TCAAGGTTTGGTGCCACACAGCCTCGAACACGACTGTCCAGAATGTGACC   1115 
 
Slc34a2b         896 GTCCCGGGAATCGCAAACTGCACTCCGGACGCCCTGTGCTGGGTGGATGG    945 
                              |...||||||||||      .|..||.||.||||        
Slc34a2a        1116 ---------ACAACAAACTGCAC------AGATCTTTGTTGGG-------   1143 
 
Slc34a2b         946 AGACTTGATCTGGACCCAAAAGAACCAAACCGATACCATCTACTTGAAGA    995 
                       |.||||            ||||....||.||.|..||..|..|.||.| 
Slc34a2a        1144 --AATTGA------------AGAATGTTACAGAAATTATAAATATTAAAA   1179 
 
Slc34a2b         996 AATGTACGCACATGTTCGTGTTTGCGGATCTGCCTGATCTGGCGGTGGGT   1045 
                     ||||.|..|||||.||||||....||...||..|.||.|||||||||||| 
Slc34a2a        1180 AATGCAGTCACATCTTCGTGAACACGAGCCTTTCGGACCTGGCGGTGGGT   1229 
 
Slc34a2b        1046 TTGATCCTGCTGGCTCTGTCTCTGCTGGCTCTCTGCACATGCCTGATCCT   1095 
                     .||||.||||||||....||||||||...|||.|||||.|||||.||... 
Slc34a2a        1230 CTGATTCTGCTGGCGGGTTCTCTGCTCATTCTGTGCACTTGCCTCATTTG   1279 
 
Slc34a2b        1096 CATAGTTAAACTCCTGAACTCCATGCTGAAGGGTCAGGTGGCCGTCGTCA   1145 
                     .||.||.||.||.|||||.||.|||||.|||||.|||||.||.||.||.| 
Slc34a2a        1280 TATTGTGAAGCTGCTGAATTCGATGCTCAAGGGACAGGTTGCTGTTGTGA   1329 
 
Slc34a2b        1146 TCAAAAAAGTGCTCAACACAGATTTCCCCTTCCCCTTCGCCTGGGTTACA   1195 
                     ||||.||..|..|.||||||||||||||.||.||.||.||.|||.|.||. 
Slc34a2a        1330 TCAAGAAGATAGTGAACACAGATTTCCCTTTTCCATTTGCTTGGCTGACT   1379 
 
Slc34a2b        1196 GGATACCTGGCCATCCTCGTGGGAGCCGGAATGACCTTCATTGTTCAGAG   1245 
                     |||||..|.||.||.||.||.||.||.||||||||.||.|||||.||||| 
Slc34a2a        1380 GGATATATTGCAATTCTGGTTGGTGCGGGAATGACTTTTATTGTCCAGAG   1429 
 
Slc34a2b        1246 CAGCTCCGTCTTCACCTCCGCCATCACTCCTCTAGTCGGTATTGGTGTGA   1295 
                     |||.|||||||||||.||.||.||.||||||||.||.|||||.|||||.| 
Slc34a2a        1430 CAGTTCCGTCTTCACATCGGCTATAACTCCTCTTGTTGGTATCGGTGTTA   1479 
 
Slc34a2b        1296 TCAGTTTGGAGAGAGCATATCCACTCACACTGGGCTCCAACATCGGCACA   1345 
                     |.|||.|.||.||.||||||||.||..|.|||||.|||||.||.||.||| 
Slc34a2a        1480 TAAGTATTGAAAGGGCATATCCTCTATCCCTGGGATCCAATATTGGAACA   1529 
 
Slc34a2b        1346 ACCACCACTGCTATACTGGCGGCCATGGCCAGTCCTGGAGAAACACTGGC   1395 
                     ||.||.|||||.|||.|.||.||||||||.||||||||.||||||||.|. 
Slc34a2a        1530 ACTACTACTGCAATATTAGCCGCCATGGCTAGTCCTGGTGAAACACTTGG   1579 
 
Slc34a2b        1396 CAACTCGCTACAGATTTCTCTGTGTCACTTCTTTTTCAACATCGCTGGTA   1445 
                     .|||||..||||||||.|..||..|||||||||.||||||.|..|.||.| 
Slc34a2a        1580 AAACTCATTACAGATTGCATTGGTTCACTTCTTCTTCAACTTATCCGGGA   1629 
 
Slc34a2b        1446 TCCTGCTGTGGTACCCCATCCCCTTCACACGTGTGCCCATCCGACTGGCC   1495 
                     |..||.||||||||||.||||||.||||||||.|.||||||||||||||. 
Slc34a2a        1630 TATTGTTGTGGTACCCAATCCCCATCACACGTATCCCCATCCGACTGGCA   1679 
 
Slc34a2b        1496 AAAGCGCTGGGCAACCGTACAGCTAAATACCGCTGGTTCGCGGGCCTGTA   1545 
                     ||.|..||.||..|....|||||..|.|||||.|||||.||.|.|.|.|| 
Slc34a2a        1680 AAGGGTCTTGGTGAAACAACAGCCCAGTACCGTTGGTTTGCAGCCTTTTA   1729 
 
Slc34a2b        1546 TCTCATTCTCTGCTTTCTGCTGTTTCCGTTGACCG-TCCTGGGACTCTCC   1594 
                     ..||||.||.||||| ||.|.||||.|.|..||.| ||.|.||.|||||. 
Slc34a2a        1730 CATCATCCTTTGCTT-CTTCGGTTTGCCTCTACTGGTCTTTGGTCTCTCT   1778 
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Slc34a2b        1595 ATTGCAGGATGGCAGGTCCTGGTGGGCATCGGGGTGCCAGTGTTGGTGCT   1644 
                     ||.||.||.||||||||.||..||||..|....||.||..|...|||..| 
Slc34a2a        1779 ATGGCCGGCTGGCAGGTACTCATGGGAGTTCTTGTCCCCATAGCGGTTAT   1828 
 
Slc34a2b        1645 CGCCATCTTTGTGATTGTGGTGAACGTCATGCAGAAACGATGCCCTCGCT   1694 
                     ....|||||.|..||..|.||.|||.|..|||||||.|.....||||..| 
Slc34a2a        1829 TCTGATCTTCGCCATCATTGTCAACATTCTGCAGAAGCACAAACCTCAAT   1878 
 
Slc34a2b        1695 TTCTGCCCTCGTTCATCCGCAGTTGGGAGTTTCTGCCCAAACCGCTGCAC   1744 
                     ..||.||.||.....||||...||||||.||.||.||...|..|...||| 
Slc34a2a        1879 GGCTTCCTTCTGCTCTCCGGTCTTGGGATTTCCTTCCTCTATGGGCTCAC   1928 
 
Slc34a2b        1745 TCTCTGAAGCCCTGGGACCGAGTGGTGACTGCGGGAATGAGCTTCTGCAG   1794 
                     |||||..|.||.||||||.||||.||.||||.         |.| |||.| 
Slc34a2a        1929 TCTCTTGATCCATGGGACAGAGTAGTCACTGT---------CAT-TGCCG   1968 
 
Slc34a2b        1795 GACTCGCTGCTGCTGCTGCTGTAAATGCTGCAGAAATGAAGAGAAAAACC   1844 
                       |.|||||.|||||.|||||.||.|||||||....|.|.||..||.|.. 
Slc34a2a        1969 --CCCGCTGTTGCTGTTGCTGCAAGTGCTGCAATTCTAATGAAGAAGATG   2016 
 
Slc34a2b        1845 ACATGGAGAA   1854 
                     |.|.||.||| 
  Slc34a2a        2017 AGAAGGCGAA   2026 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.0 CLUSTAL O(1.2.1) multiple sequence alignment 
 
     1: Slc34a2b    100.00        67.45     55.85 
     2: Slc34a2a     67.45      100.00  72.41 
     3: Antisense    55.85       72.41   100.00 
 
 
 
Slc34a2b       ------------------------------------------------------------ 
Slc34a2a       agccactctgaagaacagcacagctgagtctggatctgaacgtggtctccatcagcacca 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       ------------------------------------------------------------ 
Slc34a2a       gtgcttctgctcaggccaggactgaaggaaacagaagtgcatagagttcaggaaagactg 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       ------------------------------------------------------------ 
Slc34a2a       ttggaggagagatacgcttcagactgtagataagtcactgagctcaaaagcaggtgaaac 
Antisense      ------------------------------------------------------------ 
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Slc34a2b       ------------------------------------caggc----------tgatggctc 
Slc34a2a       gtagagtgaacagaagtgttgcacgtgaaattcagaagggcagaagcaacttgattacat 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       ctctggctgagactcatcccgcctcgc-cgccaccggaactcggagcggacgcggacaaa 
Slc34a2a       ctcggacaatggcacc-------acgtccaaagcatgagcatgaatctgacgaaaaacaa 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       catgagccccaaacc----ccgacgcgcaccctcagtccctggcccgcgcagcagtggga 
Slc34a2a       ccagaaacacttgacggtgccagaaagaagtctctgtctatggctccggctgtttctaca 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       gccggagcaggaggaagaggtggacccgtgggagctgccggagctcctggacaccggggt 
Slc34a2a       -gcggct---ctgattgaggatgatccctgggaaatgatggagctgcaggacaccggggt 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       gaagtggtcagagttggaccggcgcggaaaggtcctgcgggtctgcacctctgtcctgaa 
Slc34a2a       gaaatgggcagatctggacactaaaaagaaggtcctgagagtttttactacagcagcaaa 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       gttgctgctgctgctcggcctgctctacatgttcgtctgctccctggacatcctcagctc 
Slc34a2a       actgatcatgctgcttggtttgctctacatgtttgtttgctctctggacgtcctaagctc 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       tgctttccagctggtcggagggaaggcagcgggggacatctttaaagataatgcggtgct 
Slc34a2a       agctttccagcttgttggaggaaaagcagcaggggacattttccaggagaataaggtgct 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       gtccaaccctgtggccgggctggtgatcggggtgctggtcacggttctagtccagagctc 
Slc34a2a       ctcaaatcctttggcaggcctggttatcgggatgctggtcactctgttagtccagagttc 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       cagcacctcctcctccatcgtggtcagcatggtatcgtctggattgctggaggtgaagtc 
Slc34a2a       cagcacatcctcatctattgtggtcagcatggtctcttctggaatgctggaggtcgcaac 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       agcagtgcctatcatcatgggtgcaaatatcggcacttcagtaacaaacactatt----- 
Slc34a2a       tgctgttcccatcattatgggcacaaacatcggcacatccgtcaccaaca--ctctt--- 
Antisense      -------------------------------------------acatacacacacatttt 
                                                          **.:***  .:       
 
Slc34a2b       ---gtggccgtgatgc--aagctggagaccgcaatg--agttt----cgcagggcttttg 
Slc34a2a       ---gtagccat--tgcacaagttggggacaggaacaa--gttccgta----gggcatttg 
Antisense      aataaagccacattaaacagtatttgatctaaaacagaaatacagtatatatgtaactta 
                  .:.***.   *..  *.  *  ..:* . ** .   .*:          * .: **. 
 
Slc34a2b       cggg------ggc--gacggtgcatg---------acttcttcaactggctgtcggtgct 
Slc34a2a       cag------gagcc--actgtgcatg---------atttctttaactggctctcagtcct 
Antisense      cagtaataaaggccgtactgtgtattaccatcataactactaataaggacttttata--t 
               *.*       .**   ** *** **          * *:**: :*. *.** * . :  * 
 
Slc34a2b       ggtgctcctgcctctggaagtggcctcagggatgctctaca---------gactcaccaa 
Slc34a2a       agtgctactgcctctggaagtggcctcgggttacctggagaaggttacgagcctca---- 
Antisense      atattttttacctttta--aaatccact--ttatctg-----------atgccaca---- 
               . :  *  *.*** * .  .:. **:*    :: **              *.*:**     
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Slc34a2b       acttgtgatcgattccttcaacatccagacgggcgcagacgctccagacctgctgaaagt 
Slc34a2a       tcgtgagatc-----gtttaacatcgagagtggagaaaaagcaccagctctcctaaatgt 
Antisense      gcgga--cac-----tttgaac--catg--------cacagcacacacacac--acatgc 
                *  .  .:*      ** ***  * :*        ....**:*.... *:   ..*:*  
 
Slc34a2b       catcac--agagccg------ctcaccaagaacatcattgagctggacacct-------- 
Slc34a2a       tat--caccgatc------cgcttacccactcaatcattcagctggacgag--------t 
Antisense      acacacgcagacacacacacacacacacacacagacaaacttcctgtcgcagagagttat 
                .:  *  .** .        *: **..* :...:**:: : *  *:*..           
 
Slc34a2b       -----ctgtgat-------------------tcgt---gacatcgccactggagaccctg 
Slc34a2a       -----ctgtgatga-----------g-----------cggcattgcggttggcgatcccg 
Antisense      cagtcccgtggtaaaccttggaacaggggaatcctggatgatctgcggagggctata--a 
                    * ***.*                           ..:  ** .  **. * .  . 
 
Slc34a2b       ctgcccggaacaaaagtttgatcaagatctggtgtaaaacggaaaaaa-ttac----gaa 
Slc34a2a       aagccagaaataaatctcttatcaaggtttggtgccacacagcctcg-aacacgact--- 
Antisense      atgcctgtgacccaacagag---gccgaactgagccactctgaagaacagcacagctgag 
               .:*** * .* ..*: : :    .. .:   *:* .*.:* *.. ..    **        
 
Slc34a2b       cctgg---tgaacgtgaccgtcccgggaatcgcaaactgcact---ccggacgccctgtg 
Slc34a2a       ----gtccagaatgtgacc------------acaaca-----------aactgcacagat 
Antisense      tctggatctgaacgtggtc------------tccatcagcaccagtgcttctgctcaggc 
                   *   :*** ***. *             *.* .             . ** *:*   
 
Slc34a2b       ctgggtggatggagacttgatctggacccaaaagaaccaaaccgataccatctacttgaa 
Slc34a2a       ctttgttg----ggaattg------------aagaatgttacagaaattataaatattaa 
Antisense      cag---------gatctt---------------------ttatg--ttgttctctattca 
               *:          ..:.**                     ::. *  :  :*.:. :* .* 
 
Slc34a2b       gaaatgtacgcacatgttcgtgtttgcggatctgcctgatctggcggtgggtttgatcct 
Slc34a2a       aaaatgcagtcacatcttcgtgaacacgagcctttcggacctggcggtgggtctgattct 
Antisense      cacaggcagtcacatcttcgtgaacacgagcctttcggacctggcggtgggtctgattct 
                *.* * *  ***** ******:: .**.. **  * ** ************ **** ** 
 
Slc34a2b       gctggctctgtctctgctggctctctgcacatgcctgatcctcatagttaaactcctgaa 
Slc34a2a       gctggcgggttctctgctcattctgtgcacttgcctcatttgtattgtgaagctgctgaa 
Antisense      gctggcgggttctctgctcattctgtgcacttgcctcatttgtattgtgaagctgctgaa 
               ******    ******** . *** *****:***** **    **:** **.** ***** 
 
Slc34a2b       ctccatgctgaagggtcaggtggccgtcgtcatcaaaaaagtgctcaacacagatttccc 
Slc34a2a       ttcgatgctcaagggacaggttgctgttgtgatcaagaagatagtgaacacagatttccc 
Antisense      ttcgatgctcaagggacaggttgctatag------------------------------- 
                ** ***** *****:***** ** .* *                                
 
Slc34a2b       cttccccttcgcctgggttacaggatacctggccatcctcgtgggagccggaatgacctt 
Slc34a2a       ttttccatttgcttggctgactggatatattgcaattctggttggtgcgggaatgacttt 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       cattgttcagagcagctccgtcttcacctccgccatcactcctctagtcggtattggtgt 
Slc34a2a       tattgtccagagcagttccgtcttcacatcggctataactcctcttgttggtatcggtgt 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       gatcagtttggagagagcatatccactcacactgggctccaacatcggcacaaccaccac 
Slc34a2a       tataagtattgaaagggcatatcctctatccctgggatccaatattggaacaactactac 
Antisense      ------------------------------------------------------------ 
                                                                           
Slc34a2b       tgctatactggcggccatggccagtcctggagaaacactggccaactcgctacagatttc 
Slc34a2a       tgcaatattagccgccatggctagtcctggtgaaacacttggaaactcattacagattgc 
Antisense      -------------------------------------------------------attgc 
                                                                      *** * 
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Slc34a2b       tctgtgtcacttctttttcaacatcgctggtatcctgctgtggtaccccatccccttcac 
Slc34a2a       attggttcacttcttcttcaacttatccgggatattgttgtggtacccaatccccatcac 
Antisense      attggttcacctcttcttcaacttatccgggatattgttgtggtacccaatccccatcac 
               : **  **** **** ******:*. * ** **. ** **********.******:**** 
 
Slc34a2b       acgtgtgcccatccgactggccaaagcgctgggcaaccgtacagctaaataccgctggtt 
Slc34a2a       acgtatccccatccgactggcaaagggtcttggtgaaacaacagcccagtaccgttggtt 
Antisense      acgtatccccatccgactggcaaagggtcttggtgaaacaacagcccagtaccgttggtt 
               ****.* **************.**.*  ** ** .*.. :***** .*.***** ***** 
 
Slc34a2b       cgcgggcctgtatctcattctctgctttctgctgtt-tccgttgaccgtcctgggactct 
Slc34a2a       tgcagccttttacatcatcctttgcttc-ttcggtttgcctctactggtctttggtctct 
Antisense      tgcagccttttacatcatcctttgcttc-ttcggtttgcctctactggtctttggtctct 
                **.* * * ** .**** ** *****  * * ***  **  *..  *** * **:**** 
 
Slc34a2b       ccattgcaggatggcaggtcctggtgggcatcggggtgccagtg---------ttggtgc 
Slc34a2a       ctatggccggctggcaggtactcatgggagttcttgtccccatagcggttattctgatct 
Antisense      ctatggccggctggcaggtactcatgggagttcttgtccccatagcggttattctgatct 
               * ** **.**.********.** .****..*    ** **..*.          **.*   
 
Slc34a2b       tcgccatctttgtgattgtggtgaacgtcatgcagaaacgatgccctcgctttctgccct 
Slc34a2a       tcgccatcattgt---------caacattctgcagaagcacaaacctcaatggcttcctt 
Antisense      tcgccatcattgt---------caacattctgcagaagcacaaacctcaatggcttcctt 
               ********:****          ***.* .*******.*..:..****..*  ** ** * 
 
Slc34a2b       cgttcatccgcagttgggagtttctgcccaaaccgctgcactctctgaagccctgggacc 
Slc34a2a       ctgctctccggtcttgggatttccttcctctatgggctcactctcttgatccatgggaca 
Antisense      ctgctctccggtcttgggatttccttcctctatgggctcactctcttgatccatgggaca 
               *    .**** : ****** ** ** ** .:*  *   ******** .* **.******. 
 
Slc34a2b       gagtggtgactgcgggaatgagcttctgcaggactcgctgctgctgctgctgtaaatgct 
Slc34a2a       gagtagtcactgtcat----------tgc--cgcccgctgttgctgttgctgcaagtgct 
Antisense      gagtagtcactgtcat----------tgc--cgcccgctgttgctgttgctgcaagtgct 
               ****.** ****  .           ***   .* ***** ***** ***** **.**** 
 
Slc34a2b       gcagaaatgaagagaaaaa--------c-cacatggagaacaacgac--aggagcctgga 
Slc34a2a       gcaattctaatgaagaagatgagaaggcgaaacttgaaaatttggccaatggaatcgaga 
Antisense      gcaattcttaaccatcttcttggt---cctcccaggagtcccagcacactgc----agaa 
               ***.::.* *: .. .: .        *  ...: **.:.  :  .*  :*      ..* 
 
Slc34a2b       gatgt---acgacaatccag-------------------cactcgg-tatagaggacg-a 
Slc34a2a       taaatgataatacgatgacg-accgttgaaatcatagagcccaagaaaacagtggacagt 
Antisense      taaatatttcctcagtgaagcaacactgccatcttaa----------aaca--------- 
                *:.*   :. :*..* ..*                           :* *          
 
Slc34a2b       ggctaaa--gtgactg---ccacacatttataatgctacatggactccattttaatttat 
Slc34a2a       tgcgaaatcctgaaggcaacatctt-tat----agatgcatacaaagcatt------at- 
Antisense      ggctttatactgaaggaatggtcgcatat----ggatgatttctctgagat-----tga- 
                ** ::*   ***. *     :*   *:*     *.*..:*  :.: ..:*       :  
 
Slc34a2b       gcaagtcgtgttttgatgatcgcagggtgaagc------accatgactttttaagctgct 
Slc34a2a       ---a---ggttattattaaaca-------tatctaaatcaaactggctttga------tt 
Antisense      ---aggagggtctatataagaatatgtagtaatatcatcactctagctcatt------cc 
                  *   *  * *: :*.* ..       :*        *. .*..** : :         
 
Slc34a2b       attggtttttagtttggttataatgc---------------------------------- 
Slc34a2a       tttggtacccagagttgacagtatgcaata-tcagtggactttaaagagtttatgtcact 
Antisense      --tga---atggaggagtcttgttgcaaccgtccgtc-----------------cccact 
                 **.     .*:   *: :  :***                                   
 
Slc34a2b       ------------------------------tgcat------------------------- 
Slc34a2a       ctgtatttcttaaattaattttttttatacagcaatgctatttttataggacattgtaaa 
Antisense      ctccctacct-------------tttgatctgctcc------------------------ 
                                             :**:                           
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Slc34a2b       ------------------------------------------------------------ 
Slc34a2a       tgttgcaatatatttaaatatacaatcttatgttacacactgtgagatct--ggtgattg 
Antisense      ---------------------------------------acgtcagatctccatttcctg 
                                                                            
 
Slc34a2b       ------------------------------------------------------------ 
Slc34a2a       ttgtcgtacttgttccagtgtgaaaaggatacttgttt----atttttaataccattcgg 
Antisense      gtgtcggt------cctcagtgctcgggtctccttccttccagaaatgtttttctcacgg 
                                                                            
 
Slc34a2b       ------------------------------------------------------------ 
Slc34a2a       aggatataaaagccaaagacaaatatatattcagatttaaataagacgtcaaccctgatc 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       ------------------------------------------------------------ 
Slc34a2a       tgtgcattgttctttattcatgataatgttcttgtatttatgtcaaatattttaacatgt 
Antisense      ------------------------------------------------------------ 
                                                                            
 
Slc34a2b       --------------------------------------------------- 
Slc34a2a       gcctttctatactgtaaaatattattatgatattaaacaataatttcctgc 
Antisense      --------------------------------------------------- 
                                                                   
 
 
3.0 EMBOSS matcher: pairwise nucleotide sequence alignment of Slc34a2a 
sense and antisense (Waterman-Eggert local alignment) 
 
      
58.7 % nucleotide sequence similarity (88/150) 
 
 
Slc34a2a        2436 GAGGATATAAAAGCCAAAGACAAATATATA----TTCAGATT--TAAATA   2479 
                     |.||||.|.|||....||.|.|.|||||||    |.|..|||  ||..|| 
Slc34a2a(as)    1192 GTGGATTTTAAAAGGTAAAAAATATATATAAAAGTCCTTATTAGTAGTTA   1241 
 
Slc34a2a        2480 AGACGTCAACCCTGA-TCTGTGCATTGTT-CTTTA---TTCATG-ATAAT   2523 
                     .||.|..||..|..| |..|..|.||.|| ||.||   |.|||. |||.| 
Slc34a2a(as)    1242 TGATGGTAATACACAGTACGGCCTTTATTACTGTAAGTTACATATATACT   1291 
 
Slc34a2a        2524 GTTCTTGTATTTATG-TCAAATATTTTAACATGTGCCTTTCT-ATACTGT   2571 
                     ||..||.|.|||..| |||||||.|.|...|||||.||||.| |.|.||| 
Slc34a2a(as)    1292 GTATTTCTGTTTTAGATCAAATACTGTTTAATGTGGCTTTATTAAAATGT   1341 
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4.0 EMBOSS needle: pairwise nucleotide sequence alignment of Slc34a2b and 
Slc34a2a(as) (Needleman-Wunsch global alignment) 
 
      
37.7% nucleotide sequence similarity  
 
 
slc34a2a(as)       1 --------------------------------------------------      0 
                                                                        
slc34a2b           1 caggctgatggctcctctggctgagactcatcccgcctcgccgccaccgg     50 
 
slc34a2a(as)       1 --------------------------------------------------      0 
                                                                        
slc34a2b          51 aactcggagcggacgcggacaaacatgagccccaaaccccgacgcgcacc    100 
 
slc34a2a(as)       1 ---------------------ccgtgagaaaaacatttctgga--aggaa     27 
                                          |.|||.||        .|.|||  ||| | 
slc34a2b         101 ctcagtccctggcccgcgcagcagtggga--------gccggagcagg-a    141 
 
slc34a2a(as)      28 gga-------gaccc----gagc--actgaggacc--gacaccag---ga     59 
                     |||       |||||    ||||  .|.|||..||  ||||||.|   || 
slc34a2b         142 ggaagaggtggacccgtgggagctgccggagctcctggacaccggggtga    191 
 
slc34a2a(as)      60 aatggagatctgacgtgga-----gcagatcaaaaggtagggagagtggg    104 
                     |.|||   ||.||..||||     ||.|    ||||||             
slc34a2b         192 agtgg---tcagagttggaccggcgcgg----aaaggt------------    222 
 
slc34a2a(as)     105 gacggacggt-tgcaacaagactcctccattcaggaatgagctagag-tg    152 
                      .|.|..||| ||||        ||||          ||..||..|| || 
slc34a2b         223 -cctgcgggtctgca--------cctc----------tgtcctgaagttg    253 
 
slc34a2a(as)     153 atgatatt-----------actacatattcttat-----atagac--cct    184 
                     .||.|..|           .||||||.|||.|.|     .|.|||  ||| 
slc34a2b         254 ctgctgctgctcggcctgctctacatgttcgtctgctccctggacatcct    303 
 
slc34a2a(as)     185 --------ccttcaa-----tctcagagaaatcatc------cat-----    210 
                             |.|||.|     ||..||.|||..||.|      |||      
slc34a2b         304 cagctctgctttccagctggtcggagggaaggcagcgggggacatcttta    353 
 
slc34a2a(as)     211 ------atgc------gaccattccttcagtataaagc----ctgtttta    244 
                           ||||      |.|||..|||   ||    .||    |||.|    
slc34a2b         354 aagataatgcggtgctgtccaaccct---gt----ggccgggctggt---    393 
 
slc34a2a(as)     245 agatggcagtgttgcttcactgaggaaatatttattct------------    282 
                      |||.|..|||.|| .||||.|            ||||             
slc34a2b         394 -gatcggggtgctg-gtcacgg------------ttctagtccagagctc    429 
 
slc34a2a(as)     283 --gca--------------gtg-------tg-------ctgggactcctg    302 
                       |||              |||       ||       || |||.|.||  
slc34a2b         430 cagcacctcctcctccatcgtggtcagcatggtatcgtct-ggattgct-    477 
 
slc34a2a(as)     303 ggaggaccaagaag------------------atggttaagaattgcagc    334 
                     |||||    .||||                  ||||.|...|||..|.|| 
slc34a2b         478 ggagg----tgaagtcagcagtgcctatcatcatgggtgcaaatatcggc    523 
 
slc34a2a(as)     335 acttgcagcaacagcaac--------------------agcggg---cgg    361 
                     |||| |||.||||  |||                    |||.||   |.| 
slc34a2b         524 actt-cagtaaca--aacactattgtggccgtgatgcaagctggagaccg    570 
 
slc34a2a(as)     362 caatga------cag------------------------tgactact---    378 
                     ||||||      |||                        |||||.||    
slc34a2b         571 caatgagtttcgcagggcttttgcgggggcgacggtgcatgacttcttca    620 
 
slc34a2a(as)     379 -----ctgt-----------------cccatgga----------------    390 
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                          ||||                 ||..||||                 
slc34a2b         621 actggctgtcggtgctggtgctcctgcctctggaagtggcctcagggatg    670 
 
slc34a2a(as)     391 -tcaagaga------------gtgagc----ccat--------aga-gga    414 
                      ||.|.|||            ||||.|    ||.|        ||| ||. 
slc34a2b         671 ctctacagactcaccaaacttgtgatcgattccttcaacatccagacggg    720 
 
slc34a2a(as)     415 aggaaa---tcccaagaccgg--------------agagcag------aa    441 
                     .|.|.|   |||  |||||.|              |||||.|      || 
slc34a2b         721 cgcagacgctcc--agacctgctgaaagtcatcacagagccgctcaccaa    768 
 
slc34a2a(as)     442 ggaagccattgag--------gtttgtgctt-------------ctgcag    470 
                     |.|...|||||||        .|.||||.||             |||.|| 
slc34a2b         769 gaacatcattgagctggacacctctgtgattcgtgacatcgccactggag    818 
 
slc34a2a(as)     471 a--atgttg------acaa-----tgatggcgaagatc------------    495 
                     |  .||.||      ||||     ||||   .||||||             
slc34a2b         819 accctgctgcccggaacaaaagtttgat---caagatctggtgtaaaacg    865 
 
slc34a2a(as)     496 ---agaat----aaccgctatgg-ggacaagaac-tcccatgagt----a    532 
                        |.|||    ||||    ||| |.||..||.| ||||..||.|    | 
slc34a2b         866 gaaaaaattacgaacc----tggtgaacgtgaccgtcccgggaatcgcaa    911 
 
slc34a2a(as)     533 cctgccagccggcc----------------atagaga---------gacc    557 
                     .||||...||||.|                ||.||||         |||| 
slc34a2b         912 actgcactccggacgccctgtgctgggtggatggagacttgatctggacc    961 
 
slc34a2a(as)     558 --aaagaccagtagaggcaaacc--------------gaagaa------g    585 
                       |||||.|        ||||||              ||||||      | 
slc34a2b         962 caaaagaac--------caaaccgataccatctacttgaagaaatgtacg   1003 
 
slc34a2a(as)     586 caaaggatgatgtaaaagg--ctgcaaaccaacggtactg----ggctgt    629 
                     ||.|.|.|..|||....||  ||||            |||    |||.|| 
slc34a2b        1004 cacatgttcgtgtttgcggatctgc------------ctgatctggcggt   1041 
 
 
 
slc34a2a(as)     630 -tgtttcaccaagaccct--ttgc-cagtcggatggggatacgtgtgatg    675 
                      .||||      ||.|||  |.|| |.|||             |.||.|| 
slc34a2b        1042 gggttt------gatcctgctggctctgtc-------------tctgctg   1072 
 
slc34a2a(as)     676 gggat-tgggtaccacaacaatatcccggat-----aagttgaa------    713 
                     |...| ||     |||      ||.||.|||     .||||.||       
slc34a2b        1073 gctctctg-----cac------atgcctgatcctcatagttaaactcctg   1111 
 
slc34a2a(as)     714 -----------gaag----aggtg-------------aaccaatg--caa    733 
                                ||||    |||||             ||..|.||  ||| 
slc34a2b        1112 aactccatgctgaagggtcaggtggccgtcgtcatcaaaaaagtgctcaa   1161 
 
slc34a2a(as)     734 --------tc--------------------tatagca-acctgtccct--    752 
                             ||                    ||.||.| |||||.||.|   
slc34a2b        1162 cacagatttccccttccccttcgcctgggttacaggatacctggccatcc   1211 
 
slc34a2a(as)     753 ---------------tgagcatcgaatt-----cagcag------cttca    776 
                                    |||.|.||  |||     .|||||      ||||| 
slc34a2b        1212 tcgtgggagccggaatgaccttc--attgttcagagcagctccgtcttca   1259 
 
slc34a2a(as)     777 caatacaaatgaggcaa-----------------------gtgcacagaa    803 
                     | .|.|       ||.|                       |||..|||.. 
slc34a2b        1260 c-ctcc-------gccatcactcctctagtcggtattggtgtgatcagtt   1301 
 
slc34a2a(as)     804 t-gagcagag---aacc------------cgccagcagaatcagacccac    837 
                     | ||| ||||   |.||            |.|||.||....||.|.|||| 
slc34a2b        1302 tggag-agagcatatccactcacactgggctccaacatcggcacaaccac   1350 
 
slc34a2a(as)     838 c---------------------gccaggtcc----gaaa----gg----c    854 
                     |                     |||| ||||    ||||    ||    | 
slc34a2b        1351 cactgctatactggcggccatggcca-gtcctggagaaacactggccaac   1399 
 
slc34a2a(as)     855 tcg-------------tgt-tcac--------gaagat-gtgactg----    877 
                     |||             ||| ||||        .||.|| |   |||     
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slc34a2b        1400 tcgctacagatttctctgtgtcacttctttttcaacatcg---ctggtat   1446 
 
slc34a2a(as)     878 cctg-tgtgaatagagaacaacat-------aaaag-------atcctgg    912 
                     |||| ||||      |.||..|||       |.|.|       ||||  | 
slc34a2b        1447 cctgctgtg------gtaccccatccccttcacacgtgtgcccatcc--g   1488 
 
slc34a2a(as)     913 cctgagcagaagcactg-------gtgctgatggagaccac--gttcag-    952 
                     .||| ||..||||.|||       ||.|.|.|..|.|||.|  |||| |  
slc34a2b        1489 actg-gccaaagcgctgggcaaccgtacagctaaataccgctggttc-gc   1536 
 
slc34a2a(as)     953 --------atc-cagactcagc--tgtgctgt------------------    973 
                             ||| ||..|||.||  |.||||||                   
slc34a2b        1537 gggcctgtatctcattctctgctttctgctgtttccgttgaccgtcctgg   1586 
 
slc34a2a(as)     974 ---tcttca------gagtggctcagttc------ggcctc---------    999 
                        |||.||      || |||  |||.||      |||.||          
slc34a2b        1587 gactctccattgcagga-tgg--caggtcctggtgggcatcggggtgcca   1633 
 
slc34a2a(as)    1000 -tgttgg-----------------------------gtca--cag-----   1012 
                      ||||||                             ||||  |||      
slc34a2b        1634 gtgttggtgctcgccatctttgtgattgtggtgaacgtcatgcagaaacg   1683 
 
slc34a2a(as)    1013 --------gcatttatagccctccgcagatcatcc------aggattccc   1048 
                             || |||.| ||||||    |.||||||      .|||      
slc34a2b        1684 atgccctcgc-tttct-gccctc----gttcatccgcagttggga-----   1722 
 
slc34a2a(as)    1049 ctgtt-----ccaaggtttaccacgggactgataactct------ctgcg   1087 
                       |||     ||||     |||.|.|.|||     ||||      |||.| 
slc34a2b        1723 --gtttctgcccaa-----accgctgcact-----ctctgaagccctggg   1760 
 
slc34a2a(as)    1088 acaggaagtttgtctgtgtgtgtgtgtgtgtgtgtgtctgcgtg------   1131 
                     ||.|  |||       .|||..||.|.|..||.|..|||||..|       
slc34a2b        1761 accg--agt-------ggtgactgcgggaatgagcttctgcaggactcgc   1801 
 
slc34a2a(as)    1132 tg-tgcatgtgtgtgtgtg-tgctgtgcatggttca-aagtgtccgctgt   1178 
                     || |||           || ||||||..|||.|.|| ||.||         
slc34a2b        1802 tgctgc-----------tgctgctgtaaatgctgcagaaatg--------   1832 
 
slc34a2a(as)    1179 ggcatcagataaa----gtggattttaaaaggtaaaaa------------   1212 
                        |..|||.|||    .||||          .||.||             
slc34a2b        1833 ---aagagaaaaaccacatgga----------gaacaacgacaggagcct   1869 
 
slc34a2a(as)    1213 --atatatataaaagtccttattagtagttat-------gatggtaatac   1253 
                       |.||.||..|.|.|||  |..|.|.|.|||       ||.|.|||    
slc34a2b        1870 ggagatgtacgacaatcc--agcactcggtatagaggacgaggctaa---   1914 
 
slc34a2a(as)    1254 acagt-acggcc-----tttattactgtaa-gttacat------------   1284 
                       ||| ||.|||     ||||      ||| |.|||||             
slc34a2b        1915 --agtgactgccacacattta------taatgctacatggactccatttt   1956 
 
slc34a2a(as)    1285 -atatactgtatttc-tgtttt--agatc--------aa-----at-act   1316 
                      ||.|| ||.|..|| ||||||  .||||        ||     || ||| 
slc34a2b        1957 aattta-tgcaagtcgtgttttgatgatcgcagggtgaagcaccatgact   2005 
 
slc34a2a(as)    1317 gtttaa--tg----tggcttt-------attaaaatgtgtgtgtatgt   1351 
                     .|||||  ||    |||.|||       .|||.||||   .||.||   
slc34a2b        2006 ttttaagctgctattggtttttagtttggttataatg---ctgcat--   2048 
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Appendix B 
 
Video recordings demonstrating reactions of wildtype and injected embryos to the 
‘poke’ test are located on CD-ROM.  
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Appendix C 
 
The complimentary sequences of Slc34a2a sense/antisense from exons 10 and 13 
were compared to coding and non-coding zebrafish transcripts using BLAST. Hits 
with a minimal length of 15 nucleotides and 95% identity were further investigated. 
Moreover, matching seed regions were required. Below are the raw hits of this 
search:  
A) Non-coding RNA genes matching to exon 10 
B) Non-coding RNA genes matching to exon 13 
C) cDNA and splice variants 
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